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Abstract 
The synthesis of the N7-methylguanosine cap at the 5’ end of pre-mRNA occurs 
co-transcriptionally and is catalysed by a series of enzymes including the N7 
RNA methyltransferase (RNMT), which along with its recently discovered 
activating subunit RAM, methylates the cap. RAM, which contains an RNA 
binding domain, is required to promote RNMT activity both in vitro and in vivo. 
Although the biochemical function of RAM has been characterized, its biological 
relevance remains elusive to date. The addition of the cap moiety is a crucial 
event in gene expression as it affects several processes within the mRNAs life 
cycle including mRNA processing, stability and translation. In stem cells, every 
step of mRNA metabolism is tightly regulated to maintain the undifferentiated 
state, allowing the expression of pluripotency genes and the concomitant 
repression of the lineage-specific ones. Here, I describe a critical role for the 
mRNA cap methylation in the maintenance of pluripotency. RNMT and RAM are 
highly expressed in mESCs compared to differentiated cells. The 
reprogramming of MEFs to iPS totally restores the elevated expression levels of 
RNMT and RAM suggesting that high levels of the two proteins are a feature of 
pluripotent cells. Even more exciting, the same expression is conserved 
amongst species as also hESCs and hiPSCs exhibit high levels of RNMT and 
RAM compared to fibroblasts. So far, RNMT and RAM were described as a 
complex in all cells lines examined and it was assumed that are similarly 
regulated, instead surprisingly, during in vitro neural differentiation a specific 
reduction in RAM protein levels is observed. Gain- and loss-of-function studies 
have been employed to demonstrate that specifically high RAM levels are 
required for the maintenance of pluripotency. In fact, RAM depletion causes a 
major reduction in the methyl cap levels of important pluripotency factors, 
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ultimately resulting in a decreased of the protein levels. Therefore, RAM is 
found to function as modulator of RNMT activity, whereby it promotes cap 
methylation of fundamental transcripts required for the maintenance of ESCs 
pluripotency. I have also found that during differentiation RAM is down 
regulated post-transcriptionally, and therefore current studies are focused on 
investigating the role of RAM phosphorylation at Serine-36, which correlates 
with proteosomal degradation. Together the data corroborate previous findings 
about the methyl cap formation being a critical and regulated process within 
gene expression and propose a novel implication of this modification in the 
maintenance of pluripotency.  
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1  Introduction 
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1.1  The gene expression pathway 
The molecular biology discipline is based on the central dogma formulated by 
Francis Crick in 1970 (Crick, 1970). He firstly introduced the concept of gene 
expression describing how the hereditary DNA information is transcribed into 
RNA molecule to be then translated into proteins. Although the flow direction of 
gene expression is well conserved between prokaryotes and eukaryotes, the 
regulation mechanism of this pathway varies among species and between 
different cell types of the same organism. It is extremely fascinating how cells in 
our body, despite possessing the same genetic information, locally and 
temporally express different genes that function as hallmarks of their identity 
and allow cells to fulfil different roles. This high degree of regulation is critical to 
constantly adjust the RNA and protein content according to the environmental 
cues and intracellular signalling, and alterations of this plasticity were shown to 
be associated with abnormal cell proliferation and cancer (Delgado & Leon, 
2006). Although in eukaryotes the gene expression pathway is characterized by 
only three steps, regulation occurs at multiple levels resulting in a sophisticated 
process that finely tunes the expression of a specific gene product within cells.  
 
Gene regulation may occur at: epigenetic, transcription, post-transcriptional and 
post-translational level (Orphanides & Reinberg, 2002). As a perfect machine, 
all the above events co-ordinately ensure the expression of certain genes and 
the repression of others. In Prokaryotes and archaea, the DNA transcription in 
RNA is accomplished by a single RNA polymerase but this task in eukaryotes is 
divided within three highly related enzymes: RNA polymerase I and III devoted 
to express ribosomal and non-coding RNAs respectively, whereas the RNA 
polymerase II transcribed all the genes encoding messenger RNAs (mRNAs) 
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(Roeder & Rutter, 1969). An RNA polymerase of the mitochondrial origin, 
named snRNAP-IV, has also been found to transcribe mRNA of certain 
mammalian protein coding genes in the nucleus (Kravchenko et al., 2005).  
 
1.1.1 Transcription initiation 
Transcription of a specific DNA segment into mRNA represents the first step of 
gene expression. In eukaryotes, a multi subunit DNA dependent RNA 
polymerase (RNA Pol II) is responsible for the transcription of genes encoding 
mRNA, additionally to U small nuclear RNA (U snRNA) and micro RNA 
(miRNA). Transcription by RNA Pol II is preceded by the sequential and 
coordinated assembling of different transcription factors (TFs), resulting in a 
multi-protein complex generally referred as pre-initiation complex (PIC). Firstly, 
the TFIID that contains the TATA binding protein (TBP) binds the core promoter 
element, which dictates initiation and orientation of transcription (Hahn, 2004). 
Subsequently TFIIA and TFIIB are recruited to stabilise the core-promoter 
bound TFIID and lastly, the PIC is completed by the binding of TFIIE and TFIIH 
(Nikolov & Burley, 1997). In addition to these basal transcription factors, the 
transcription initiation complex may include further regulators such as the 
mediator complex and/or gene-specific transcription factors which activate or 
repress transcription in response to metabolic or environmental signals (Sikorski 
& Buratowski, 2009).  
 
The largest subunit of RNA Pol II (Rbp1) is characterised by the presence of a 
specific structure on the Carboxyl-terminal domain (CTD) that consists in 
tandem heptad repeats with a consensus sequence of Tyrosine1-Serine2-
Proline3-Threonine4-Serine5-Proline6-Serine7. Although the CTD is an exclusive 
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and ubiquitous feature of RNA Pol II, the repeats length varies among species 
and considering that yeast presents 26 repeat and human 52, it is believed the 
length increases with the complexity of the genome (Liu et al., 2010). The CTD 
extends from the core enzyme close to RNA exit channel and from this strategic 
position, the CTD functions as landing scaffold that actively and dynamically 
recruits different components of the RNA processing machinery through the 
different stages of transcription, including chromatin remodelling and capping 
enzymes (Bentley, 2005; Egloff & Murphy, 2008). This high degree of CTD 
flexibility is reached through changes in the phosphorylation status of the 
Serine-5 and Serine-2 of the tandem repeats.  
 
RNA pol II is recruited to promoters in a non-phosphorylated version (Feaver et 
al., 1991) however, following the assembly of the PIC, the CTD is subsequently 
phosphorylated by TFIIH-associated kinase CDK7 (cyclin-dependent kinase 7) 
at the Serine-5 (Lu et al., 1991). This event is associated with promoter 
clearance and release of the mediator complex from RNA Pol II (Sogaard & 
Svejstrup, 2007). Chromatin immunoprecipitation (ChIP) followed by 
sequencing revealed that shortly after promoter clearance, RNA Pol II pauses at 
the promoter proximal site (Guenther et al., 2007; Rahl et al., 2010; Kim et al., 
2005). More precisely, when RNA Pol II reaches 20-60 bp after the transcription 
start site (TSS), two factors bind to it: 5,6-dichloro-1-β-D-
ribofuranosylbenzimidazole (DRB) sensitive induced elongation factor (DSIF) 
and negative elongation factor (NELF) causing the RNA Pol II to pause. DSIF 
consists of the two subunits Spt4 and Spt5 whereas NELF is composed of five 
polypeptides named NELF A-E (Wada et al., 1998; Yamaguchi et al., 1999). 
This pausing occurs also for genes thought to be transcriptionally inactive, 
suggesting that transcription is regulated at the elongation step rather than at 
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initiation. The negative effect of these factors is reversed by CDK9 or P-TEFb 
(the positive transcription elongation factor b), which by phosphorylating the 
CTD Serine-2 as well as the two factors, promotes DSIF and NELF release and 
thus favours transcription elongation (Peterlin & Price, 2006; Rahl et al., 2010). 
The scenario that emerges is that high level of phosphorylated Serine-5 are 
found at the TSS whereas high level of phosphorylated Serine-2 are found 
downstream the TSS and when RNA Pol II is actively engaged in elongation. It 
has been recently reported that RNA Pol II landscape is more complex than it 
was originally thought because other CTD residues (threonine 4 and tyrosine 1) 
can be phosphorylated or modified with other post translational modifications 
(Egloff & Murphy, 2008; Heidemann et al., 2013). These features further 
amplifies the possible regulation mechanisms of RNA Pol II in the transcription 
process.  
 
1.1.2 Pre-mRNA processing 
Once the pre-mRNA is transcribed, three main events, catalysed by different 
protein complexes, are required for the pre-mRNA maturation: the addition of 
N7-methylguanosine cap, splicing and polyadenylation. The CTD 
complementary phosphorylation pattern of Serine-5 and Serine-2, temporally 
and spatially coordinates the recruitment of the different protein complexes to 
ensure fidelity and efficiency of gene expression (Hsin & Manley, 2012; Moore 
& Proudfoot, 2009). The first process consists in the addition of 
methylguanosine cap at the 5’ end of an emergent pre-mRNA, and the 
mechanism and function of this modification will be later discussed.  
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Splicing is the second mRNA modification that occurs when the methyl-capped 
mRNA encounters the spliceosome complex, recruited by phosphorylated CTD 
(Braunschweig et al., 2013). Splicing is a two-step process that provides first 
the removal of non-coding intronic sequences, or introns, and secondly the 
joining of exons fragments to generate a functional message. In human, five 
main small nuclear ribonucleoprotein particles (U snRNPs) U1, U2, U4, U5 and 
U6 constitute the spliceosome machinery along with a large number of other 
proteins (Hoskins & Moore, 2012). Evolutionary processes result in alternative 
splicing (AS) documented as differential use of splice site that generates two 
different mRNAs and thus two different proteins. The evidence that 95% of 
human multi-exon genes is alternatively spliced highlights how the production of 
different protein isoforms from a single gene represents a real strategy to 
expand the genomic coding capacity (Braunschweig et al., 2013; Fu & Ares, 
2014). 
 
Temporally, the last modification of pre-mRNA is the polyadenylation, which is a 
two-step reaction that occurs in all protein encoding mRNAs with the exception 
of histone transcripts. The pre-mRNA is first cleaved at a certain signal 
sequence and then the poly (A) polymerase (PAP) catalyses the addition of 
200-250 adenosine residues upstream to the cleavage site (Di Giammartino et 
al., 2011; Bentley, 2005). Also for the 3’ process has been shown that 
phosphorylated Serine-2 of CTD is required to mediate the recruitment of the 
processing factors (Hocine et al., 2010; Hsin & Manley, 2012). The 
polyadenylation step is required for mRNA stability, export, localization and 
translation efficiency. Alternative polyadenylation (APA) events have been 
reported and similarly to alternative splicing, they further increase the number of 
mechanisms to diversify gene expression control (Di Giammartino et al., 2011).  
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Following the maturation process, mRNA is transported into the cytoplasm to be 
translated. In eukaryotes, the physical and functional compartmentalization 
between nucleus and cytoplasm triggered the evolution of a nucleocytoplasmic 
machinery to tightly regulate the trafficking of RNAs and proteins between the 
two compartments. Different nuclear pore complexes (NPCs) are present on the 
nuclear membrane, and each has nuclear receptors that will specifically 
recognise nucleotide motifs in RNA cargoes allowing their transition. This is the 
case for miRNAs and tRNAs (Kohler & Hurt, 2007), whereas the mRNA due to 
the different length and structure, needs some adaptors to interact with its 
export receptors. Several adaptors have been identified among which TAP-15 
complex, exon-junction complex, and also the cap binding complex that will be 
further discussed. Another complex involved in the mRNA nuclear export is the 
THO/TREX (TRanscription-Export) so called because the components of this 
complex are involved in both transcription elongation, transcript-dependent 
recombination and nuclear export (Hocine et al., 2010; Kohler & Hurt, 2007). In 
fact, it has been described a model where the TREX complex is recruited to the 
transcribing genes and travels with the polymerase during the transcriptional 
elongation step (Strasser et al., 2002). These findings highlighted how the 
different steps involved in mRNA biogenesis are physically and functionally 
coupled, and failure of one process compromises the progression into the other 
step (Katahira, 2012).  
 
1.1.3 Translation initiation 
Following transcription and mRNA processing, mRNA functions as template for 
protein synthesis. Efficient translation of most mRNAs is dependent on the N7-
methylguanosine cap moiety as the m7G is bound by the eIF4F complex which 
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consist in eIF4E, eIF4G and eIF4A. eIF4E specifically recognises the N7-
methylguanosine cap and interacts with the scaffolding protein eIF4G, which 
presents binding sites also for the RNA helicase eIF4A, which unwinds 
otherwise inhibitory RNA secondary structures (Koromilas et al., 1992) and for 
eIF3. The latter promotes not only the assembly of the 43S pre-initiation 
complex (PIC), which consists in 40S ribosomal subunit, the initiator methionyl 
tRNA (Met-tRNAiMet) and several translation initiation factors but also its 
recruitment to the mRNA. Once the PIC is engaged to mRNA, it scans for the 
AUG start codon that would base pair with Met-tRNAiMet. Subsequently, certain 
translation factors are removed and the 60S ribosomal subunit joins the 80S 
initiation complex proceeding into the elongation stage (Jackson et al., 2010; 
Sonenberg & Hinnebusch, 2009). eIF4E function can be repressed by eIF4-
BPs, which in an unphosphorylated state binds to eIF4E preventing its 
interaction with eIF4G (Sonenberg & Hinnebusch, 2009; Topisirovic et al., 
2011). 
 
Additionally to the canonical scanning mechanism, an alternative cap 
independent mechanism of translation initiation has been described. A subset of 
mRNAs can engage with the 40S subunit via specific sequence within their 5’ 
untranslated regions (UTRs) known as internal ribosome entry site (IRES). 
IRES were originally observed in virus mRNA but it is now established that 
eukaryotic mRNA contains IRES and they recruit the 40S subunit in proximity of 
the start codon, independently from the methyl cap structure. It has been 
suggested that the cap dependent translation may occur in optimal growth 
condition, whereas as soon cells face any kind of stress the IRES dependent 
translation replaces the canonical process (Komar & Hatzoglou, 2011; Spriggs 
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et al., 2010). Different IRES structures exist within cells and their function and 
mechanism remain unclear. 
1.2  The N7-methylguanosine cap structure 
It was 1975 when the N7-methylguanosine cap (m7GpppN or simply m7G) was 
identified at the 5’ end of viral mRNA (Furuichi & Miura, 1975; Furuichi et al., 
1975a) and subsequently its presence was described also on HeLa mRNA 
(Furuichi et al., 1975b). This structure, indicated as cap 0 (Figure 1.1a), is found 
in all eukaryotic RNA Pol II transcripts and on eukaryotic viral RNAs but 
evidence of its presence was not reported for bacterial or archael RNA 
(Shuman, 2002). The N7-methylguanosine cap consists of a guanosine cap, 
linked to the first transcribed nucleotide via the unusual 5’-> 5’ triphosphate 
linkage (Shatkin, 1976), further methylated in N7 position. The characterization 
and function of the cap 0 will be further discussed. 
 
Additionally to cap0, mRNA of high eukaryotes but not yeast (Furuichi & 
Shatkin, 2000), was found to be methylated at the 2’-O position of the first or 
second nucleotide identifying respectively cap 1 and cap2 structure (Figure 
1.1b) (Furuichi et al., 1975b). The methyltransferase, hMT1, which is 
responsible for the methylation of cap 1 and hMT2, required for the cap 2 
methylation, have been only recently characterised (Belanger et al., 2010; 
Werner et al., 2011). Evidence suggest that hMT1 may function within the 
nucleus whereas hMT2 is thought to be cytoplasmic. To date the dynamic of 
cap 1 and 2 formation and their biological function remain elusive. Moreover, 
small nuclear RNAs (snRNAs) exhibit an alternate methyl cap structure that 
carries methylations on the positions 2,2,7 of the terminal guanosine, 
generating a trimethylguanosine (TMG) cap (Reddy et al., 1992).
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Figure 1.1: The structure of the N7-methylguoanosine cap (Cap0), 
Cap1 and Cap2.  
(a) The N7-methylguaonsine cap (Cap 0) consists of an inverted 
guanosine group that is linked via a triphosphate bridge to the first 
transcribed nucleotide and is methylated at the N7 position. (b) In addition 
to the Cap O, the Cap1 structure is methylated at the 2’-O ribose of the 
first transcribed nucleotide and the Cap2 structure is further methylated at 
the 2’-O ribose of the second transcribed nucleotide. 
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1.2.1 Enzymology and mechanics of N7-methylguanosine cap  
Three sequential enzymatic activities coordinate the formation of the N7- 
methylguanosine cap. The process starts when the RNA triphosphatase 
hydrolyses the -phosphate from the triphosphate end of the pre-mRNA 
generating a dephosphorylated 5’ end (pppN  ppN). The resulting 
diphosphate is then modified by the addition of a guanosine monophosphate 
(GMP) known as guanosine cap (ppN  GpppN), catalysed by the 
guanylyltransferase. Lastly, the process terminates when the RNA 
methyltransferase transfers a methyl group from the methyl donor S-
adenosylmethionine (SAM), to the guanosine cap in the N7 position (GpppN  
m7GpppN) (Figure1.2) (Furuichi & Shatkin, 2000). Cap methylation is a well 
conserved mechanism that occurs in all eukaryotes (also in eukaryotes virus) 
and the majority of our understanding derives from extensive studies performed 
in yeast.  
 
In lower eukaryotes such as yeast, the catalysis of the three reactions to form 
the methyl cap is assigned to three independent polypeptides (Mao et al., 1995; 
Shibagaki et al., 1992; Tsukamoto et al., 1997). On the contrary, in metazoa 
and mammals evolution resulted in a unique bi-functional enzyme called 
RNGTT or capping enzyme (CE), which harbours the triphosphatase activity on 
its N-terminal domain (1-210) and the guanylyltransferase activity on its C-
terminal domain (211-597). 25 amino acids residues are predicted to form a 
flexible loop that merges the two domains together (Pillutla et al., 1998a; 
Yamada-Okabe et al., 1998; Yue et al., 1997; Chu et al., 2011). However, the 
methyltransferase activity resides in a distinct protein known as RNA 
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methyltransferase (RNMT) (Pillutla et al., 1998a; Pillutla et al., 1998b; Saha et 
al., 1999; Tsukamoto et al., 1997).  
 
The first step of the methyl cap reaction is catalysed by the RNA triphosphatase 
and the sequence analysis revealed that it is not conserved amongst 
eukaryotes (Changela et al., 2001; Lima et al., 1999). The human 
triphosphatase RNGTT has been described as belonging to the cysteine 
phosphatase superfamily and the specificity towards its substrate, the 
triphosphate group, is accomplished by the deep active site that can 
accommodate only the triphosphate group but it is inaccessible to diphosphate 
or monophosphate. 
 
The guanylyltransferase is responsible for the second step of the reaction and 
catalyses the addition of the guanosine cap to the diphosphate mRNA. Contrary 
to the triphosphatase enzyme, the guanylyltransferase are structurally related in 
eukaryotes (Chu et al., 2011; Fabrega et al., 2003; Gu et al., 2010; Hakansson 
et al., 1997; Hakansson & Wigley, 1998). The addition of the guanosine cap 
occurs in two steps: firstly the GTP binds a Lysine within the enzyme active site 
generating an intermediate enzyme-lysine-GMP conjugate. The GTP binding 
induces the guanylyltransferase to assume an open conformation able to 
release pyrophosphate and to ligate GMP to the diphosphate RNA (Fabrega et 
al., 2003; Hakansson et al., 1997; Hakansson & Wigley, 1998).  
 
The last step in the methyl cap synthesis is the methylation of the guanosine 
cap mediated by the RNA methyltransferase enzyme. RNMT catalyses the 
transfer of a methyl group from the methyl donor S-adenosylmethionine (SAM) 
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to GpppRNA resulting in the m7GpppRNA and releasing the by-product of the 
reaction S-adenosylhomocysteine (SAH). Studies of the crystal structures 
revealed how the active site, which is conserved amongst eukaryotes, contains 
two distinct ligand-binding pockets to accommodate the methyl donor SAM and 
the methyl acceptor guanosine cap. Moreover, the crystal structure 
demonstrated as RNMT does not physically interact with either the methyl 
donor or the methyl acceptor, suggesting that RNMT role is to orientate the 
substrates in proximity to facilitate the methyl transfer (Fabrega et al., 2004).  
 
Apart from the triphosphatase, the enzymes required for the formation of the 
methyl cap are functionally conserved from yeast to human. The growth defect 
of yeast cap guanylyltransferase or cap methyltransferase deletion mutants can 
be totally rescued by their mammalian orthologues (Saha et al., 1999; Yamada-
Okabe et al., 1998; Yue et al., 1997). In addition, it has been reported that the 
human and yeast capping enzymes, are essential for cell viability (Chu & 
Shatkin, 2008; Shafer et al., 2005). There is no redundant triphosphatase, 
guanylyltransferase and methyltransferase which can compensate the loss of 
RNGTT and RNMT. All together these observations highlight the important role 
that these enzymes play in the gene expression pathway.
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Figure 1.2: Reactions that are required for N7-methylguanosine cap synthesis. 
The synthesis of the N7-methylguanosine cap is described in the main text. The 
activities responsible for the reaction catalysis are indicated next to the arrows. The 
name of the actual enzyme in mammals is indicated in brackets. RNGTT contains 
both the tryphosphatase and the guanylyltransferase activity while RNMT harbours 
the methyltransferase activity. Contrary to the methyltransferase and the 
triphosphatase, the guyanylyltransferase reaction is reversible. 
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1.2.2 The methyltransferase complex: RNMT and RAM  
Homo Sapiens RNA methyltransferase consists of 576 amino acids with a 
molecular weight of 64 kDa. RNMT is structurally divided in two domains: N-
terminal domain (1-120) and C-terminal domain (120-476). The N-terminal 
domain was initially speculated to have a regulatory mechanism whereas the 
catalytic activity resides in the C-terminal domain (Saha et al., 1999). 
Immunofluorescence studies on different RNMT truncated constructs 
demonstrated that RNMT is a nuclear protein and three redundant nuclear 
localisation site (NLS) were found at residue 80, 103 and 126 (Aregger & 
Cowling, 2013; Shafer et al., 2005; Wen & Shatkin, 2000). Yeast two-hybrid 
experiments combined with in vitro pull down assay showed that the nuclear 
localization is mediated by the binding with Importin-α. Importin-α is the adaptor 
protein that associating with Importin-β, which interacts with the NPCs (Lange et 
al., 2007), allows RNMT translocation into the nucleus (Shafer et al., 2005; Wen 
& Shatkin, 2000). Moreover it has been shown that Importin-α induces an 
increase in cap methylation of up to 10 fold possibly enhancing specific binding 
of RNMT to methyl capped RNAs whereas Importin-β was shown to prevent this 
stimulation (Wen & Shatkin, 2000). The N-terminal domain has recently been 
described mediating the recruitment of RNMT to the TSS (Aregger & Cowling, 
2013). The catalytic C-terminal domain, is conserved in sequence, function and 
structure in all mRNA cap methyltransferases. 
 
In 2011, the C-terminal domain of RNMT was found physically interacting with a 
small protein named RNMT Activating Miniprotein (RAM) (Gonatopoulos-
Pournatzis et al., 2011).  
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Homo sapiens RAM consists of 118 amino acids with a molecular mass of 14.3 
kDa. RAM is only present in vertebrates and it is well-conserved in higher 
eukaryotes. Three functional domains were identified: the N-terminal activation 
domain (amino acids 1-55) is well conserved among vertebrates and it directly 
interacts with the catalytically active RNMT domain. The central RNA-binding 
domain (56-90) is enriched in positively charged Arginine and Asparagine 
residues (Figure 1.3a), which are characteristic of proteins with a RNA binding 
activity (Bayer et al., 2005). The RAM C-terminal domain (amino acids 91-118) 
is not well conserved and is highly enriched in Glutamine, Tyrosine and Proline 
(QYP) amino acids. Recent findings in our lab established that this domain is 
required for the nuclear import of RAM as it contains two PY-NLSs. PY motifs 
are recognised by karyopherin β2 that binds to cargoes and target them to the 
NPCs. Therefore, similarly to other RNA-binding proteins, RAM via direct 
interaction with karyopherin β2 is imported into the nucleus where it interacts 
with RNMT (Gonatopoulos-Pournatzis & Cowling, 2014).  
 
Studies in vivo with MG132 treatment showed that RNMT and RAM protect 
each other from proteasome degradation (Gonatopoulos-Pournatzis et al., 
2011). Moreover, methyl cap immunoprecipitations demonstrated that RAM 
depletion caused an impairment in the level of capped endogenous transcripts. 
Combining these observations together RAM was described as an obligate 
component of the mammalian cap methyltransferase complex because required 
for promoting RNMT activity both in vitro and in vivo. Interestingly, the RNA-
binding motif is not required for RNMT activation suggesting that RAM binding 
may induce a conformational change in RNMT that results in an increased 
methyltransferase activity.  
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To date, no crystal structures of RNMT and RAM complex are currently 
available, nonetheless studies in our laboratory suggest that RAM may facilitate 
the recruitment of the methyl donor SAM to RNMT binding pocket (Varshney et 
al., unpublished). However, the exact mechanism of how RAM functions or how 
is regulated have not been uncovered yet. 
 
1.3  N7-methylguanosine cap synthesis occurs co-
transcriptionally 
As described earlier, the synthesis of N7-methylguanosine cap is the first pre-
mRNA processing event. Several studies showed it occurs co-transcriptionally, 
possibly as soon as the transcript emerges from the exit channel of RNA Pol II 
(Figure 1.3b). In fact, different studies showed that transcripts between 20 and 
80 nucleotides in length do present the methylguanosine cap structure (Coppola 
et al., 1983; Mandal et al., 2004; Rasmussen & Lis, 1993). First evidence to 
suggest that the cap methylation is coupled with the transcription process came 
from studies in vitro showing that formation of the methyl cap proceeds faster 
when RNA is associated in elongation complex compared to free RNA. 
Additionally, it was observed that the S-adenosylhomocysteine (SAH), the by-
product of the methylation step, inhibits the in vitro transcription (Jove & Manley, 
1984; Moteki & Price, 2002). Moreover, when CTD truncated version of RNA 
Pol II was used for the transcription, an impairment of capping process was 
observed suggesting that the concomitance in transcription and capping events 
is very likely permitted by the physical interaction between CTD of RNA Pol II 
and the capping machinery (McCracken et al., 1997). 
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The model of co-transcriptional N7-methylguanosine cap formation is further 
corroborated by studies on association of the capping machinery with chromatin 
and RNA Pol II. In fact, ChIP analysis showed that particularly in human, 
RNGTT and RNMT are found at the TSS (Glover-Cutter et al., 2008; Guiguen et 
al., 2007; Komarnitsky et al., 2000; Schroeder et al., 2000) but also in the gene 
body and at the 3’ end (Glover-Cutter et al., 2008).  
In yeast, both guanylyltransferase and methyltransferase directly bind to the 
phosphorylated CTD, while the triphosphatase is recruited via binding of the 
guanylyltransferase (Cho et al., 1997; McCracken et al., 1997). In mammals, a 
direct interaction of the RNGTT with phosphorylated CTD was also reported (Ho 
& Shuman, 1999; Ho et al., 1998; Yue et al., 1997) but contrary to yeast, not 
direct association was observed between RNMT and RNA Pol II (Shatkin & 
Manley, 2000). However, recent findings in our laboratory showed that DRB 
treatment, the RNA pol II kinase inhibitor, reduced RNMT recruitment to 
promoters (Aregger & Cowling, 2013). 
 
Subsequently, studies in human clarified that Serine-5 phosphorylation is not 
only required for the recruitment of RNGTT to TSS but also promotes the 
formation of the enzyme-GMP intermediate, favouring the capping reaction (Ho 
& Shuman, 1999; Wen & Shatkin, 1999). Recent biochemical data in yeast 
revealed that in addition to binding Serine-5 phosphorylated CTD, the capping 
enzyme requires an intact RNA 5’-triphosphate to efficiently bind to RNA pol II. 
The strategic position of capping enzyme allows an instant recognition of exiting 
RNA 5’ end and the guanylation reaction, combined with the decrease in 
Serine-5 phosphorylated CTD, leads to complete release of capping enzyme 
(Martinez-Rucobo et al., 2015).  
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Furthemore, it was observed that capping enzyme interacts also with DSIF 
subunit Spt5, and this association additionally to stimulate capping activity also 
relieves transcription repression by the negative elongation factor. This data are 
consistent with a role of capping enzyme in elongation checkpoint control during 
promoter clearance (Mandal et al., 2004).
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Figure 1.3: RNMT forms a complex with RAM and together with RNGTT provide the 
synthesis of the N7-methylguanosnie cap co-transcriptionally.  
(a) As pre-mRNA emerges from RNA Pol II, RNGTT mediates the addition of the guanosine 
cap to the 5’ end of mRNA. Then RNMT and RAM complex catalyses the methylation of the 
guanosine cap. S-adenosylmethionine (SAM) serves as methyl donor in the reaction. The C-
terminal domain of RNA methyltransferase (RNMT) interacts with the N-terminal domain of 
RAM. RAM is a RNA-binding protein that recruits RNA to RNMT. (b) The CTD domain of RNA 
Pol II is strategically placed next to the RNA exit channel. The CTD, being sequentially 
phosphorylated on different residues, functions as scaffold and recruits RNA processing 
complexes. When RNA Pol II is recruited to promoter the CTD is hypophosphorylated, but 
shortly after initiation, TFIIH-associated kinase phosphorylates the CTD on Serine-5. As RNA 
Pol II elongates, Ser-2 is increasingly phosphorylated by CDK9 or P-TEFb, while Ser-5 
phosphorylation is gradually removed by phosphatases. The recruitment of the capping 
machinery is dependent on Serine-5 phosphorylated RNA Pol II. 
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1.4  Regulation of the N-7 methylguanosine cap 
Since the methyl guanosine cap was discovered, it was assumed to be a 
constitutive modification of all the RNA Pol II transcripts. On the contrary, 
increasing number of evidence over the last decades shed the light on possible 
regulation of this important step during mRNA maturation. Pioneering studies 
demonstrated that the transcription factors c-Myc and E2F1 promote the N7-
methylguanosine cap of specific transcripts (Cole & Cowling, 2009; Cowling & 
Cole, 2007). The proto-oncogenes Myc and E2F1 are upregulated in response 
to growth factors and they are required for cell growth and proliferation. The 
Myc family comprises c-Myc, N-Myc and L-Myc (Meyer & Penn, 2008).  
 
c-Myc has been recently described as an amplifier of the gene expression 
programme, resulting in increased levels of transcripts and thus in protein 
synthesis (Cowling, 2010; Lin et al., 2012; Nie et al., 2012). Initially it was 
observed that N-Myc increases translation of its target genes in a post-
transcriptional mechanism without upregulating their mRNA levels (Cowling & 
Cole, 2007). Further experiments revealed that N-Myc increases the recruitment 
of TFIIH, which contains CDK7 that will phosphorylate CTD Serine-5 of RNA 
Pol II. As previously discussed, this phosphorylation event promotes capping 
machinery recruitment and activity (Cowling & Cole, 2007). In fact, experiments 
with an anti-methylguanosine cap antibody showed elevated N7-
methylguanosine cap levels upon N-Myc expression. Additionally, it has been 
demonstrated that c-Myc promotes the methyl cap formation by relieving the by-
product of the process. Following the methylation reaction, SAM, the methyl 
donor, is converted to S-adenosylhomocysteine (SAH) and elevated levels of 
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SAH inhibit RNMT activity. The loop is alleviated by the presence of S-
adenosylhomocysteine hydrolases (SAHH) that removes the SAH allowing the 
reaction to carry on (Chiang et al., 1996). It has been shown that c-Myc 
upregulates SAHH, which reduces SAH thus promoting RNMT activity (Figure 
1.4a). c-Myc induced cap methylation is an essential mechanism by which c-
Myc fulfils its proto-oncogene effect, promoting protein synthesis, cell 
proliferation and cell transformation (Fernandez-Sanchez et al., 2009). Similarly 
to c-Myc, it has been reported that also E2F1 induces upregulation of the 
methylguanosine cap levels (Cole & Cowling, 2009) via promoting RNA Pol II 
CTD phosphorylation (Figure 1.4b) (Aregger & Cowling, 2013). Although c-Myc 
does not directly promote RNMT activity, it has been reported that RNMT 
overexpression induces cell transformation equivalently to c-Myc effect. The 
same study showed that methyl cap levels of oncogene Cyclin D1 increased in 
response to RNMT overexpression (Cowling, 2010). In light of these 
observations, the mRNA cap methylation emerges as a more sensitive process 
within gene expression than it was originally thought. Indeed the process can be 
regulated by environmental clues and internal signalling and the capping 
machinery need to be expressed within a certain threshold to avoid deleterious 
consequences. Thus the methyl cap formation may represent a critical step to 
directly and rapidly regulate the expression of specific genes.  
 
Furthermore, latest evidence reported that in yeast, amino acids or glucose 
starvation impairs the mRNA cap methylation process resulting in unmethylated 
capped RNAs (Jiao et al., 2010). 
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Recent studies showed that aberrantly capped RNAs may be generated also in 
normal growth condition and a novel class of endonucleases, which includes 
Rai1 and Dxo1, was first identified in yeast. Subsequently, the human 
orthologue DXO was found to specifically recognise and mediate the decay and 
clearance of incompletely capped mRNAs (Chang et al., 2012; Jiao et al., 2013; 
Jiao et al., 2010). These observations led to reformulate the assumption that 
mRNA cap methylation not necessarily always proceeds to completion. In fact, 
from these studies, it emerges that within cells aberrantly capped pre-mRNAs 
may be specifically degraded by particular enzymes that operate a surveillance 
mechanism to avoid the accumulation of potential deleterious defectively 
capped pre-mRNAs.  
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Figure 1.4: c-Myc and E2F1 upregulate N7-methylguanosine cap synthesis. 
(a) Efficiency of cap methylation is increased by stimulation of RNMT activity by c-Myc and 
E2F1. Both factors promote methyl cap formation by increasing the recruitment of TFIIH, 
responsible for the phosphorylation of Serine-5 CTD. Moreover, c-Myc, which dimerizes 
with Max, promotes SAHH activity, which removes the inhibitory by-product of the 
methylation reaction. (b) Additionally, RNMT activity is regulated by Importin-α, which 
interacting with RNMT increases the cap methylation. This stimulation is inhibited by 
Importin-β. 
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1.5  N7-methylguanosine cap in gene expression 
The synthesis of N7-methylguanosine cap moiety at the 5’ end of transcripts is 
required for numerous processes within the gene expression pathway. Some 
examples include transcription, pre-mRNA processing, RNA stability, mRNA 
export and translation. The ability of m7G to accomplish so many different 
functions relies on its interaction with several binding proteins, amongst which, 
the cap binding complex (CBC) and eukaryotic translation initiation factors 4E 
(elF4E) are the best characterised (Topisirovic et al., 2011). Additionally, other 
interacting partners have been reported such as the poly(a) binding protein C 
(PABPC), the RNA binding proteins Pumillo 2 (Pum2) and the exon junction 
component Y14 (Cao et al., 2010; Chuang et al., 2013; Khanna & Kiledjian, 
2004), but their functional role remains unclear.  
 
1.5.1 elF4E and CBC 
elF4E was identified and purified as interacting partner of the m7G both in yeast 
and mammals (Altmann et al., 1985; Altmann et al., 1987; Sonenberg et al., 
1978; Sonenberg et al., 1979). Its specific association with the methylated cap 
structures was lately confirmed by crystallography studies (Marcotrigiano et al., 
1997; von der Haar et al., 2004). The interaction and binding between elF4E 
and m7G clarified the importance of the methyl cap for a correct translation 
process. In fact, as previously discussed, the elF4E, elF4G and elF4A are all 
part of the elF4F complex, the role of which is to facilitate the engagement of 
the 43S pre-initiation complex with the mRNA (Sonenberg & Hinnebusch, 
2009). The process starts when the scaffold polypeptide elF4G interacts with 
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elF4E, and this induces an allosteric change that increases the affinity of elF4E 
to specifically bind the m7G (Gross et al., 2003; Haghighat & Sonenberg, 1997). 
Therefore, the elF4E is essential for cap-dependent translation since it firstly 
mediates the recruitment of the translation machinery onto the 5’ end of mRNA. 
Considering these evidence, it does not surprise that overexpression of elF4E 
was found to promote tumour formation in mice and in a plethora of human 
malignancies (Lazaris-Karatzas et al., 1990; Ruggero et al., 2004; Topisirovic et 
al., 2011).  
 
CBC was found in HeLa extracts as heterodimer consisting of two subunits 
named according to their molecular weight Cbp20 and Cbp80. Competition 
experiments with vary cap analogues showed that the CBC binds specifically to 
the m7GpppRNA (Izaurralde et al., 1995a; Izaurralde et al., 1994). Moreover, 
RNA bind shift assay showed that both subunits synergistically bind RNA since 
none of them can bind the m7G as monomer (Izaurralde et al., 1995a; 
Izaurralde et al., 1994; Kataoka et al., 1995). Crystal structures studies revealed 
that Cbp80 contains a nuclear localization site (Izaurralde et al., 1995b) 
whereas the m7G binding pocket resides into the Cbp20 subunit. It was 
suggested that Cbp80 induces conformational changes required for Cbp20 to 
bind the m7G (Calero et al., 2002; Mazza et al., 2001; Mazza et al., 2002). In 
mammals, depletion of CBC causes decrease in cell proliferation (Narita et al., 
2007; Pabis et al., 2013). Although elF4E and CBC fulfil different roles, they 
exhibit similar molecular structure of the cap binding pocket characterized by 
aromatic amino acids that specifically accommodate the m7G. Biophysical 
assay demonstrated CBC has 25% higher affinity for m7G than elF4E (Worch et 
al., 2005). 
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1.5.2 The N7-methylguanosine cap stabilises mRNA 
One of the multiple functions of the m7G is the ability to stabilise the mRNA. 
Evidence to sustain this hypothesis were first collected when uncapped or 
capped RNA were microinjected into Xenopus leavis oocytes and the methyl 
cap was shown to be more stable than the uncapped version (Furuichi et al., 
1977; Green et al., 1983). Furthermore, it was observed that ApppG was stable 
as the m7GpppG and that incubation of m7G analogues, which compete for 
binding to cap-binding proteins, did not destabilise the capped transcripts. All 
together these observations led to the conclusion that the methyl cap acts as a 
blocking structure sufficient to protect the mRNA from exoribonucleolytic 
degradation (Inoue et al., 1989; Murthy et al., 1991; Shimotohno et al., 1977). 
RNA stability, a part from the cap itself, is strongly increased also by the 
consequent interaction with the cap binding proteins. In fact, several studies 
revealed that CBC and elF4E, showing high affinity for the m7G, not only 
compete with decapping enzymes to bind to m7G (Grudzien et al., 2006; Jiao et 
al., 2013; Schwartz & Parker, 2000) but also inhibits activity of poly (A)-specific 
ribonuclease (PARN), which catalyses the deadenylation step in mRNA decay 
(Balatsos et al., 2006; Gao et al., 2000). Noteworthy, and in contrast to the 
capping reaction, the methylation is not reversible (Shatkin, 1976) and 
considering that there are specific decapping enzymes degrading unmethylated 
capped RNAs, the presence of the methyl group further protects the cap 
structure preventing formation of aberrantly capped mRNAs and thus their 
degradation. 
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1.5.3 The role of N7-methylguanosine cap in transcription 
ChIP studies found both Cbp20 and Cbp80 subunits at the 5’ of genes as well 
as within the gene body (Glover-Cutter et al., 2008; Lahudkar et al., 2011; 
Listerman et al., 2006; Narita et al., 2007; Zenklusen et al., 2002). Moreover, 
the evidence that only the heterodimer was bound to chromatin, strongly 
suggests that the CBC recruitment is mediated by m7G (Lahudkar et al., 2011; 
Wong et al., 2007). In mammal cells, CBC which binds the pre-mRNA 
concomitantly to RNA Pol II pausing, was found to recruits P-TEFb which 
promotes transcription elongation as previously described. CBC depletion was 
indeed found to reduce levels of phosphorylated Serine-2 CTD, accompanied 
by accumulation of RNA Pol II in gene bodies (Lenasi et al., 2011).  
 
Additionally to CBC-mediated effects, also RNGTT was found to promote 
transcription elongation in vitro. It was showed that as soon as RNA Pol II 
pauses at the promoter, RNGTT is recruited to the transcription complex not 
only by phosphorylated Serine-5 CTD but also by DSIF subunit Spt5. The 
interaction between RNGTT and Spt5 rescues the NELF repressive effect 
restoring transcriptional elongation (Mandal et al., 2004; Pei & Shuman, 2002). 
These observations directly couple pre-mRNA capping with transcription 
elongation. 
  
1.5.4 The role of N7-methylguanosine cap in splicing 
The m7G plays also a pivotal role in pre-mRNA splicing as shown by incubation 
of in vitro uncapped or methyl capped transcripts with HeLa cell extracts. 
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These experiments demonstrated that the m7G moiety was required for efficient 
splicing event (Edery & Sonenberg, 1985; Izaurralde et al., 1994; Konarska et 
al., 1984; Ohno et al., 1987; Patzelt et al., 1987). In fact, although both capped 
and methyl capped RNA were efficiently spliced, the addition of SAH, which 
inhibits the methylation reaction, inhibited only the splicing of capped RNA 
(Edery & Sonenberg, 1985; Ohno et al., 1987). Moreover, it was shown that 
incubation with the cap analogues m7GpppG and m7Gppp inhibited splicing 
more efficiently than the GpppG. These evidence combined together 
strengthened the hypothesis that the effect of cap methylation on splicing is 
mediated by a methylguanosine cap binding protein. In fact, immunodepletion of 
CBC showed that it is required for efficient pre-mRNA splicing and recent 
studies in mammals revealed that CBC is required for the recruitment of the 
spliceosome machinery (Pabis et al., 2013). Despite initial studies found that 
only the splicing of the 5’ proximal intron was m7G dependent, latest findings 
reported that m7G and CBC promotes removal of downstream introns as well 
(Jiao et al., 2013). Recent evidence described that CBC, is also involved in the 
alternative splicing as it is able to recruit the alternative splicing factors SRSF1 
(Lenasi et al., 2011). 
 
1.5.5 The N7-methylguanosine cap and 3’ processing 
The hypothesis that m7G influences also the addition of poly (A) tail was based 
on experiments where in vitro transcribed mRNAs were injected into X. leavis 
oocytes, and the presence of the m7G moiety strongly enhanced the cleavage 
at the poly (A) site (Georgiev et al., 1984).  
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Further experiments in mammals confirmed that methylguanosine capped 
transcripts are more efficiently cleaved than guanosine capped or uncapped 
transcripts (McCracken et al., 1997). Moreover, the addition of the cap analogue 
inhibits 3’ end cleavage suggesting that also in this step, a cap binding protein 
could mediate the m7G effect on the RNA 3’ processing. CBC was indeed 
found being involved in the process because following CBC depletion, HeLa 
extracts exhibited a reduced mRNA 3’ end cleavage, and the effect was 
rescued by addition of recombinant CBC (Flaherty et al., 1997). This confirmed 
that m7G moiety and CBC are required for correct pre-mRNA 3’ processing 
although the exact mechanism remains unclear (Cheng et al., 2006; Kohler & 
Hurt, 2007). 
 
1.5.6 The N7-methylguanosine cap and mRNA export 
After the maturation process, mature mRNA is translocated into the cytoplasm 
to be translated and this process was also revealed to be highly dependent on 
the m7G. In fact, it was shown that when methylguanosine cap and uncapped 
mRNAs were injected into X. laevis, the export of m7G mRNAs was more 
efficient compared to the uncapped RNAs. The potential role of m7G in mRNA 
export was validated by immunoprecipitation experiments were the Cbp80 
subunit of CBC was found interacting with the Aly component of the TREX 
nuclear export complex (Cheng et al., 2006; Kohler & Hurt, 2007). It was found 
that the efficient recruitment of TREX to mRNAs is both cap and splicing 
dependent (Cheng et al., 2006). According to the RNA length other CBC-
dependent mRNA export pathways have been identified (McCloskey et al., 
2012).  
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Furthermore, an elF4E-mediated export of gene specific mRNAs was 
described, as experiments showed that an elF4E mutant incapable to bind m7G 
was unable to export mRNA. Consistently to this, the addition of promyelocytic 
leukemia protein (PML), which reduces eIF4E affinity for the cap, also inhibited 
eIF4E-mediated mRNA export (Cohen et al., 2001; Culjkovic et al., 2006). 
Therefore, the eIF4E mRNA export seems to be methyl cap–dependent and is 
independent of its function in translation (Culjkovic et al., 2006). It is proposed 
that elF4E mRNA export could provide a rapid response to adapt to 
environmental cues but the mechanism remains unclear. 
 
1.5.7 The role of N7-methylguanosine cap in translation  
From yeast to mammals, the N7-methylguanosine cap is required for translation 
of mRNAs. Removal of the cap structure from in vitro transcribed RNA 
abolishes translation in wheat germ cell-free systems (Muthukrishnan et al., 
1975; Shimotohno et al., 1977; Zan-Kowalczewska et al., 1977). When 
unmethylated capped RNA was added to wheat germ extracts, it was translated 
only in presence of the methyl donor S-adenosylmethionine (SAM), whereas 
translation of methylated RNA did not depend on SAM (Both et al., 1975). When 
in vitro methylguanosine capped RNA was microinjected into X. leavis oocytes, 
it was translated more efficiently compared to the guanosine capped RNA 
(Drummond et al., 1985; Gillian-Daniel et al., 1998). elF4E was demonstrated to 
stimulate the translation of specifically methyl capped RNAs but not uncapped 
RNAs, revealing that eIF4E mediates the role of m7G in translation (Sonenberg 
et al., 1979; Sonenberg et al., 1980).  
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In yeast, it has been reported that inactivation of the methyltransferase causes 
reduction in protein synthesis and the effect is not amenable to reduced 
transcripts stability (Schwer et al., 2000). Moreover, recent findings suggest that 
protein translation can be increased when the cap structures physically interacts 
with the poly (A) tail via PABP. This mechanisms provides that PABP interacts 
with the poly (A) tail and eIF4G, which in turn stabilises the association of eIF4E 
with the cap (Kahvejian et al., 2005) and circularises the mRNA (Wells et al., 
1998). This interaction results in a close loop that enhances the recycling of 
ribosomes thus promoting other rounds of translation initiation (Sonenberg & 
Hinnebusch, 2009; Topisirovic et al., 2011). Although the majority of translation 
is dependent on elF4E, a pioneer round of translation was found to be mediated 
by CBC. This translation does not aim to produce large amount of proteins but 
functions as mRNA quality control. For example, mRNAs containing a 
premature termination codon (PTC) are targeted for nonsense mediating 
degradation (NMD) via CBC. The exchange between CBC pioneers translation 
and steady state translation is regulated by Importin-α (Sato & Maquat, 2009).  
 
Taken together the evidence discussed above describe how many events within 
the mRNA life cycle are methyl cap-dependent and therefore highlight the 
importance of m7G and cap-binding proteins in regulation of gene expression 
(Figure1.5).
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Figure 1.5: Summary of the functions of the N7-methylguanosine cap mediated by 
the relative by cap-binding proteins. 
Most of the functions of N7-methylguanosine cap are mediated by two cap binding 
proteins: CBC and eIF4E. The former in the nucleus promotes transcription, pre-mRNA 
splicing and 3’ processing and nuclear exports. In the cytoplasm CBC is responsible for a 
pioneer round of translation. eIF4E promotes the export of mRNAs and in the cytoplasm 
is required for cap-dependent translation. The methyl cap itself stabilises RNA which is 
further promoted by the binding of CBC or eIF4E. 
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1.6  Decapping 
The steady state of a given mRNA results from the balance between its 
transcription and its degradation, therefore an important contribution to 
regulation of gene expression derives from mRNA decay. In mammals, two 
main mRNA degradation pathways have been identified and in both 
mechanisms, bulk mRNA decay initiates with the shortening of poly(A) tail, 
following which the mRNA body is degraded either from 5’->3’ or 3’->5’ (Chen & 
Shyu, 2011). In the 5’->3’ decay pathway, the cytoplasmic decapping enzyme 
Dcp2, which is thought to accumulate in foci, presumably P-bodies, interacts 
with Dcp1 and hydrolyses the methyl cap of m7GpppG-RNAs longer than 25-29 
nt releasing m7GDP (Lykke-Andersen, 2002; Wang et al., 2002). Following the 
decapping reaction, 5’ monophosphorylated mRNAs are targeted for 5’ 
exoribonucleolytic decay by Xrn1. Recently another Nudix hydrolases protein, 
Nudt16, was found having a decapping activity 5’->3’. It is thought that Dcp2 
and Nudt16 preferentially function on different subsets of mRNAs and pathways 
(Song et al., 2013). More precisely, a comparison of microarray results from 
Dcp2β/β, β-geo cassette inserted into intron 1 of the Dcp2 gene, Nudt16 
knockdown and Dcp2β/β /sh-Nudt16 MEFs demonstrated that only a subset of 
mRNAs are jointly regulated by Dcp2 and Nudt16, with their stabilities 
increasing upon reduction of both proteins (Song et al., 2013; Song et al., 
2010). Further studies were based on MEF cells depleted of Dcp2 or Nudt16 
and transfected with plasmids encoding either transcripts lacking a nonsense 
mutation or its nonsense mutation-containing. Comparison between the two 
transcript populations was analysed by quantitative real-time PCR and authors 
shown that NMD preferentially utilises Dcp2 over Nudt16, Dcp2 and Nudt16 are 
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redundant in microRNA-mediated silencing but differentially used for ARE-
mRNA decay (Li et al., 2011). 
 
In the 3’->5’ decay, following the deadenylation, the RNA is degraded by the 
exoribonuclease complex, called the exosome (Chlebowski et al., 2013). In this 
process, the m7G is further hydrolysed by a scavenger decapping enzyme 
called DcpS, that specifically targets methyl capped RNA 10 nt in length (Liu et 
al., 2002; Wang & Kiledjian, 2001).  
 
In mammals, DXO decapping enzyme has been recently identified to function 
as quality control mechanism that targets incomplete cap structure pre-mRNAs 
(Jiao et al., 2013). It was reported that aberrant capped pre-mRNAs do not 
proceed into normal RNA processing of splicing and polyadenylation but they 
are degraded by DXO. All these different complexes give an idea about the 
specialized mechanism cells evolved to tightly control and regulate the release 
of viable and functional transcripts and simultaneously prevent the accumulation 
of potentially deleterious mRNAs. 
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1.7  Embryonic stem cells 
The processes discussed above describe the gene expression pathway and the 
important role that the synthesis of the methyl cap plays within the different 
steps of the process. As previously mentioned, through regulation of gene 
expression, cells spatiotemporally express specific genes required to fulfil their 
biological role. For example, a specific gene expression machinery allows 
embryonic stem cells to self-renew while maintaining the concomitant possibility 
to differentiate into any cell type according to the environmental stimuli (Young, 
2011).  
 
1.7.1 What is an embryonic stem cell? 
In 1970 it was reported that early mouse embryos grafted into adult mice 
generated malignant multidifferentiated tumours known as teratocarcinomas 
(Solter et al., 1970; Stevens, 1970). Within the tumour there are undifferentiated 
cells, named embryonal carcinoma (EC), which can be propagated in culture 
and are able to differentiate in all three germ layers: ectoderm, mesoderm and 
endoderm, like EC cells derived from spontaneous germ cell teratocarcinomas 
a few years earlier (Kleinsmith & Pierce, 1964; Martin & Evans, 1975). 
Therefore, the stem cells of teratocarcinomas were the first self-perpetuating 
pluripotent cells to be characterized. In 1981, permanent pluripotent cell lines 
were derived directly from the inner cell mass (ICM) of mouse blastocyst. These 
cells exhibited the same features of teratocarcinomas stem cells and were 
termed embryonic stem cells (ESCs) to specify the embryo origin and to 
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distinguish them from embryonal carcinoma (EC) cells (Evans & Kaufman, 
1981; Martin, 1981). 
ESCs harbour three hallmarks: they undergo symmetrical self-renewing 
divisions, they are pluripotent as they are able to differentiate into any fetal and 
adult cell lineages, and if incorporated into blastocyst-stage embryos, they can 
contribute to functional tissue generation (Smith, 2001). The stem cells potential 
to generate both stem cells and differentiated cells generated controversy in the 
field for the type of division stem cells may undergo. In fact, one strategy by 
which stem cells could accomplish both self-renewal and ability to differentiate 
is via asymmetric cell division, whereby each stem cell divides to generate one 
daughter with a stem cell fate and the other able to differentiate (Clevers, 2005). 
On the other hand, with the symmetrical cell division each stem cell can divide 
symmetrically to generate either two daughter stem cells or two differentiated 
cells. Within a population, a pool of stem cells with equivalent developmental 
potential may produce only stem-cell daughters in some divisions and only 
differentiated daughters in others (Morrison & Kimble, 2006). Therefore, 
symmetrical division is required to expand a stem cell pool or to commit stem 
cell to differentiation. The evidence for symmetrical cell division is well 
documented in C. elegans, Drosophila and vertebrates and are well described 
in wound heling and regeneration (Morrison & Kimble, 2006). The unlimited 
expansion and the multilineage differentiation of ESCs cells, caught the 
worldwide scientific interest and few years later, human ESCs (hESCs) cells 
were also derived from human blastocyst (Thomson et al., 1998). The unique 
features of ESCs led to expectations that these cells might be useful to treat a 
host of degenerative diseases, such as Parkinson’s disease and diabetes, as 
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well as injuries, such as spinal cord injury. However, clinical application of 
hESCs cells raises issues about the ethical use of human embryos and 
problems with tissue rejection after implantation. A major breakthrough in the 
field was the generation of pluripotent cells directly from somatic cells 
(Takahashi & Yamanaka, 2006). By reprogramming somatic cells, the ethical 
issues were circumvented. Once established, these cells may be used in 
regenerative medicine and also to elucidate disease mechanisms and to screen 
drugs.  
 
1.7.2 How is pluripotency maintained? 
1.7.2.1 Extrinsic factors 
For each cell division, ESCs have to decide whether to self-renew or to 
differentiate. The instructions and signals to balance the two choices come from 
the growth factors present in the external environment and from internal 
regulators. Mouse ESCs (mESCs), were initially co-cultured with mitotically 
inactivated mouse embryonic fibroblast (MEFs) (Evans & Kaufman, 1981; 
Martin, 1981), but later studies on leukemia inhibitory factor (LIF) null fibroblasts 
elucidated that the fibroblast feeder layer dependency was due to the 
production of LIF (Smith et al., 1988; Stewart et al., 1992). LIF belongs to the 
interleukin-6 cytokine family and its effect is mediated by heterodimerization of 
the cytokine receptors LIF receptor (LIFR) and gp130. Stat3 is then recruited to 
the receptor complex where it is phosphorylated by Jak, resulting in its 
subsequent dimerization, nuclear translocation and target gene activation 
(Darnell, 1997). Inactivation of Stat3 promotes spontaneous differentiation thus 
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Stat3 is essential for LIF-R/gp130-mediated mESCs self-renewal (Niwa et al., 
1998). However, the findings that cells require the presence of serum coupled 
with the evidence that hESCs do not need LIF, suggested that other external 
regulators could play a role in the maintenance of pluripotency. In fact, it was 
reported that a critical signal contribution comes from the bone morphogenetic 
proteins (BMPs), which act via the Smad pathway and induce expression of 
inhibitor of differentiation (Id) genes to suppress differentiation (Ying et al., 
2003a).  
 
Additionally, a role for Wnt-dependent signalling in self-renewal of human and 
murine ESCs was reported. The activation of Wnt pathway leads to inhibition of 
Glycogen Synthase Kinase 3 (GSK3) that in turn results into nuclear 
accumulation of β-catenin, which eliminates the repressive influence of Tcf3 on 
the pluripotency network (Wray et al., 2011). Wnt signalling can be activated by 
direct, intracellular inhibition of GSK3 using specific inhibitor.  
Activation of the canonical Wnt pathway was shown to maintain the 
undifferentiated phenotype as it sustains the expression of pluripotency factors 
such as Oct4 and Nanog (Sato et al., 2004). Therefore, LIF, BMP and Wnt, 
together with others, synergistically act to maintain self-renewal and 
pluripotency of mESCs. Some pathways have also common targets as for 
example LIF and Wnt that converge on c-Myc, whereby the former ensures the 
gene transcriptional activation and the latter c-Myc protein stability through 
inhibition of T58 phosphorylation (Cartwright et al., 2005). It is well established 
that the culture conditions required for maintenance of mESCs and hESCs are 
different. hESCs do not need LIF but instead require Fgf2 and Activin/Nodal 
signalling to sustain self-renewal (Ohtsuka & Dalton, 2008). 
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1.7.2.2 Intrinsic factors 
Cells sense and respond to their cellular and biochemical environment through 
signal transduction pathways, which can deliver information to the genome in 
the form of activated transcription factors or cofactors. Transcription factors 
(TFs) are class of proteins that bind to both promoter proximal and distal DNA 
elements of target genes and in mammals, approximately 10% of all protein-
coding genes encodes for transcription factors emphasising the important role 
of these proteins (Levine & Tjian, 2003). In ESCs, Oct4, Sox2 and Nanog 
constitute the “core” pluripotency factors required to maintain stem cells in 
undifferentiated state (Avilion et al., 2003; Chambers et al., 2003; Mitsui et al., 
2003; Nichols et al., 1998; Niwa et al., 2000). 
 
Oct4 belongs to the POU factors which recognise the octamer motif 
ATGCAAAT. The POU class includes the Pit, Oct and Unc transcription factors 
that interact with DNA through two DNA-binding domains: POU-specific and a 
higher affinity POU-homeodomain, connected by a flexible linker (Phillips & 
Luisi, 2000). In the mouse blastocyst, Oct4 is expressed in the ICM but 
downregulated in trophectoderm and when Oct4−/− embryos were cultured in 
vitro, the developmental potential was restricted to trophectodermal lineage 
since none of ICM-derived structures were observed (Nichols et al., 1998). 
Moreover, a study based on Oct4 conditional expression and repression 
showed that increase in Oct4 levels causes differentiation into primitive 
endoderm and mesoderm, whereas Oct4 repression results in dedifferentiation 
to trophectoderm (Niwa et al., 2000).   
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Sox2 is a member of the Sox (SRY-related HMG box containing) family that 
binds DNA through the 79-amino acid high mobility group (HMG) domain. 
Similarly to Oct4, Sox2 is expressed in the ICM, but also in the extra embryonic 
ectoderm in the early embryo and in developing central nervous system (CNS) 
(Avilion et al., 2003). As for Oct4, Sox2-null cells differentiated primarily into 
trophectoderm (Masui et al., 2007). Oct4 and Sox2 bind to adjacent sites within 
the enhancer of target genes resulting in a ternary complex protein-protein-
DNA. The physical interaction is a prerequisite for the enhancer activity and it is 
now established that Oct4 and Sox2 function as heterodimer binding to 
common target genes regulating their expression (Ambrosetti et al., 1997; 
Ambrosetti et al., 2000; Botquin et al., 1998; Nishimoto et al., 1999; Williams et 
al., 2004; Yuan et al., 1995). Moreover, it has been shown that Sox2 contributes 
to pluripotency by regulating Oct4 levels (Masui et al., 2007). 
 
Nanog protein contains a homeodomain which shares a maximum of only 50% 
amino acid identity with members of the NK2 family, making Nanog a divergent 
homeodomain protein. Nanog was identified by two distinct groups either with 
functional cDNA expression cloning or an in silico differential expression 
analysis (Chambers et al., 2003; Mitsui et al., 2003). Nanog is first detected in 
the morulae and in the ICM but it is downregulated prior to implantation. nanog-
deficient ICM failed to generate epiblast as they expressed markers of both 
parietal and visceral endoderm (Mitsui et al., 2003). On the contrary, 
constitutive Nanog expression confers cytokine independent self–renewal to 
undifferentiated ESCs and based on this phenotype the gene was named after 
Tir Na Nog, the Land-of-the-Ever-Young Celtic myth (Chambers et al., 2003). 
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ESCs with reduced Nanog levels have higher propensity to differentiate unless 
Nanog is re-expressed (Chambers et al., 2007). Differently from the uniform 
Oct4 levels, Nanog is heterogeneously expressed within the cell population as 
low-Nanog-level cells, with higher propensity to differentiate, coexist with high-
Nanog-level cells, which on the contrary, exhibit high self-renewal efficiency. 
This heterogeneity confers different degrees of responsiveness to differentiation 
signals in individual cells and allows to maintain a percentage of cells resistant 
to differentiation (Abranches et al., 2013; Chambers et al., 2007).  
 
c-Myc, despite not being a part of the core pluripotency network, is another 
fundamental TF required for stem cell pluripotency (Chen et al., 2008; Hu et al., 
2009; Kim et al., 2008). c-Myc binds to physiological target genes through a 
heterodimer complex with basic region helix-loop-helix/leucine zipper  protein 
Max (Dunn & Cowling, 2015). The N-terminal domain includes the transcription 
activation domain. Additionally to Max, the proteins TFII-I, BRCA1 and MIZ-1 
have been implicated in interactions with this region. Dimerization of Myc with 
MIZ-1 leads to its recruitment to MIZ-1 responsive genes causing histone 
deacetylation, promoter DNA methylation and consequently repression of 
transcription (Peukert et al., 1997). Fundamentally important for Myc to promote 
transformation is its interaction with transformation-transactivation domain-
associated protein (TRRAP), which recruits a histone acetyltransferase (HAT) 
complex that acetylates histone H4, thereby opening chromatin structure and 
promoting transcription at Myc-bound genes (Nikiforov et al., 2002). Moreover, 
a biotin labelling technique has recently identified and validated as DNA 
helicase protein chromodomain as novel Myc interacting partner (Dingar et al., 
2015). 
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Cartwright and colleagues identified c-Myc as a direct target of LIF/Stat3 
pathway and therefore it is required for the maintenance of pluripotency. 
Following LIF withdrawal, c-Myc downregulation occurs via phosphorylation by 
GSK3β on Threonine-58 leading to its ubiquitin-dependent degradation 
(Cartwright et al., 2005). c-Myc works as a universal amplifier of gene 
expression and this explains the plethora of physiological processes it is 
involved in (Nie et al., 2012).  
 
1.7.3 Induced pluripotent stem cells 
The critical role of the above TFs in specifying stem cell identity was further 
documented when mouse and human embryonic fibroblasts were 
reprogrammed to induced pluripotent stem (iPS) cells by overexpression of 
Oct4, Sox2, c-Myc and Klf4 (Takahashi et al., 2007; Takahashi & Yamanaka, 
2006). This evidence proved that those factors have a hierarchical role in 
driving expression of genes that are required to maintain the undifferentiated 
state. The first reprogramming process was achieved through retroviral 
transduction with 24 transcription factors highly expressed in ES cells. This 
cadre of genes was gradually reduced to four that encode the transcription 
factors octamer Oct4, Sox2, Klf4, and c-Myc (Takahashi & Yamanaka, 2006). A 
major limitation of reprogramming strategies was the use of potentially harmful 
genome integrating viruses to deliver reprogramming factor transgenes. 
Therefore other alternative gene factor delivery systems have been approached 
including the doxycycline-inducible excisable piggyBac (PB) transposon system 
(Woltjen et al., 2009). iPS cells exhibit the morphology and growth properties of 
ES cells and express ES marker genes, however controversy in the field comes 
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from evidence that question the similarity of the two cell types. In fact,  recent 
works comparing the gene expression profiles of ESCs and iPSCs have 
suggested that iPSCs, regardless of their origin or the method by which they 
were generated, are a unique cellular subtype distinct from ESCs (Chin et al., 
2009). ChIP followed by hybridization to a human promoter array indicated that 
the hiPSCs had not acquired a completely novel epigenetic identity and that 
hiPSCs have a miRNA signature that defines them as unique from hESCs (Chin 
et al., 2009; Marchetto et al., 2009). 
 
Moreover, despite the generation of iPS cells offers promising opportunities for 
patient-specific pluripotent cell-based regenerative medicine, a major concern is 
their potential to develop tumours. A part form Myc, which is a well established 
oncogene, also the other reprogramming factors are also known to be highly 
expressed in various types of cancer (Ben-David & Benvenisty, 2011). It was 
also reported that reactivation of the reprogramming factors predispose iPSCs 
to genomic instability and thus promotes tumorigenicity (Ramos-Mejia et al., 
2010). Similar data were reported for murine iPS whereby histological analysis 
showed that mice derived from iPSCs developed different tumours in different 
organs (Tong et al., 2011). Therefore, a more comprehensive knowledge of the 
reprogramming process is crucial for future clinical applications of iPS cells. 
 
1.8  Gene expression in stem cells  
1.8.1 The core pluripotency network 
To gain more insight into how pluripotency is maintained, genome wide 
analyses in mouse and human ESCs were performed (Boyer et al., 2005; Loh 
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et al., 2006) and three main observations were made. Firstly, the core 
pluripotency factors Oct4, Sox2 and Nanog co-occupy hundreds of target genes 
recruiting other TFs to form multiple transcription factor binding loci (MTL) 
(Chen et al., 2008; Kim et al., 2008; Wang et al., 2006). Secondly, amongst the 
hundreds of target genes, the core TFs bind both actively expressed genes 
required for pluripotency but also lineage-specific genes silent in ESCs.  
Thirdly, each factor binds its own promoter suggesting the presence of self-
reinforcing autoregulatory loop mechanism (Jaenisch & Young, 2008). Oct4 and 
Sox2 positively regulate each other as they bind to the composite sox-oct 
elements in both Pou5f1 (gene encoding for Oct4) and Sox2 generating a 
positive feedback loop (Chew et al., 2005). This architecture presumes that the 
pluripotency factors could be homogenously expressed and initially, also Nanog 
was included in this positive feedback (Loh et al., 2006). However, contrary to 
Oct4 levels, Nanog is heterogeneously expressed within a cell population 
(Chambers et al., 2007). Recent evidence revealed that Nanog represses 
Nanog gene activation and this autorepression contributes to heterogeneous 
Nanog expression (Fidalgo et al., 2012; Navarro et al., 2012). The ability of 
Oct4, Sox2 and Nanog to positively regulate genes required for the 
maintenance of pluripotency, while repressing lineage commitment genes, may 
explain the ability of ESCs to self-renew and, at the same time, be able to 
differentiate in response to development cues. To accomplish this, pluripotent 
cells exhibit a peculiar gene expression landscape different from differentiated 
cells.  
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1.8.2 Chromatin structure in stem cells 
Undifferentiated cells exhibit a decondensed heterochromatin and a 
hyperdynamic binding of chromatin-associated proteins (Meshorer et al., 2006). 
This open chromatin structure confers stem cells the flexibility needed to initiate 
rapid induction of expression of lineage-specific genes (Efroni et al., 2008; 
Meshorer et al., 2006). Another peculiar feature of stem cell chromatin is the 
presence of bivalent domains, which exhibit the concomitant histone 
modification H3 Lysine 4 trimethylation (H3K4me3) and H3 Lysine 27 
trimethylation (H3K27me3), associated with transcription activation and 
repression, respectively (Bernstein et al., 2006). The H3K27me3 modification is 
catalysed by Polycomb repressive complex (PRC2) (Lee et al., 2006). During 
stem cell differentiation many bivalent marks are resolved to a monovalent one, 
suggesting they maintain the developmental genes in a poised state, ready to 
be activated when the differentiation pathways are triggered (Mikkelsen et al., 
2007). Also chromatin regulatory proteins are actively involved in the 
maintenance of self-renewal and pluripotency. For example, Tip60-p400 
represses differentiation genes to maintain ESCs identity (Fazzio et al., 2008), 
whereas INO80 complex, selectively occupies promoters of core pluripotency 
genes and facilitates the recruitment of RNA Pol II to those genes (Wang et al., 
2014a). 
 
1.8.3 Control of transcription in stem cells 
Genes transcribed by RNA polymerase II typically contain two distinct families 
of cis-acting transcriptional regulatory DNA elements: (a) a promoter, which is 
the region of the gene at which RNA Pol II binds to initiate transcription and (b) 
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distal regulatory elements, which can be enhancers, silencers, insulators, or 
locus control region (LCR) (Spitz & Furlong, 2012). Enhancers, despite being 
situated distal to promoters, located upstream or downstream the core 
promoter, increase gene expression by recruiting different TFs, RNA Pol II and 
chromatin remodelling enzymes. ChIP-based high-throughput assays have 
mapped the binding sites of pluripotency-associated TFs (Chen et al., 2008; 
Kim et al., 2008) and their co-regulators in mESCs. Two different modules were 
identified: the “Oct4-centric” and “Myc-centric” modules. The core pluripotency 
network factors and c-Myc are bound at different position across the genome 
and their location is intimately connected to the mechanism by which they 
regulate transcription in stem cells. The “Oct4-centric” includes the Oct4, Sox2 
and Nanog triumvirate additionally to Zfp281, Esrrb, Nr5a2, Tcfcp2l1, Klf4, 
Smad1, Stat3 and Tcf3, the last three being the downstream effectors for 
signalling pathways controlled by BMP, LIF and Wnt respectively. This module 
clearly elucidates the interplay between the extracellular signals and the core 
transcriptional regulatory network (Boyer et al., 2005).  
 
The “Oct4-centric” module is mainly located at enhancer sites of their target 
genes and depending on the association with other factors, it can either 
promote or repress gene expression. The association of Oct4 with the above 
TFs as well as with p300 cofactor and the Mediator, which physically and 
functionally connects the enhancers and the core promoters of active genes, 
helps to recruit RNA Pol II, thus promoting expression of those genes required 
for pluripotency (Chen et al., 2008; Kagey et al., 2010; Kim et al., 2008).  
Recent studies identified super-enhancers as a cluster of enhancers bound by 
Oct4, Sox2, Nanog as well as Klf4 and Esrrb (Whyte et al., 2013). Super-
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enhancers are mostly found on key pluripotency genes, including Oct4, Sox2 
and Nanog themselves. Super-enhancers drive high-level expression of their 
associated genes (Hnisz et al., 2013) and as a consequence, super-enhancer 
associated genes are more vulnerable to perturbation of their components and 
they are often the first genes to be downregulated during ESCs differentiation.  
Some developmental genes are marked by the presence of bivalent domains 
that allow those genes to be silenced to maintain pluripotency but 
simultaneously poised for activation (Bernstein et al., 2006). It was shown that 
PCR2 occupies these developmental genes (Ku et al., 2008). The core 
pluripotency factors were found to occupy the promoters of lineage-specific 
genes already occupied by PRC2. This co-occupancy reveals an intimate link 
between repression of developmental regulators and cell pluripotency (Lee et 
al., 2006). The picture that emerges is that the core pluripotency factors, 
occupying promoters with different complexes, form a complicated network that 
drives the expression of pluripotency genes and the repression of lineage 
commitment ones. 
 
The “c-Myc-centric” module comprises c-Myc, n-Myc, E2f1, Zfx, Rex1 and 
Ronin (Chen et al., 2008; Kim et al., 2008) and contrary to the core pluripotency 
factors, this module is found at the promoter sites of paused genes. c-Myc 
recruits P-TEFb to alleviate RNA Pol II stalling. As mentioned previously, the 
catalytic subunit of P-TEFb, Cdk9, phosphorylates the CTD of RNA Pol II at 
Serine-2 position, thus promoting transcription elongation (Rahl et al., 2010).  
Therefore, c-Myc rather than acting as a transcription activator, functions as a 
universal amplifier of all genes that are already “on” but paused (Nie et al., 
2012). Combined together, the data suggest that Oct4, Sox2 and Nanog mark 
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the set of ESCs genes for an active expression and recruit RNA Pol II to those 
genes, while c-Myc regulates the efficiency of their transcription by promoting 
RNA Pol II pause release (Young, 2011).  
 
The undifferentiated cells present a unique and complex transcriptional profile 
and each component of the gene expression machinery collaborates to 
maintain pluripotency. The general transcription factor IID (TFIID) contains TBP, 
which recognizes the promoter sequence, additionally to 13 TBP associated-
transcription factors (TAFs). The ability of TFIID to bind the promoter makes it 
essential for the initiation of transcription by RNA Pol II. In mESCs TFIID is 
highly expressed and its depletion induces downregulation of pluripotency 
genes and concomitant upregulation of lineage–specific genes. These findings 
lead to the conclusion that TFIID is required to maintain the transcriptional 
program of undifferentiated cells (Pijnappel et al., 2013). 
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Figure 1.6: Illustration of the Oct4-centric and c-Myc-centric modules. 
ChIP-based high-throughput assays mapped the binding sites of pluripotency-associated 
transcription factors and their co-regulators in mESCs and two modules were identified. 
(a) In the Oct4-centric, the core pluripotency network binds at the enhancer site of target 
genes and interacts with many other transcription factors. The transcriptional co-activator 
p300 is almost exclusively localised to Oct4/Sox2/Nanog targets and helps recruiting 
RNA pol II as it bridges the interaction between the enhancer-bound transcription factors 
and RNA Pol II. (b) The c-Myc module is mainly found at the transcription start site and 
promotes transcription of a large population of genes in ESCs by alleviating the RNA Pol 
II pause. 
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1.8.4 Translational regulation in stem cells 
The abundance of chromatin-remodelling factors in ESCs endows the genome 
a preferential open conformation that facilitates the access of the transcriptional 
machinery and the stochastic formation of PIC even on silenced genes. These 
features result in a global transcriptional activity, which accounts for another 
hallmark of undifferentiated state (Efroni et al., 2008). It was also found that in 
ESCs, normally repressed genome regions, such as satellite repeats, 
transposons and many tissue-specific genes are stochastically transcribed at 
low levels, and as soon as cells undergo differentiation, global transcription is 
gradually reduced, most prominently in these intergenic regions. However, 
whether the permissive transcripts generate functional proteins was not clear at 
that time.  
 
Sampath and colleagues started to bridge the gap between transcriptome and 
proteome profiles that arises during ESCs differentiation. They studied the gene 
expression between undifferentiated cells and embryoid bodies performing a 
translation state array analysis (TSAA) that combines global assessment of 
ribosome loading with microarray analysis (Sampath et al., 2008). They 
observed that, despite undifferentiated cells present a global transcriptional 
activity, they display a parsimonious translation, as indicated by the abundance 
of free ribosomes. On the contrary, when stem cells differentiate, an increase in 
transcript engagement with ribosomes occurs, leading to a higher translation 
efficiency, therefore elevating protein synthesis.  
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The hypothesis of tight translation levels in pluripotent cells is further supported 
by a recent study about the elF4E-binding proteins (4E-BPs). Initiation is the 
rate-limiting step of translation and is subjected to an extensive control 
(Sonenberg & Hinnebusch, 2009). At this step, mRNA is recruited to the 
ribosome by eIF4F complex, which amongst other factors, contains the cap-
binding protein eIF4E. 4E-BPs are translational inhibitors that when 
dephosphorylated avidly bind elF4E inhibiting the assembly of elF4F complex, 
consequently preventing translation initiation. mESCs maintain 4E-BP1 
hypophosphorylated whereas differentiation induces phosphorylation and thus 
promotes the translation of lineage-specific mRNAs (Tahmasebi et al., 2014). 
Authors found that the low 4E-BP1 phosphorylation state is a feature of 
pluripotent cells, both ESCs and iPSCs. 
 
1.9  RNA binding proteins in pluripotency 
The study of protein-nucleic acid interaction initially focused its efforts on DNA 
binding proteins. However, the biochemical properties of RNA, the complexity of 
the processes in which RNA is involved, and the documented deregulation of 
RNA binding proteins (RBPs) with several human disorders (Cooper et al., 
2009), brought the attention to the biology of RBPs (Sharp, 2009). The technical 
development of a cross-linking and immunoprecipitation assay (CLIP) (Ule et 
al., 2005) and the further improvement of the technology (Darnell, 2010), found 
that numerous RBPs are involved in the maintenance of pluripotency and in the 
reprogramming processes (Guallar & Wang, 2014; Kwon et al., 2013).  
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RBPs play an important role in all successive steps that follow pre-mRNA 
transcription, including maturation, transport and stabilization, thus directly 
influencing the protein synthesis. Particularly the “Myc-centric” module relies on 
RBPs to accomplish its regulatory function (Kwon et al., 2013).  
 
1.9.1 RPBs in mRNA processing: splicing and polyadenylation  
As mentioned earlier, the splicing consists of the removal of introns and the 
following joining of exons together (Braunschweig et al., 2013). The alternative 
splicing (AS) event represents a real strategy to increase the biological 
complexity referable to a single locus. Recent studies showed that during stem 
cells differentiation the repertoire of splice isoforms is gradually reduced (Wu et 
al., 2010) and therefore it is assumed that splice variants are important for the 
maintenance of pluripotency. The major evidence is that the pluripotency 
transcription factors Dnmt3b, Nanog, Sall4, and Oct4 are themselves subjected 
to AS (Das et al., 2011; Rao et al., 2010; Tsai et al., 2014). Importantly, the 
different splice versions can fulfil different and even opposite roles as shown for 
Forkhead box (Fox). The FOXP1-ES specific isoform stimulates the expression 
of Oct4 and Nanog and thus sustains pluripotency, whereas the other variant 
promotes differentiation (Gabut et al., 2011). SON and Tip110 are RBPs 
identified in human ESCs, required to specifically regulate the OCT4A, active 
splicing version of OCT4 and other pluripotency regulators (Liu et al., 2012; Liu 
et al., 2013; Lu et al., 2013). It has been shown that knockdown of SON results 
in human ESCs differentiation. In mESCs, Nanog, but not Oct4 or Sox2, was 
found to be bound to another RBP known as Rbm47 but further studies are 
needed to elucidate its function (Yeganeh et al., 2013).  
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Collectively, these findings suggest that the RBPs regulate the AS of 
pluripotency transcripts in a gene specific manner. 
 
Additionally to methyl cap synthesis and splicing, the third step of mRNA 
maturation consists in the addition of the poly(A) tail catalysed by a 
polyadenylate polymerase (PAP) and the cleavage by polyadenylation 
specificity factor (CPSF). An alternative polyadenylation (APA) generates 
different 3’UTRs that in turn affect stability, translation and localization of 
mRNAs and thus their expression (Di Giammartino et al., 2011). It was reported 
that stem cells are characterized by short 3’ UTR (Mueller et al., 2013) and a 
recent study revealed that Fip1, RBP of the CPSF complex, promotes self-
renewal by regulating the APA profile of critical pluripotency markers. In fact, 
depletion of Fip1 caused a decrease in levels of pluripotency markers and a 
reduction in the reprogramming efficiency (Lackford et al., 2014). Therefore, 
APA regulation serves as fine-tuning mechanism for gene regulation in ESCs, 
adding a new layer of control of self-renewal and pluripotency.  
 
1.9.2 RPBs involved in mRNA nuclear export  
Apart from gene specific mRNA processing, a selective nuclear transport 
constitutes another layer of RNA-related regulation of pluripotency. As 
previously mentioned, the export of mRNA from the nucleus to the cytoplasm is 
mediated by several adaptors amongst which is THO/TREX complex. The 
THO/TREX couples mRNA biogenesis with the nuclear export of mature 
transcripts. The RPBs Thoc5 and Thoc2, components of the THO complex, 
were recently identified in genome-wide siRNA screens searching for ESCs 
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self-renewal factors (Ding et al., 2009). Further studies revealed that their 
expression is correlated with the pluripotent state and their depletion leads to 
ESCs differentiation (Wang et al., 2013). In fact, knockdown of the two 
components caused reduction in the association of polysome with Nanog, Sox2, 
Klf4 and Esrrb mRNAs resulting in a decrease of their protein levels. However, 
the impairment in the protein levels was not accompanied by a decrease in their 
transcript abundance and this discrepancy was caused by retention of the 
respective transcripts in the nucleus, thus preventing them from translation. 
Therefore it was concluded that THO properly directs some pluripotency 
transcripts for nuclear export to the cytoplasmic translation machinery in a 
Thoc5 dependent manner. Interestingly, Oct4 expression was not affected by 
Thoc2 or Thoc5, further supporting that RBPs exert their functional role on 
some pluripotency transcripts but not others, thus regulating pluripotency in a 
gene specific manner.  
 
Adaptor proteins interact with the nuclear receptors to mediate the export of 
mRNAs, whereas karyopherins, including both Importin and Exportin, are 
mobile targeting receptors that mediate the bidirectional trafficking of 
macromolecules across the nuclear envelope (Fried & Kutay, 2003). Also 
karyopherins collaborate to maintain the undifferentiated cell state, by 
modulating the import/export of specific proteins. Importin-α binds the cargo 
through its NLS binding site. Following the recognition of the cargo NLS, 
Importin-α dimerizes with Importin-β which directly interacts with the 
nucleoporins allowing the cargo translocation. There are several Importin-α 
family members and a recent study revealed that a particular subtype, Importin-
α2, is required to maintain pluripotency. 
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The mechanism proposed is that in undifferentiated cells, Importin-α2 is able to 
selectively mediate Oct4 nuclear import, while retaining differentiation factors 
Oct6 and Brn2 in the cytoplasm (Yasuhara et al., 2013). Importin-α2 is highly 
expressed in ESCs and its expression is reduced during differentiation, whereas 
Importin-α1/4 levels exhibit the opposite trend, possibly to allow the import of 
the TFs required for the lineage commitment. Therefore, the dual Importin-α2 
activity and the various expression patterns of its different subtypes contribute 
to maintain pluripotency via regulating TFs localization. 
 
1.10 Decapping in stem cells 
As discussed earlier, RNA degradation plays an important role in the regulation 
of gene expression, therefore it is not surprising that mRNA decapping process 
collaborate to maintain the pluripotency. Utf1, one of the downstream targets of 
Oct4 and Sox2, apart from preventing the excessive loading of PRC2 on 
bivalent gene, is also able to repress genes through mRNA pruning (Jia et al., 
2012). More precisely it was shown that Utf1 recruits Dcp1a (a non-catalytic 
subunit of the mRNA decapping complex) to the bivalent promoters and 
therefore it promotes the degradation of mRNAs transcribed from leaky bivalent 
genes, actively participating in the repression of genes that are not required for 
pluripotency. 
 
1.11 mRNA modification 
The RNA modifications join the long list of multiple layers of gene expression 
regulation. The most abundant internal modification of mRNA of all higher 
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eukaryotes is the N6-methyladenosine (m6A). A recent research found that in 
mESCs the two methyltransferase like enzymes, Mettl3 and Mettl14, 
synergistically work to methylate the RNA of target genes (Wang et al., 2014b). 
The depletion of the two enzymes by RNAi led to downregulation of the 
pluripotency markers and upregulation of developmental genes (more enriched 
in m6A) suggesting that m6A is involved in the maintenance of pluripotency. 
Further analysis demonstrated that the modification prevents the binding of a 
RNA stabilizer protein HuR. Therefore the model proposed is that the 
modification, destabilising the transcripts of lineage commitment genes, favours 
mESCs undifferentiated state. 
 
A parallel study based on Metll3 Knockout (KO) showed opposite results as 
rather than affecting mESCs viability and self-renewal, the Metll3 KO mESCs 
renewed at an improved rate and resulted in blocked differentiation (Batista et 
al., 2014). Consistently with Batista et al work, Guela and colleagues recently 
observed that depletion of m6A in mRNA of Metll3 KO mESCs hampers their 
priming and differentiation competence, which leads to a “hyper”-naïve 
pluripotency phenotype. Authors conclude that m6A acts as a timely maintainer 
of the balance between pluripotency and lineage priming factors, thus ensuring 
orderly differentiation of mESCs (Geula et al., 2015).  
These controversial findings about the effect of m6A suggest that more studies 
are required to fully understand how the mRNA modifications affect cell 
pluripotency. 
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Figure 1.7: Schematic representation of transcriptional and post-
transcriptional regulation of the ESCs state.  
In order to maintain pluripotency the gene expression program of stem cells is 
different from differentiated one. Transcription factors, chromatin remodelling 
enzymes, TFIID of RNA Pol II, alternative splicing, alternative polyadenylation, 
m6A and mRNA export function in concert to maintain pluripotency. 
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1.12 Summary and aim of the project 
Regulation of gene expression allows cells to spatiotemporally control their 
transcript and protein content to fulfil their biological role and adapt to the 
environmental cues. The synthesis of the N7-methylguanosine cap is 
fundamental within the gene expression pathway as CBC and elF4E proteins 
recognising the mRNA cap moiety, promotes RNA Pol II transcription initiation 
and elongation, mRNA splicing, 3’ end pre-mRNA processing, mRNA nuclear 
export, translation and stability. Recent studies reported that some transcripts 
are incompletely capped as they lack the methyl moiety on their cap structure 
and the decay of these aberrantly capped transcripts is mediated by specific 
decapping machinery (Jiao et al., 2013). Moreover, it was recently reported that 
growth factors and TFs regulate the formation of the methyl cap. Altogether 
these evidence strongly support that the m7G rather than being a constitutive 
process is subjected to an active regulation (Aregger & Cowling, 2013; Chang 
et al., 2012; Cole & Cowling, 2009). Within the mRNA cap synthesis, RNMT has 
been found to be associated with a small protein called RAM, which activates 
the enzyme and contains an RNA binding domain. RAM was recently identified 
(Gonatopoulos-Pournatzis et al., 2011) and despite its biochemical function 
being characterised (Gonatopoulos-Pournatzis & Cowling, 2014), its biological 
relevance remains elusive.  
 
As previously described, embryonic stem cells, in order to maintain the unique 
features of self-renewal and pluripotency, exhibit a peculiar gene expression 
landscape, whereby each singular event in the mRNA life cycle is regulated, to 
maintain the undifferentiated state.  
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All the events, orchestrated by the main TFs, function in concert to sustain 
ESCs state by activating pluripotency genes and simultaneously repressing 
lineage-specific genes (Young, 2011). Based on the important role of RNA 
binding proteins in the maintenance of pluripotency and considering mRNA cap-
dependent events, which are regulating gene expression, the investigation of 
mRNA cap methylation in stem cells may provide a novel insight into the biology 
of ESCs. Therefore, this PhD project aims to investigate whether RNMT and 
RAM are regulated during cell differentiation to ultimately uncover the role of 
cap methylation in undifferentiated cells.  
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2  Materials and Methods 
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2.1  Materials 
2.1.1 Lab equipment and consumables 
Automatic film processor (Konica Corporation)c, Autoradiography cassette 
(Siemens), C1000 thermal cycler (Bior-Rad), Cell countess (Invitrogen), Cell 
Lifter (Corning Incorporated), Centrifuge 5415-R (Eppendorf), CO2 incubators 
(Mackay+Lynn), Eppendorf Tubes (Star Lab),  Eppendorf Tubes (Star Lab), 
Falcon Tubes (Greiner), Falcon Tubes (Greiner), Filter 45 m (Sartorius), Filter 
Units (Thermo Scientific), Gel Loading Tips (Star Lab), Gel Loading Tips (Star 
Lab), Pipette Tips (Star Lab),  Phosphor screen (FujiFilm), Phosphorimager 
FLA-500 (FujiFilm), Pipette Tips (Star Lab), Pipettes (Greiner), Syringe needle 
(Terumo), Syringe needles (Terumo), Tissue culture safety cabinets (Medical 
Air technology), Versa Max microplate reader (Molecular Devices). 
 
2.1.2 Chemicals 
2-Mercaptoethanol (Sigma), Bridge (Merk), Dithiothreitol (DTT) (Formedium), 
Ethanol (VWR International), Glycerol (VWR International), Glycine (VWR 
International), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hepes) 
(Sigma), Formaldehyde (Sigma), Hydrochloric Acid (VWR International), 
Methanol (VWR International), Sodium Chloride (VWR International), Sodium 
Dodecyl Sulfate (SDS) (Sigma), Sodium Fluoride (Sigma), Tris-Base (VWR 
International), TritonX-100 (VWR International), Tween 20 (VWR International), 
Sucrose (VWR International). 
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2.1.3 Mammalian cell culture and maintenance 
100 mm Petri Dishes (Helena), 150 mm Petri Dishes (Helena), 6-Well Plate 
(Greiner), A8301 (DSTT), B27 supplement serum free (Gibco), Cover Glass 13 
mm (VWR International), Cryovials (Alpha Labs), DAPI (Sigma), DPBS 
(Invitrogen), DPBS (Sigma), Dulbecco’s Modified Eagle Medium (DMEM) 
(Invitrogen), Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 (Gibco), 
Fetal Bovine Serum (FBS), .C. Approved (Invitrogen), Gelatin from porcine skin 
(Sigma), Glasgow MediGlasgow Minimum Essential Medium (GMEM) (Sigma), 
Kanamycin (Sigma) Knockout Serum Replacement (Gibco), L-Ascorbic acid 
(Sigma), L-Glutamine (Gibco), Lipofectamine 2000 (Invitrogen), MG132 
(Sigma), Lipofectamine RNAiMax (Gibco), Neurobasal media (Gibco), Non-
Essential Amino Acids (Gibco), Penicillin/Streptomycin (Invitrogen), Puromycin 
(Sigma), Sodium Pyruvate (Gibco), Trypan Blue solution (0.4%) (Sigma), 
Trypsin-EDTA solution (Invitrogen). 
 
2.1.4 Protein analysis 
40% Acrylamide : Bis-acrylamide 29:1 (Flowgen Biosciences), Ammonium 
Persulfate (APS) (Sigma), Aprotinin (Sigma), BenchMark Prestained Protein 
Ladder (Invitrogen), Bovine Serum Albumin (BSA) (NE BioLabs), DAPI 
Fluorescent Stain (Invitrogen), Donkey Serum (Sigma), Dried Skimmed Milk 
(Marvel), Immobilon Transfer Membrane (Millipore), Leupeptin Hydrochloride 
(Sigma), NNN’N’-Tetramethyletylenediamine (TEMED) (VWR International), 
Pepstatin (Sigma), Phosphatase Inhibitor Cocktail 2 (Sigma), Phosphatase 
Inhibitor Cocktail 3 (Sigma), Protein A/G PLUS-Agarose (Santa Cruz 
Biotechnology), X-RAY FILM (Konica Minolta). 
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Table 2.1: Buffers and solutions employed for experiments in this study. 
Buffer Composition 
F-Buffer 10 mM Tris (pH 7.05), 50 mM NaCl, 30 mM Na 
pyrophosphate, 50 mM NaF, 10% Glycerol, 
0.5% Triton 
SDS Running buffer 25 mM Tris, 0.1% SDS, 250 mM glycine 
Transfer buffer 25 mM Tris, 192 mM glycine, 20% methanol 
TBST 25 mM Tris (pH 8.1), 155 mM NaCl, 0.1% tween 
20 
4x Laemmli buffer 242 mM, 10% SDS, 25% glycerol, 100 mM DTT, 
bromophenol blue 
MT assay buffer 50 mM Tris (pH 8.0), 6 mM KCl, 1.25 mM MgCl2 
Ponceau Ponceau 5 % (v/v) Acetic Acid, 0.1 % (w/v) 
Ponceau S 
Gel filtration calibration 
buffer 
25 mM HEPES, 10 mM NaCl, 0.03% Bridge, 1 
mM DTT 
Polysome Lysis buffer 10% Triton x-100, 10 % sucrose buffer, 50µL 
RNAsin  
 
 
2.2  Methods 
2.2.1 Transformation of E.coli and plasmid purification 
For each transformation 25 µL of competent E. coli DH5α were incubated with 2 
µg of plasmid DNA on ice for 20 min. To facilitate the incorporation of the 
plasmid, heat-shock was performed by incubating cells at 45°C for 45 sec 
following by 5 min incubation on ice. Cells were then streaked on selective LB 
agar plates containing the appropriate antibiotic (50 µg/mL ampicillin, 50 µg/mL 
kanamycin) and inverted plated were incubated at 37°C overnight. A single 
isolated colony was then picked and grown in 200 mL of LB at 37°C overnight. 
In case of kanamycin selection the bacteria were incubated in SOC media for 
1hr at 37°C before plating.  
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Cells were then collected by centrifugation at 4000 rpm for 10 min at 4°C. DNA 
QIAprep Miniprep kit (Qiagen) was used to purify 5-10 µg DNA eluted in 50 µL 
distilled water according to manufacturer’s instructions. To produce large 
amount of plasmids DNA Maxi kit (Qiagen) was used according to 
manufacturer’s instructions. Typically 500-1000 µg DNA were resuspendend in 
1 mL of distilled water. 
 
2.2.2 Cloning  
Sequencing of the constructs was performed by the DNA sequencing service 
(College of Life Science, University of Dundee). All the constructs employed in 
this thesis (Table 2.2) encode the human orthologous of the gene and were 
cloned by Dr. Mark Peggie from the Division of Signal Transduction Therapy 
(DSTT) cloning team. All the constructs were used to transfect mESCs to make 
stable cell lines expressing the protein encoded in the plasmid. 
Table 2.2: List of cDNA constructs utilised for the purpose of this study. 
Construct Vector Clone Number 
Empty Vector pPyPCAGGS DU43266 
RAM-GFP pPYPCAGGS RAM GFP WBL DU42605 
FLAG-RAM pPYPCAGGS FLAG-RAM DU 42391 
FLAG-RAM S36 pPYPCAGGS FLAG-RAM S36 DU 42567 
 
 
2.2.3 DNA concentration and determination 
Nanodrop Spectrophotometer 1000 (Thermo Scientific) was employed to 
determine the concentration of purified DNA. A baseline measurement was 
performed using distilled water. The absorbance was measured at 260/280 nm 
according to manufacturer’s instructions. 
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2.2.4 Cell culture and maintenance 
All cell culture was carried out in a class II hood, using aseptic techniques, 
sterile equipment and reagents. All cell lines were cultured in at 37°C under 
humidified atmosphere containing 5% CO2. The 46C mouse embryonic stem 
cells were kindly provided by Dr. Marios P Stavridis (University of Dundee). 
mESCs were cultured in GMEM (Sigma) supplemented with 10% Knockout 
Serum Replacement (Invitrogen), 1mM Sodium pyruvate (Gibco), 1% Non-
Essential Amminoacids (Gibco), 0.35 µM beta-Mercaptoethanol (Gibco) and 
100 Unit of leukemia inhibitory factor (LIF). This media composition will be 
further referred as mESCs media. 
 
Primary MEFs were derived from 12.5 days old 129 Ola mice strain whereas 
immortalised MEFs were a kind gift form Ganley’s lab. Both primary and 
immortalised MEFs were cultured in Dulbecco's Modified Eagle's Medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM L-Glutamine, 
100 units/ml penicillin and 0.1 mg/ml streptomycin.  
 
For cell passaging, each flask of mESCs or MEFs was washed twice with 
Dulbecco’s phosphate buffered saline (DPBS), then 1 mL of 0.05% Trypsin-
EDTA (Gibco) was added and the flask was put back in the incubator to allow 
cell detachment. Following trypsinization, fresh media was added to the 
dissociated cells to neutralise the Trypsin-EDTA, mESCs and MEFs were spun 
down at 300 g for 5 min and at 1200 rpm for 3 min respectively. Cell pellet was 
resuspended in fresh media and plated in a new flask. For passaging or 
seeding mESCs, plates were coated with 0.1% gelatin for 10 min unless 
differently specified. 
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2.2.5 Cell counting  
Cell suspension was mixed 1:1 with Trypan blue (0.4%) and cells were then 
counted using a Countess cell counter (Life technologies) according to 
manufacturer’s instructions. 
 
2.2.6 Freezing cells 
Cryo-freezing was used for storage of all cell lines. mESCs and MEFs were 
grown in a 75 cm2 flask until 80% confluent and were then trypsinised as 
described above and pelleted at 300 g for 5 min and 1200 rpm respectively. The 
resultant pellet was resupsended in GMEM media (mESCs) or serum (MEFs) 
supplemented with 10% dimethyl sulphoxide (DMSO, Sigma) and transferred 
into a cryo-vial (1 mL aliquots for 1.5 mL cryo-vial). Cells were frozen gradually 
submerging the cryo-vials in propanol and placing the propanol container (Mr. 
Frosty) in -80°C. Cells were transferred in liquid nitrogen storage the following 
day. For cell recovery after liquid nitrogen storage, the cryo-vials were quickly 
thawed at 37°C and cells were washed in culture media to remove DMSO. Cells 
were then cultured in a 25 cm2 flask in the relative appropriate media. 
2.2.7 In vitro neural differentiation  
mESCs were grown in a 75 cm2 flask until 80% confluent and were then 
detached as aforementioned. Cell pellet was resupended in N2B27 medium 
consisting of one volume of DMEM/F12 combined with one volume of 
Neurobasal media. The mixed media was supplemented with 0.5% N2 
component (homemade) (Table 2.3), 2 mM L-glutamine, 1% B27 Supplement, 
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50 mM beta-mercaptoethanol (all from Gibco). 2.5x105 were seeded on 10 cm 
plates previously coated for 2 hr with 0.1% gelatin. Media was changed every 
two days in all experiments unless otherwise indicated.  
 
Table 2.3: List of components used to make N2 supplement.  
Final concentration of each component is shown. 
Component Final concentration 
Insulin from bovine pancreas (Sigma) 25 µg/ mL 
apo-Transferrin human 100 µg/ mL 
Progesterone (Sigma) 6 µg/ mL 
Putrescine (Sigma) 16 µg/ mL 
Sodium selenite (Sigma) 30 nM 
BSA Fraction V (7.5%) (Gibco) 50 µg/mL 
 
 
2.2.8 Generation of stable cell lines 
To make mESCs stably expressing the protein encoded in the plasmid (listed in 
Table 2.2), 1x 106 cells were seeded into a well of 6 well dish coated with 0.1% 
gelatin. Cells were then transfected with 3 µg of DNA using 3 µL Lipofectamine 
2000 (Life technologies) according to manufacturer’s instructions. 24 hr post 
transfection, transfected cells were dissociated using 0.05% Trypsin-EDTA and 
5x104 cells were seeded into a 10 cm plate previously coated with 0.1% gelatin. 
Successfully transfected cells were selected using 1.5 µg/mL of Puromicyn. 
 
2.2.9 Reprogramming 
Dr. Marios Stavridis kindly donated plasmids used to transfect MEFs: PB-TAP 
IRI 2OKSMimO (containing the reprogramming factors), AG-rtTA (reverse 
tetracycline transactivator) and HyPBase (transposase), the latter was kindly 
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provided by Dr. Keisuke Kaji (Woltjen et al., 2009). MEFs were seeded into a 
dish of a 6 well dish in mESCs media supplemented with 1 µg/µL Fgf2. The 
next day, 1.5 µg of DNA (0.5 µg of each plasmid) were combined with 6 µL of 
Fugene HD and 100 µL of Optimem and used to transfect seeded MEFs. After 
24 hr of transfection, media was changed with mESCs media supplemented 
with 1 µg/mL doxycycline (Sigma), 10 µg/mL Vitamin C (Sigma) and 500 nM 
A83-01 (Alk5 inhibitor, DSTT) to select transfected cells. Selection was carried 
out for 7 days following which selection media was substituted with mESCs 
media. iPSC colonies were isolated from untransfected MEFs and used for 
analysis. 
 
2.2.10 siRNA transfection 
siRNA-mediated RNA-Interference (RNAi) was employed to deplete RNMT and 
RAM expression level throughout this thesis. mESCs were transfected with 
siRNAs using Lipofectamine RNAiMax (Gibco) transfection reagent according to 
manufacturer’s instructions. In a well of 6 well dish, 1x105 cells were seeded 
and immediately transfected with 200pmol of siRNA (Table 2.4) combined with 
4 µL of Lipofectamine RNAiMax and 500 µL of GMEM serum free media. For 
the polysome profile analysis, the siRNA treatment was performed in a 10 cm 
dish where 2.5x106 cells were seeded and immediately transfected with 800 
pmol of siRNA combined with 16µL of Lipofectamine RNAiMax and 800 µL of 
GMEM serum free media. Cells were left to grow for 48 hr before harvesting. 
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Table 2.4: Oligonucleotide sequence of the siRNAs used in this study. 
All siRNAs employed were obtained from Dharmacon. 
siRNA target Catalogue details Sequence 
scRNA 4 D-001210-04-20 AUGAACGUGAAUUGCUCAA 
RNMT 1 D-059345-01-0050 GGAAAGAGGUGAUGUGUCG 
RNMT 2 D-059345-02-0050 CGGAUACGAUGCUUAGAAA 
RNMT 3 D-059345-03-0050 GCUUAACCCUGGCGGCUAU 
RAM 1 D-049592-01-0050 CAAGACAACAGACAAUUUA 
RAM 2 D-049592-02-0050 GACCAGAGCCCUACUAUCA 
RAM 3 D-049592-03-0050 GCAGAUUCACGAAAGAUGA 
 
2.2.11 Alkaline phosphatase 
To assess the pluripotency of mESCs, alkaline phosphatase activity was 
revealed using Alkaline Phosphatase (AP) staining kit (Sigma) according to 
manufacturer’s instructions. Cells were seeded into a dish of a 6 well dish and 
when 80% confluent were fixed with fixative solution for 30 sec. Cells were then 
rinsed in deionised water and incubated in the dark with the staining solution  
for 15 min. Cells were then washed and stained colonies counted. To reveal AP 
activity following siRNA treatment, cells were transfected with siRNA as 
previously described. 48 hr post transfection, cells were dissociated using 
0.05% Trypsin-EDTA and ~100 cells per well were seeded into 6-well dish 
previously coated with 0.1% gelatin. Cells were grown for 7 days and then 
stained for AP as described above. 
 
2.3  Mammalian Protein analysis 
2.3.1 Cell lysis 
Cell lysis was performed at 4°C to avoid protein degradation. Culture medium 
was removed and cells were washed twice with ice-cold PBS. Cells were lysed 
with F buffer (Table 2.1) supplemented with 1 mM DTT, 0.1 TIU (trypsin inhibitor 
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unit) Aprotinin, 1 µM pepstatin and 10 µM leupeptin. For immunoblot analysis of 
phosphorylated proteins the F-buffer was further supplemented with 
Phosphatase inhibitors (cocktail mixture 2+3) to avoid dephosphorylation of 
proteins. Cells were collected by scraping and left on ice for 10 min to be then 
centrifuged at 13000 rpm for 10 min at 4°C to separate cell extracts from 
cellular debris (pellet). Supernatant was collected and transferred into a new 
tube. Proteins concentration was estimated using Bradford method. 
 
2.3.2 Protein concentration determination 
Protein concentration was determined using Bradford reagent diluted 1 in 5 with 
distilled water. To generate a standard curve, dilution of Bovine Serum Albumin 
(BSA) were made in F buffer and 4 µL of each dilution, or F-buffer only used as 
blank, were added to 200 µL of 1x Bio-Rad protein assay reagent in a 96-well 
plate. The absorbance was measured at 595 nm with a plate reader. The 
measurement obtained from the blank was subtracted from all other samples 
measurements. A standard curve was derived by plotting the absorbance 
reading of the protein versus the concentration of BSA and a linear equation 
determined. The absorbance readings of whole extracts were performed in 
duplicate and the protein concentration of each sample was determined by 
plotting the average reading on the standard curve.  
2.3.3 Immunoprecipitation 
All the steps were performed at 4°C to avoid protein degradation. 1 mg of cell 
extracts were pre-cleared with Protein A/G Plus-Agarose (Santa Cruz) for 30 
min on a rotating wheel. The agarose beads were then pelleted at 4000 rpm for 
1 min.  
72 
 
The pre-cleared supernatant was incubated with 1 µg antibody (polyclonal anti-
RNMT or sheep polyclonal anti-RAM) and with Protein A/G-Agarose on a 
rotating wheel for 2 hr to precipitate the antibodies. Immunoprecipitates were 
pelleted by centrifugation at 4000 rpm for 4 min and washed three times with 1 
mL of F-buffer. Immunoprecipitated proteins were eluted in 50 µL of 1X Loading 
dye and 10-15 µL resolved by SDS-PAGE. Loading dye was also added to the 
input and to the flow through which were analysed alongside with the IPs. 
 
2.3.4 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE)  
SDS-PAGE was performed to resolve proteins according to the molecular 
weight. The resolving gel composition was made of 400 mM Tris-HCl pH 8.8, 
0.1% SDS and 8-15% acrylamide and water. The stacking gel was made 
combining 400 mM Tris base pH 6.8, 0.1% SDS, 5% acrylamide and water. To 
trigger the polymerization reaction APS and TEMED were added to final 
concentration of 0.1% (v/v) and 0.01% (v/v) respectively. Homemade gels were 
resolved in a Mini-PTROEAN Tetra Electrophoresis system (Bio-Rad) using 
SDS Running buffer (Table 2.1). Protein samples were combined with 1x 
Laemmli buffer (Table 2.1) and denatured at 100°C for 5 min and then 
centrifuged ad 13000 rpm for 1 min. In the first lane of each gel 5 µL of 
molecular weight markers were loaded. Marker and protein samples (Gibco) 
were separated at 150 V. The amount of protein resolved and the percentage of 
acrylamide gel used in the resolving gels for the detection of specific proteins 
are shown in table 2.5. 
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Table 2.5: List of the protein resolved by SDS-PAGE in this study.  
The molecular weight of the proteins, the amount of total protein extracts 
analysed and the percentage of acrylamide gel are indicated. 
Protein analysed Molecular 
weight (kDa) 
Amount of 
protein analysed 
(µg) 
% of Acrylamide 
gel 
RAM 15 15 15 
RAM S36 15 15 15 
RNMT 64 8 8 
Oct4 54 8 8 
Sox2 35 15 15 
Klf4 54 10 15 
Nanog 35 10 15 
Actin 50 8 8 
E-cadherin 120 10 8 
Vimentin 54 15 8 
c-Myc 70 15 10 
GFP 27 15 15 
Pax6 47 15 8 
Flag (M2) 9 15 15 
 
 
2.3.5 Western blot analysis  
After separation by SDS-PAGE, resolved proteins were transferred onto 
polyvenylfluoride (PVDF) membranes in transfer buffer (Table 2.1) using Mini 
Trans-Blot Cell (Bio-Rad) at 66 V for 90 min at 4°C. The transferred proteins 
were visualised by Ponceau S solution (Table 2.1) to ensure the efficient 
transfer. 
Subsequently, membranes were blocked for 60 min with TBST (Table 2.1) 
containing 5% milk or 3% BSA according to the primary antibody. Incubation 
with primary antibody was carried out overnight at 4°C. List of primary 
antibodies, blocking solution, working dilution and species where the secondary 
antibody was raised are listed in Table 2.6. Following incubation with the 
primary antibodies membranes were then washed three times with TBST to 
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remove eventual unbound primary antibody. The membranes were then 
incubated for 45 min with the appropriate secondary antibody at room 
temperatures. The membranes were then washed five times with TBST. 
Immunoreactive proteins were visualised on X-ray film using enhanced 
chemiluminescence reagent according to manufacturer’s instructions.  
 
Table 2.6: List of antibodies used for Western blot.  
The dilution of the antibody and the blocking reagent used are indicated. 
Target Company Cat N WB 
con 
Blocking 2nd Ab 
Dilution 
Species 
RAM In house / 1:100 BSA 1/1000 Sheep 
RAM 
S36 
In house / 1:1000 BSA 1/1000 Sheep 
RNMT In house / 1:1000 Milk 1/5000 Sheep 
Oct4 Abcam 18976 1:1000 BSA 1/5000 Rabbit 
Sox2 Cell 
Signalling 
4900 1:1000 5% BSA 1/1000 Mouse 
Klf4 Santa 
Cruz 
20691 1:1000 BSA 1:2000 Rabbit 
Nanog Abcam 80892 1:1000 BSA 1:2000 Rabbit 
Actin Abcam 3280 1:1000 Milk 1:5000 Mouse 
E 
cadherin 
BD 610181 1:5000 Milk 1:5000 Mouse 
Vimentin Abcam 92547 1:1000 BSA 1:4000 Rabbit 
c-Myc Cell 
Signalling 
9402S 1:1000 BSA 1:2000 Rabbit 
GFP Roche 11814460001 1:1000 BSA 1:1000 Rat 
Pax6  Santa 
Cruz 
11357 1:1000 BSA 1:1000 Rabbit 
FG (M2) Sigma F1804 1:1000 BSA 1:1000 Mouse 
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2.3.6 Gel filtration analysis 
mESCs were collected and lysed as previously described and passed through a 
20G needle 10 times and centrifuged at 14,000 g for 10 min at 4ºC. The 
supernatant was centrifuged at 100,000 g for a further 60 min at 4ºC. 1 mg cell 
extract was resolved on a Superose 6 column (10x300mm, 13μm particles, 
40nm pores, GE Healthcare). Before the run, the column was equilibrated in 
calibration buffer (Table 2.1). 0.5 ml fractions were collected, combined with 
Laemmli buffer and analysed by SDS-PAGE followed by western blot to identify 
elution profile of our proteins of interest 
 
2.3.7 Immunofluorescence 
Cells were seeded into round cover slides previously washed with Ethanol 70%. 
For the in vitro neural differentiation, cover slides were coated with Laminin 
(Sigma L2020) for 3 hrs. The whole protocol was performed at room 
temperature. The day of collection, culture media was removed and cells were 
washed twice with ice-cold PBS to be then fixed with fresh 4% 
paraformaldehyde for 30 min. Cells were then washed in PBS and 
permeabilised in 1% Triton X-100 diluted in PBS. Following which, cells were 
blocked with 1% Donkey serum in PBS with 0.05% Tween 20 (primary and 
secondary antibody dilution solution) for 30 min. Primary antibodies (Table 2.7) 
were incubated for 1 hr in antibody dilution solution. Cells were then washed 
three times with PBS to be subsequently incubated with the appropriate 
secondary antibodies (Alexa) diluted 1:500 in dilution solution in the dark for 1 
hr. Cells were washed three times with PBS to remove any unbound antibody 
and stained with DAPI 1:15000 in antibody dilution solution for 5 min.  
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Finally, cells were washed with distilled water and mounted on glass plates. 
High-resolution images were collected with an imaging system (DeltaVision 
Restoration; Applied Precision) using a 40X/ 1.514 oil (Olympus) objective lens. 
Images were then processed using OMERO software unless otherwise 
specified. 
 
Table 2.7: List of antibodies used for immunofluorescence.  
The species where antibodies were raised and the dilution used for this study 
are shown. 
 
 
2.4  RNA Extraction and Analysis 
2.4.1 RNA extraction 
The culture medium was removed and cells were washed twice with ice-cold 
PBS. RNA was then isolated with RNeasy GeneJet RNA purification kit 
(Thermo Scientific) following manufacturer’s instructions and quantified using 
Nanodrop.   
 
2.4.2 Quantitative reverse transcriptase (RT-qPCR) 
500 ng of RNA was converted into complementary DNA (cDNA) with random 
hexamer primers using the iScript cDNA Synthesis Kit (Quanta) according to 
Antibody Company Working dilution 
RNMT In house  1:500 
RAM In house 1:100 
Oct4  Abcam 18976 1:500 
Pax6  Santa Cruz 11357 1:500 
Tubulin-βIII Abcam 11309 1:500 
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manufacturer’s instructions. The converted cDNA was diluted 1:10 in distilled 
water and 3 µL were subjected to qPCR with a Bio-Rad iQ5 RT-PCR detection 
system. The total volume of qPCR reaction was 10 µL using 5 µL of Quanta 
Bioscience SYBR Green FastMix for iQ and 0.3 µM of appropriate primers 
(Table 2.8). Each sample was loaded in duplicate to avoid pipetting errors. The 
Critical threshold (Ct) values were determined and expression values were 
normalised against the reference gene, e.g. Actin.  
Following siRNA treatment, the expression levels in RT-qPCR assay were 
obtained using ΔΔC(t) of the average of duplicate samples and the average of 
loading control, e.g. Actin. 
 
Table 2.8: List of primers employed for RT-qPCR study.  
Sequence and melting temperature of primers used in this study are shown. 
The species specificity of a primer pair is mentioned next to its name, e.g. (m) 
for mouse and (h) for human primers. 
Locus name 
(Species) 
 Primers T (a) N 
RNMT (m) F 
R 
GCAGGCGGATACGATGCTTA 
CTTTGCCATTATCAGTTCAAAGCTA 
59°C 20 
25 
RAM (m) F 
R 
AGTCGGGTGGTTGAGGGATT 
TTAAGATCCTTCATGGGACGCAC 
60°C 20 
23 
Pou5f1 (m) F 
R 
GAGACTTTGCAGCCTGAGGG 
CTTTCATGTCCTGGGACTCCTC 
60°C 20 
22 
Sox2 (m) F 
R 
CAGGAGTTGTCAAGGCAGAGA 
CTTAAGCCTCGGGCTCCAAA 
60°C 21 
20 
Klf4 (m) F 
R 
AGAACAGCCACCCACACTTG 
GTGGTAAGGTTTCTCGCCTGT 
60°C 20 
21 
Nanog (m) F 
R 
AAAGGATGAAGTGCAAGCGG 
GTGCTGAGCCCTTCTGAATC 
59°C 20 
20 
Vimentin (m) F AACGAGTACCGGAGACAGGT 60°C 20 
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R CAGGGACTCGTTAGTGCCTTT 21 
Nestin (m) F 
R 
ACATACAGGACTCTGCTGGAG 
CCAAGAGAAGCCTGGGAACT 
59°C 21 
20 
Actin (m) F 
R 
CGCCACCAGTTCGCCAT 
CTTTGCACATGCCGGAGC 
60°C 17 
18 
RNMT (h) F 
R 
TGAGTGTGACGGCTGGAACTC 
CACGCGTTGGGTAGTGTGAAG 
60°C 21 
19 
RAM (h) F 
R 
CCTCAAACCTTTGGGATT 
TTCCTGATACTCCTTGTC 
50°C 18 
18 
POU5F1 (h) F 
R 
CCCACACTGCAGCAGATCA 
ACCACACTCGGACCACATCC 
60°C 19 
20 
SOX2 (h) F 
R 
GCGGAAAACCAAGACGCTCAT 
CATGCTATTGCCGCCGGG 
61°C 21 
18 
NANOG (h) F 
R 
ACAGGTGAAGACCTGGTTCC 
GAGGCCTTCTGCGTCACA 
59°C 20 
18 
PAX6 (h) F 
R 
AGTGCCCGTCCATCTTTGC 
CGCTTGGTATGTTATCGTTGGT 
60°C 19 
22 
GAPDH (h) F 
R 
CTTCGCTCTCTGCTCCTCCT 
CGATGTGGCTCGGCTGG 
61°C 20 
17 
 
 
2.4.3 Polysome profiling 
To perform polysome profiling 2.5x 106 mESCs were seeded into a 10 cm dish 
and treated with non-targeting control and siRNA against RAM for 48 hr. Cells 
were replenished with fresh culture media 1 hr prior to cell lysis. Cells were 
incubated 10 min at 37°C with 100 µg/mL of cycloheximide prior to the start of 
polysome purification procedure. From now on all the steps were carried out on 
ice. Cells were quickly washed with ice-cold PBS containing 100µg/mL of 
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cycloheximide and collected by scraping with in Polysome Lysis buffer (Table 
2.1).  
The lysates were loaded on top of 10 mL sucrose gradients (2 mL of each 
gradient 10-50% were disposed on tubes in an increment order) and centrifuged 
at 38,000 rpm for 2 hr at 4°C in Beckman ultracentrifuge using a SW41 rotor. 
Gradients were fractionated (0.5 mL fractions) and each fraction was collected 
with a Foxy Jr. (Teledyne) fraction collector. RNA content from each fraction 
was purified using RNeasy GeneJet RNA purification kit (Thermo Scientific), 
quantitated and checked for purity by Nanodrop 1000 and used for RT-qPCR 
analysis. Ct values were normalised to input (RNA prior fractionation). 
 
2.4.4 In vitro cap methyltransferase activity 
For the in vitro cap methylation reaction, protein extracts (0.25 µg, 0.5 µg or 1 
µg) lysed with F-buffer were combined with 200 μM S-adenosylmethionine and 
1/50 purified capped transcripts in MT assay buffer (Table 2.1) in a final volume 
of 10 μL and incubated at 37ºC for 10 min unless indicated differently. Following 
the reaction, RNA was purified by phenol/chloroform extraction.  
 
The pelleted RNA was resuspended in 4 μL of 50 mM sodium acetate (pH 5.5) 
and incubated with 1 U P1nuclease for 60 min at 37ºC to release free GpppG or 
m7GpppG. [α-32P]–labelled GpppG, or [α-32P]–labelled m7GpppG spots were 
resolved by thin layer chromatography (TLC) using PEI (polyethylenimine) 
cellulose plates in 0.4 M ammonium sulphate. The TLC was visualised using 
autoradiography and quantified using AIDA imager analyser. 
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2.4.5  Immunoprecipitation of methyl capped mRNAs 
Total RNA from mESCs transfected with non-targeting control or with siRNA 
against RAM was extracted as described previously. The immunoprecipitation 
protocol was performed by Dr. Victoria Cowling. mRNA was purified from 100 
μg of total RNA using standard laboratory protocol. 10 μL purified anti-m7G 
antibody or control antibody was pre-bound to 25 μL Protein A/G agarose in 
PBS, 0.01% Triton, 0.1 mg/mL BSA, 0.1 mg/mL polyU and 1 mM DTT for 30 
min at room temperature followed by two washes. Immunoprecipitations were 
carried out using 2 μg oligo dT-purified RNA in 200 μL of the same buffer 
complemented with 5 U RNasin for 1 hr at room temperature followed by three 
washes. RNA was purified from the IPs by phenol/chloroform extraction and 
precipitated using 1/10th volume of 5 M sodium acetate and 4 μg tRNA as a 
carrier. RNA was resuspended in 50 μL water. RT-qPCR was performed to 
detect the methyl cap transcript levels of mRNAs of interest and Ct values were 
normalised to control methyl IP. 
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3 RNMT and RAM are highly 
expressed in embryonic stem cells 
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3.1  Introduction 
The methylation of the mRNA cap represents a crucial checkpoint during 
eukaryotic gene expression through which the fate of certain transcripts can be 
regulated. In fact, it is well established that the synthesis of N7-
methylguanosine cap at the 5’ end of mRNA affects several processes involved 
in RNA metabolism such as splicing, nuclear export, mRNA decay and silencing 
(Cheng et al., 2006; Topisirovic et al., 2011). In mammals, addition of the 
methyl cap is mediated by the sequential activity of two enzymes: the bi-
functional guanylyltransferase/triphosphatase or RNGTT and RNA 
methyltransferase RNMT and its coactivator subunit RAM (Furuichi & Miura, 
1975; Gonatopoulos-Pournatzis et al., 2011). The formation of the RNA methyl 
cap is so critical for viability and the relative functions of mRNA that it has long 
been considered to be a constitutive process within cells. Only recently, 
accumulating evidence has suggested that this modification is subject to 
regulatory mechanisms. Indeed pioneering studies have not only revealed that 
environmental conditions can affect the cellular levels of cap methylation but 
also that this regulation may be specific for certain transcripts (Chang et al., 
2012; Fernandez-Sanchez et al., 2009) 
 
One of the most fascinating scenarios where the gene expression machinery 
needs to be regulated to quickly adapt to the cues that cells receive from the 
environment is during stem cell fate determination. An open chromatin 
structure, the presence of “bivalent” domains and the activity of super 
enhancers are some of the characteristic features of the unique gene 
expression landscape within stem cells (Bernstein et al., 2006; Efroni et al., 
2008; Meshorer et al., 2006; Whyte et al., 2013). 
83 
 
Moreover, although controversial data have been reported, recent evidence is 
directly correlating the most abundant internal modification of mRNA, the N6-
methyladenosine (m6A) with cell pluripotency. Despite having opposite results, 
both studies showed that alterations in the expression levels of the 
methyltransferase responsible for the formation of m6A, cause perturbations in 
the ability of cells to self-renewal either increasing or diminishing it (Batista et 
al., 2014; Wang et al., 2014b). Furthermore, it was recently reported that in 
ESCs, the THO nuclear export complex preferentially recognises and binds 
mRNAs expressing pluripotency factors mediating their nuclear export and 
consequently their efficient translation. Depletion of components of the THO 
complex led to the loss of self-renewal (Wang et al., 2013). Taken together 
these findings strengthen the role that post-transcriptional mechanism such as 
RNA modifications and RNA binding proteins play in the maintenance of 
pluripotency (Guallar & Wang, 2014; Kwon et al., 2013).  
 
Considering the aforementioned data, the study of mRNA cap methylation in 
stem cells may reveal novel insight into the specific gene expression program 
required for the maintenance of pluripotency. This chapter will be focused on 
investigating the expression and activity of RNA methyltransferase (RNMT) and 
its interacting partner RAM in embryonic stem cells. 
 
3.2  Results 
3.2.1 Characterization of the mESC line 46C. 
To accomplish the aims of this chapter, a mouse embryonic stem cell line 
cultured in media supplemented with LIF was established for the first time in the 
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Cowling lab. The Sox1:GFP knock-in (46C) ESCs were employed in this work 
and were kindly donated by Dr. Marios Stavridis (University of Dundee), who 
regularly provides advice and suggestions. It is extremely important that stem 
cells are constantly and unequivocally maintained in an undifferentiated state 
during the whole experimental process. To verify the cell pluripotency, three 
independent assays were performed periodically and in concomitance of every 
experiment. Alkaline phosphatase (AP) assay was used as a first method to 
assess cell pluripotency. It is well described that the high activity of AP on the 
surface of undifferentiated cells makes the AP a suitable marker of pluripotent 
stem cells (Marti et al., 2013). Briefly, mESCs were plated on a 6-well dish and 
after three days cells were fixed and stained to reveal alkaline phosphatase 
activity. The activity levels of AP were compared in mESCs and in immortalised 
mouse embryonic fibroblasts (MEFs), used as a negative control, which were 
kindly donated by Ian Ganley’s lab. The presence of purple colonies confirmed 
the pluripotency of the mESCs and the concomitant absence of staining in 
MEFs ensured the specificity of the assay (Figure 3.1a).  
 
Extensive studies on stem cells have established the main transcription factors 
required for pluripotency (Avilion et al., 2003; Niwa et al., 2000; Chambers et 
al., 2003). Thus, the second assay used to evaluate pluripotency involved the 
analysis of protein and transcript levels of these previously defined pluripotency 
factors. Sox2 and Oct4 protein expression was found to be abundant in mESCs 
but was undetectable in MEFs (Figure 3.1b). Further validation came from RT-
qPCR analysis, which revealed that mRNA levels of Sox2, Oct4, Nanog and 
Klf4 were tenfold higher in stem cells compared to MEFs (Figure 3.1c). 
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Vimentin, which is the most frequently found intermediate filament protein in 
fibroblasts (Franke et al., 1982), was used as positive control for MEFs.  
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Figure 3.1: Three different assays to characterise the pluripotency of the mouse 
embryonic stem cells.  
(a) Alkaline phosphatase expression in mouse embryonic stem cells (mESCs) and immortalised 
mouse embryonic fibroblast (MEFs). Cells were seeded into a 6 cm dish and after three days 
were stained to reveal alkaline phosphatase activity. Images were taken with Canon camera 
EOS 100D. Scale bar measures 500 µm. (b) Cell extracts from mESCs and immortalised MEFs 
were analysed by Western blot with antibodies against the indicated proteins. Actin serves as 
the loading control. (c) RNA extracted from mESCs and MEFs was analysed by RT-qPCR. The 
data were normalised to Actin mRNA levels. Statistical significance (p<0.05) for all 
measurements was determined by two-tailed student’s test, assuming unequal variance (n=3). * 
indicates p< 0.05, ** indicates p<0.005, *** indicates p<0.001 and ns indicates p>0.05. Bar 
charts depicts the average values and relative standard deviation of three independent 
experiments. All the above assays are representative of three biological replicates. 
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Once the stem cells were characterized, the next step was to test the specificity 
of anti-RNMT and anti-RAM antibodies. Previously, Cowling laboratory has only 
used human cell lines and consequently antibodies were only raised against the 
human orthologues of RNMT and RAM. In order to work with mESCs, 
antibodies that recognise the mouse homologue were required. The existing 
anti-RAM antibodies were found to recognise a band of the appropriate size in 
Western blot analysis, whereas the existing RNMT antibody did not. This could 
be because human and mouse RNMT homologues differ in the N-terminal 
domain. Thus an antibody against mouse RNMT was raised by the University of 
Dundee DSTT (Division of Signal Transduction Therapy) service. Briefly, 
recombinant GST-RNMT was injected into a sheep and 20 weeks later blood 
serum was collected and anti-RNMT antibodies were affinity purified. The 
specificity of the generated anti-RNMT, and that of the already available anti-
RAM antibody, was determined by depleting the enzymes from mESCs using 
RNAi. Cells were treated for 48 hr with three independent siRNAs against 
RNMT, three independent siRNAs against RAM or with a non-targeting siRNA 
(Ct) used as negative control. Clearly the depletion of RNMT and RAM caused 
the loss of the respective bands observed by Western blot analysis confirming 
the specificity of the antibodies tested (Figure 3.2). This also confirmed that the 
siRNAs successfully reduced protein expression and thus can be further 
employed in this study.  
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Figure 3.2: Characterization of anti-RNMT and anti-RAM 
antibody specificities in mESCs using three different 
siRNAs. 
mESCs were transfected with three independent siRNAs 
against RNMT, three independent siRNA against RAM (1, 2, 
and 3) and a non-targeting control (siCt) for 48 hr. Cell 
extracts were analysed by Western blot with antibodies 
against the indicated proteins. Actin serves as loading 
control. The above assays are representative of two 
biological replicates. 
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3.2.2 RNMT and RAM expression in mESCs  
In order to address the aims of the project, the expression levels of the 
enzymes involved in the methylation of the mRNA cap were investigated for the 
first time in mESCs. The expression of RNMT and RAM in mESCs was 
compared to immortalised MEFs, a terminally differentiated cell line (Figure 
3.3). Both RNMT and RAM protein levels were found to be elevated in mESCs 
compared to MEFs, which was also mirrored by the mRNA levels. In fact, the 
mRNA levels of RNMT and RAM also revealed that the two proteins are also 
transcriptionally regulated. Concerning the transcript data, RNMT primers were 
designed against the most abundant splicing variants whereas RAM only 
presents one splicing variant. The efficiency of the primers was also tested and 
they were found to work specifically.  
This results documented the abundance of RNMT and RAM expression in 
mESCs and raised the question whether the overall methyltransferase activity 
could be higher in mESCs than in MEFs. To address this, an in vitro 
methyltransferase activity was performed, where the cap methyltransferase 
activity within titration of mESC and MEF whole cell extracts was measured in a 
5 min reaction with 32P-capped transcript and S-adenosylmethionine (SAM). 
Following the reaction, the capped transcript was nuclease digested and the 
resultant GpppG (cap) and m7GpppG (methyl cap) were resolved by thin layer 
chromatography (Figure 3.4). The amount of m7GpppG are plotted as 
percentage of total cap (i.e. m7GpppG x 100/ (m7GpppG + GpppG)) relative to 
amount of protein lysate used. As expected, higher cap methyltransferase 
activity was observed in mESCs compared to MEFs. In particular, the maximal 
difference in methyltransferase activity between mESCs and MEFs was 
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threefold. Overall these results show that not only the expression of 
methyltransferase complex is higher in mESCs, but also its activity is 
substantially elevated when compared to MEFs.  
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Figure 3.3: RNMT and RAM show elevated expression in mESCs 
compared to immortalised MEFs. 
In vitro cap methyltransferase activity assay. (a) Cell extracts from 
mESCs and in immortalised MEFs were analysed by Western blot with 
antibodies against the indicated proteins. Actin serves as the loading 
control. (b) RNA extracted from mESCs and MEFs was analysed by RT-
qPCR. The data were normalised to Actin mRNA levels. Statistical 
significance (p<0.05) for all measurements was determined by two-tailed 
student’s test, assuming unequal variance (n=3). *** indicates p<0.001. 
Bar charts depicts the average values and relative standard deviation of 
three independent experiments. All the above assays are representative 
of at least three biological replicates. 
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Figure 3.4 In vitro cap methyltransferase activity assay. 
(a) RNMT and RAM activity was assessed in an in vitro cap methyltransferase 
activity assay. This schematic diagram represents the major steps of the assay. A 
typical picture of an autoradiography exposure is shown on the right. (b) Relative 
cap methyltransferase activity was detected in cell extracts using an in vitro cap 
methyltransferase assay. Activity was measured for 5 min with a titration of cell 
extracts. Quantification of thin layer chromatography was performed using ImageJ 
densitometry and the activity expressed as percentage methylation (i.e. (m7GpppG 
x 100) / (m7GpppG + GpppG)). The above assay is representative of two biological 
replicates. 
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To discard the hypothesis that the immortalisation of MEFs could have 
somehow affected the expression of RNMT and RAM, mice of 129/Ola strain 
(same mice from which mESCs used in this work were derived) were used to 
isolate primary MEFs. The experiments were repeated with primary MEFs and 
confirmed that RNMT and RAM expression in mESCs is indeed higher than in 
MEFs, both at protein and transcript levels (Figure 3.5). In all the replicates, 
expression of RAM in primary MEFs was slightly higher compared to RAM 
levels observed in immortalised MEFs as well as Actin levels. Therefore, 
combing these observations together it emerged that the immortalisation 
process has indeed affected RAM expression. Nevertheless, the results 
between immortalised and primary MEFs consistently showed that the 
expression both at protein and transcripts levels of RNMT and RAM is higher in 
mESCs than MEFs. The concomitant analysis of pluripotency markers validated 
the pluripotent status of stem cells employed in the study. 
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Figure 3.5: RNMT and RAM are highly expressed in mESCs in comparison to 
primary MEFs. 
(a) Cell extracts from mESCs and primary MEFs from 129 Ola mice were analysed 
by Western blots with antibodies against the indicated proteins. Actin serves as the 
loading control. (b) RNA extracted from mESCs and primary MEFs was analysed by 
RT-qPCR. The data were normalised to Actin mRNA levels. Statistical significance 
(p<0.05) for all measurements was determined by two-tailed student’s test, assuming 
unequal variance (n=3). * indicates p< 0.05, ** indicates p<0.005 and *** indicates 
p<0.001. Bar charts depicts the average values and relative standard deviation of 
three independent experiments. All the above assays are representative of at least 
three biological replicates. 
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The aforementioned data shed the light on a differential expression of enzymes 
involved in methyl cap mRNA in mESCs. These observations encouraged 
further characterisation of the RNMT and RAM complex in mESCs. With this 
purpose, gel filtration or size exclusion analysis was performed to analyse the 
elution pattern of the RNMT and RAM complex (Figure 3.6a). 1 mg of extracts 
from mESCs were separated through a Superose 6 column, 24 fractions were 
collected and the elution profile was analysed by Western blot (Figure 3.6b). As 
previously reported in our laboratory, co-elution of RNMT and RAM was 
detected in fractions 6-7. The finding that RNMT and RAM complexes migrate 
approximately at 150 kDa, which is higher than the expected size, suggests that 
may be part of a higher order complex and this may also explain the presence 
of the two proteins immediately after the void volume (fractions 1 and 2). 
However, differently from previous data, RNMT was individually detected in 
fraction 8 and 9. This could indicate the presence of monomeric RNMT in 
mESCs. To collect more evidence, anti-RNMT or anti-RAM antibodies were 
used to immunodeplete the relative proteins from 1 mg of mESCs extract. The 
experimental conditions were sufficient to totally and successfully 
immunodeplete RAM following RNMT immunoprecipitation (IP) (Figure 3.6c). 
On the contrary, RNMT was clearly detectable in the flow through following 
RAM IP indicating that not all RNMT may interact with RAM in mESCs. Hence, 
the gel filtration and the immunodepletion experiments suggest that RNMT in 
mESCs may be present independently from RAM. The previous findings 
support further investigation of RNMT and RAM expression during development 
to see whether the expression of this complex changes following differentiation.  
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For this purpose, protein extracts from different mouse organs were analysed 
by Western blot (Figure 3.7). Organs from two mice were processed and 
extracts kindly provided by Dr. Francisco Inesta Vaquera. The results between 
the two mice are consistent and showed firstly, that the individual expression of 
RNMT and RAM changes dramatically amongst different mouse organs. 
Secondly, RNMT and RAM stoichiometry is variable between the different 
organs. For instance, RNMT levels in some organs were higher than RAM (e.g. 
the brain) and vice versa (e.g. the heart). These data together indicate that the 
expression levels of the cap methylation machinery can vary drastically 
following differentiation depending on the cell lineage specification. 
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Figure 3.6: Not all RNMT is bound to RAM in mESCs. 
(a) Elution profile of size exclusion chromatography. The blue line represents the UV 
absorbance at 280 nm. (b) 1 mg of mESCs cell extracts were resolved through a 
Superose 6 column and fractions collected and analysed by Western blot with antibodies 
against the indicated proteins. (c) 1 mg of mESCs cell extracts were incubated with 1 µg 
of anti RNMT or anti RAM antibody for 2 hr at 4°C analysed by Western blot with 
antibodies against the indicated proteins. All the above assays are representative of two 
biological replicates. 
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Figure 3.7: RNMT and RAM are differentially expressed amongst different mouse 
organs. 
Protein extracts (30 µg) from different mouse organs listed above were analysed by 
Western blot with antibodies against the indicated proteins. The analysis was performed 
with 5 weeks old mice. Ponceau staining as the loading control. Tissue samples were 
prepared by Dr. Francisco Inesta-Vaquera. The above assays are representative of two 
biological replicates. 
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3.2.3 RNMT and RAM in reprogramming 
In the last decade the major breakthrough in stem cells biology was the 
reprogramming of a differentiated cell to an induced pluripotent stem cell (iPSC) 
(Takahashi & Yamanaka, 2006). Nowadays the generation of iPSCs is a 
common protocol used to investigate whether the protein under investigation is 
involved in the establishment of the pluripotent state. In figure 3.3 and 3.5, it 
was observed that RNMT and RAM expression was lower in MEFs (both 
immortalised and primary) than in mESCs. With the intention to establish 
whether the expression of the two proteins was restored when MEFs were 
reprogrammed, different protocols were tried to make iPSCs from MEFs.  
 
For the first protocol, transduction of MEFs with lentivirus expressing Oct4, Klf4, 
Sox2 and c-Myc (OKSM) factors, kindly donated by Dr. Lindsay Davidson 
(University of Dundee), was attempted. This transduction method was first tried 
in a 96 well format with HEK293 cells and despite being successful, the process 
of scaling up the protocol on MEFs was not (data not shown). Subsequently, Dr. 
Marios Stavridis suggested and kindly donated reagents for a protocol in which 
MEFs were transfected with plasmid containing the defined transcription factors 
(Oct4, Sox2, Klf4, and c-Myc) (OSKM), fused in frame via 2A sequences and 
co-expressed as a single origin of replication (ORF). Optimization of the 
protocol included seeding different cell densities and trying different media 
compositions.  
 
Briefly, MEFs were plated in a well of a 6 well plate and were transfected with 
the plasmid containing OSKM the day after. Selection of transfected cells was 
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performed with doxycycline on the following day. After 4 days of selection, 
alterations in cell morphology were observed whereby cell shape changed from 
the typical stretched fibroblast shape to a more rounded circular one. Group of 
cells that were successfully reprogrammed started to assume a colony 
morphology that became evident after 15 days (Figure 3.8a). These colonies 
were big enough to be picked and cultured to make independent iPS cell lines. 
Once the cell line was established, cells were seeded and stained for AP 
activity to verify the acquired pluripotency. The purple staining of iPSC colonies 
confirmed that the reprogrammed cells were pluripotent. For this assay, MEFs 
provided the negative control, whereas mESCs were the positive one (Figure 
3.8b). The high expression levels of Oct4, Sox2, Nanog, c-Myc and E-cadherin 
further confirmed the pluripotent state of mESCs and mouse iPSCs. The band 
indicated to recognise c-Myc has been verified by c-Myc siRNA transfection. 
Vimentin expression identified MEFs as fibroblast (Figure 3.9a). Remarkably, 
the expression of RNMT and RAM was totally restored in mouse iPSCs to 
similar levels observed in mESCs. The upregulation of RNMT and RAM 
following reprogramming was also confirmed at mRNA levels by RT-qPCR 
(Figure 3.9b) whereby mESCs and mouse iPSCs, apart from exhibiting high 
levels of pluripotency factors, were characterized by high RNMT and RAM 
transcript levels. Also in this case, Vimentin was exclusively highly expressed in 
MEFs. 
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(a)
(b)
Figure 3.8: Derivation of induced pluripotent stem cells.  
Primary MEFs were reprogrammed by transfection with plasmid containing defined 
transcription factors (TFs) (Oct4, Sox2, Klf4, and c-Myc) fused in frame via 2A 
sequences and co-expressed as a single ORF. (a) Bright field image of an iPS 
colony at 20x magnification. Scale bar measures 50 µm. (b) Bright field image of 
mESCs, MEFs and iPS stained to reveal alkaline phosphatase activity. Scale bar 
measures 200 µm. 
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Figure 3.9: RNMT and RAM expression levels are restored in iPSCs. 
Cell extracts from mESCs, MEFs and mouse iPSCs were analysed by Western blot 
with antibodies against the indicated proteins. Actin serves as the loading control. 
(b) RNA extracted from mESCs, MEFs and mouse iPSCs was analysed by RT-
qPCR. The data were normalised to Actin mRNA levels. The above analyses are 
representative of three biological replicates. 
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Even more importantly, when the same analysis was carried out with human 
ESCs, human fibroblast and human iPSCs, the same pattern of RNMT and 
RAM expression was observed as with the mouse cell lines (Figure 3.10). In 
fact, the pluripotent hESCs and hiPSCs, characterized by the elevated levels of 
pluripotency factors, presented higher expression at both transcript and protein 
levels of RNMT and RAM compared to fibroblasts. The three human cell lines 
were kindly provided by Dr. Lindsay Davidson. The data presented so far clearly 
show that high levels of RNMT and RAM are a feature of pluripotent cells, 
whereas their expression is reduced in terminally differentiated MEFs. 
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Figure 3.10: RNMT and RAM expression levels are restored in human 
iPSCs. 
(a) Cell extracts from human ESC 181 cell line (hESCs), human fibroblasts and 
human induced pluripotent stem cells (hiPSCs), kindly donated by Dr. Lindsay 
Davidson, were analysed by Western blot with the antibodies against the 
indicated proteins. Actin serves as the loading control. (b) RNA extracted from 
human ESCs, human fibroblast and human iPSCs was analysed by RT-qPCR. 
The data were normalised to Actin mRNA levels. Samples were kindly provided 
by Dr. Lindsay Davidson. The above analyses are representative of three 
biological replicates. 
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3.3  Discussion 
Considering that addition of the cap, its methylation and its eventual removal 
are fundamental processes that control RNA metabolism in mammalian cells, 
we reasoned that the regulation of cap methylation might be critical for the 
maintenance of pluripotency. With the aim to understand whether mRNA cap 
methylation represents a novel regulatory process in stem cell transcription, a 
stem cell line was established for the first time in the Cowling laboratory. 
Characterisation of the cell line confirmed cell pluripotency and thus the 
reliability of the cell system. The speculation that the enzyme responsible for 
cap methylation could play a role in maintenance of pluripotency was 
strengthened by data comparing the expression of the methyltransferase RNMT 
and its co-factor RAM in mESCs and MEFs. Although the Western blot is not a 
quantitative analysis, the dramatic difference in RNMT and RAM expression, 
compared to primary and immortalised MEFs, strongly supported the conclusion 
that the two proteins are highly expressed in mESCs. As expected, despite 
exhibiting lower methyltransferase activity compared to mESCs, MEFs were 
able to convert the guanosine cap to methyl guanosine cap. This observation 
reinforced the assumption that the methylation of the cap, being so critical for 
mRNA half-life, is a fundamental process and despite the proteins responsible 
for the modification could be less abundant, they are ubiquitously present in 
cells and consequently active. This result led to assume that the higher 
enzymatic activity may be specifically required to face the high global 
transcription levels that characterize stem cells (Efroni et al., 2008) whereas the 
basal RNA methyltransferase activity is sufficiently catalysed by lower levels of 
RNMT and RAM.  
106 
 
 
The high level of RNMT and RAM expression in mESCs encouraged further 
investigation into the nature of the RNMT and RAM complex by gel filtration and 
IP assays. RNMT, but nor RAM, was eluted in fractions 8 and 9 of gel filtration 
analysis and the data was corroborated by the immunodepletion experiment 
whereby RNMT signal was found in the flow through following RAM IP. 
Therefore, both assays pointed out that not all RNMT might be bound to RAM in 
mESCs. This is surprising because in all the cell lines previously investigated, 
RNMT has always been seen in a complex with RAM and monomeric RNMT or 
RAM have never been detected. Although previous findings on the equimolar 
RNMT and RAM complex have led to the assumption that the two proteins are 
co-regulated, the data described above prompted us to investigate whether the 
two proteins are differently expressed in the mouse organs. Western blot 
analysis showed that RNMT and RAM expression is organ-specific as their 
levels are differently regulated in different organs. Moreover, the variability in 
the detection of RNMT and RAM in different organs supports the hypothesis 
that RNMT and RAM may exist as monomers or in different complexes in 
different cell types. Consistently to this, the individual depletion of RNMT or 
RAM in mESCs did not significantly alter the expression of the other (Figure 
3.2), which is contrary to what has been previously observed in other cell lines 
whereby following RNMT depletion by RNAi, RAM expression was also 
impaired and vice versa (Gonatopoulos-Pournatzis et al., 2011).  
 
These finding together show that RNMT and RAM expression in mESCs may 
be differently regulated than previously described and raise the question 
whether these two proteins fulfil different roles within the cap methylation 
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process. The reported findings are relevant in light of the aforementioned work 
which identified the THO complex, the nuclear protein complex, as a novel 
regulator of pluripotency (Wang et al., 2013). Wang and colleagues 
hypothesised that the recognition mechanism is due to the presence of the 
methyl cap that could specifically be present on mRNA of pluripotency factors. 
These data could potentially explain that high level of RNMT and RAM in 
mESCs preferentially methylates certain transcripts to make them available for 
the further steps of gene expression. 
 
Lastly, to assess whether high levels of RNMT and RAM complex are a feature 
of all pluripotent cells, MEFs were reprogrammed to iPSCs and expression of 
the complex was investigated. The reprogramming caused the expression of 
RNMT and RAM to be restored to levels observed in mESCs. Excitingly, the 
same results were observed in human ESCs and human iPSCs. This clearly 
shows that the regulation pathway of RNMT and RAM in stem cells is 
conserved from mice to humans. In order to discern whether RNMT and RAM 
are required for pluripotency or their expression is consequently upregulated 
following acquisition of pluripotency, in the future the transcript and protein 
levels will be analysed during the reprogramming process. Furthermore, to 
know how important RNMT and RAM expression are for reprogramming, the 
efficiency of the process will be assessed counting the iPS colonies following 
overexpression or depletion of RNMT and RAM. Data described above strongly 
encouraged us to carry on with the study of methyl cap mRNA in stem cells 
because any findings in mESCs could possibly be validated in hESCs and 
therefore having significant therapeutic implications. 
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4 RAM is regulated during neural 
differentiation 
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4.1  Introduction 
One of the multiple reasons to study the stem cell biology is the possibility to 
closely investigate the phenomena that occurs during early embryo 
development. Additionally, ESCs possess the ability to generate a wide range of 
differentiated cell types (Smith, 2001) and this feature prompted investigation of 
different protocols to terminally derive pluripotent stem cells into specific cell 
lineage.  
 
To date, one of the best characterised protocol to establish the conversion of 
mESCs into a differentiated cell type is represented by the in vitro neural 
differentiation. Previous studies identified Sox1 as an early neuroectodermal 
marker highly expressed in dividing neuroepithelial cells. Both in vivo (Sox1 is 
expressed in the neural tube) and in vitro, the expression of this transcription 
factor is related with the acquisition of neural fate and it is gradually lost during 
neuronal and glial differentiation (Pevny et al., 1998). Based on these evidence, 
Ying and colleagues have engineered the 46C ES cells to express Sox1:GFP, 
where the open reading frame of the Sox1 gene was replaced by GFPiresPac, 
and developed a protocol to differentiate the cells into neuroepithelial 
precursors. Authors were able to derive neural precursors by culturing the 
reporter cell line on gelatin coated plates, in serum free media and following LIF 
withdrawal. The Sox1:GFP+ neural precursors could further give rise to neurons 
and glial cells (Ying et al., 2003b). Since then, the Sox1:GFP knock-in 46C ES 
cells have been widely used to investigate the kinetics of neural progenitor 
derivation.  
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Moreover, Abranches and colleagues were able to differentiate mESCs into 
neural progenitors in a rosette-like structure that recapitulates the neural tube 
formation. These evidence strongly support the similarity between the in vitro 
monolayer differentiation and the embryonic neural development (Abranches et 
al., 2009).  
 
In the previous chapter, it was reported that RNMT and RAM are expressed at 
higher levels in pluripotent stem cells than terminally differentiated cells. These 
data combined with the findings that RNMT and RAM levels vary among 
different organs, strongly encourage further studies to uncover the mechanism 
that drives RNMT and RAM expression during cell fate specification. 
Considering the brain tissue data and the simplicity of the monolayer protocol, 
we reasoned to closely study the regulation of RNMT and RAM expression 
levels during neural derivation. Therefore this chapter will be focused in the in 
vitro neural differentiation of mESCs. 
 
4.2  Results  
4.2.1 RNMT and RAM levels in neuronal cells 
To begin with, RNMT and RAM expression was investigated in three different 
neuronal cell types. Primary cortical neurons and astrocytes were extracted, 
lysed and kindly donated by Dr. Ritchie Williamson (Daan van Aalten lab, 
University of Dundee). Astrocytes were established from post-natal day 2, while 
primary cortical neurons were isolated from 16-day old mouse embryos (Figure 
4.1a). The expression of both RNMT and RAM was found to be dramatically 
reduced in astrocytes compared to mESCs, on the contrary, primary cortical 
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neurons retained similar levels of RNMT but low levels of RAM expression. To 
further confirm the abundance of RNMT and RAM in mESCs compared to 
differentiated cells, Dr Ritchie kindly provided other neuronal cells such as 
hippocampal neurons. Hippocampal cells were isolated from 16-day old mouse 
embryos and were cultured in vitro for the time indicated to obtain a fully 
polarized and mature phenotype (Williamson et al., 2002) (Figure 4b). Fresh 
mESCs were run with astrocytes (sample was rerun) and hippocampal cells to 
directly compare the different cell types. The western blot analysis corroborated 
the data obtained so far whereby the protein levels of RNMT and RAM is clearly 
abundant in mESCs and poorly present in differentiated cells. In the fresh 
mESCs RNMT expression was higher than that in Figure 4.1a possibly due to 
longer incubation with chemiluminescent reagent whereas in astrocytes 
possibly the freezing-thawing process impoverished the already weak 
expression of RNMT, although a weaker band was still visible. The composition 
of lysis buffer used by Dr. Ritchie Williamson is very similar to the lysis buffer 
employed in this thesis. Therefore differences between samples were not 
amenable to different buffer composition. These results firstly confirm the higher 
levels of RNMT and RAM expression in mESCs compared to differentiated cells 
and secondly, it suggests that in the process of neural differentiation and 
consequential down regulation of RNMT and RAM proteins, RAM expression 
may be lost earlier compared to RNMT. 
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Figure 4.1: RNMT and RAM expression compared between mESCs and 
primary cortical neurons, astrocytes and hippocampal cells.  
RNMT and RAM expression levels were analysed by Western blot performed on 
protein extracts from mESCs, primary cortical neurons (a), astrocytes (a) and 
hippocampal cells (b) with antibodies against the indicated proteins. Astrocytes 
were established from post-natal day 2. Primary cortical neurons and 
hippocampal cells were isolated from 16-days old mouse embryos, the latter 
were cultured in vitro for the time shown before being used for the analysis. 
Actin serves as the loading control. Primary cortical neurons, astrocytes and 
hippocampal cells were extracted, lysed and kindly donated by kindly donated 
by Dr. Richard Williamson (Daan van Aalten lab, University of Dundee). The 
above assay is representative of one biological replicate. 
(a) (b) 
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4.2.2 In vitro neural differentiation 
In order to trace when exactly RNMT and RAM levels change during the 
differentiation process, mESCs were differentiated in vitro. As previously 
mentioned, the mESCs employed in this study were the Sox1:GFP knock-in 
(46C) ESCs, expression of which is restricted to proliferating neuroectodermal 
cells, thereby providing a marker for neural differentiation (Ying et al., 2003b). 
Initially, two neural differentiation protocols were tested, whereby the first one 
led to the formation of embryoid bodies (EBs). When ESCs are grown to high 
density and in non-coated plates, they spontaneously form cell aggregates 
called embryoid bodies, which contain cells from the three germ layers (Bain et 
al., 1995). Once formed, the embryoid bodies were then dissociated with trypsin 
and cultured as a monolayer in the absence of LIF. The neural cell morphology 
in the cell monolayer and the concomitant expression of Sox1:GFP confirmed 
that the neural differentiation occurred. However, the major limitation of this 
approach resides in the generation of an extremely heterogeneous cell 
population (data not shown). In fact the size of the EBs, strictly correlated to the 
initial cell density, has already been shown to greatly influence the lineage 
derivation efficiency (Zhou et al., 2008).  
 
In order to overcome this problem, a second protocol that comprises of 
monolayer differentiation of mESCs into neural cells was employed. As 
mentioned before, this protocol provides culturing ES cells in defined free serum 
condition and following LIF withdrawal (Ying et al., 2003b). In order to evaluate 
the efficiency of the in vitro neural differentiation, colonies were examined by 
fluorescent microscopy for GFP and images acquired over time (Figure 4.2). 
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It was extremely fascinating to observe how cell phenotype gradually changed 
during the neural differentiation. After three days, few colonies of mESCs 
started to express low level of Sox1:GFP that became stronger and more 
homogenous by day 6. The increase in Sox1:GFP signal was accompanied by 
changes in cell morphology whereby cells started to assume a rosette 
conformation (typical of neural epithelial precursors). By day 9, the neural 
precursors exhibited a clear and perfectly distinguishable neuronal morphology 
with extended protrusions that connects cells to each other.  
 
The cell morphology clearly confirmed that the neural differentiation had 
successfully occurred but further validation at a molecular level came from the 
Western blot analysis (Figure 4.3). The protein levels of Nanog and Klf4 were 
dramatically reduced already two days after seeding, whereas protein levels of 
both Oct4 and Sox2 slightly increased during the first days of differentiation to 
be then gradually reduced. The reduction of these factors and the concomitant 
increase in Sox1:GFP level, which became detectable only towards the last 
days of differentiation, confirmed that the mESCs gradually lost their 
pluripotency features to simultaneously gain the neural marker expression. 
Interestingly, RNMT levels remained stable throughout the differentiation 
process, whereas RAM expression initially increased, to then dramatically drop 
to nearly undetectable levels. This result was found to be consistent amongst 
three independent biological replicates. These data perfectly reproduced the 
observation made with the mouse brain, which was characterised by high level 
of RNMT and low level of RAM expression.  
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Figure 4.2: Morphology of mESCs changes during neural 
differentiation in N2B27 media. 
mESCs were seeded into a 10 cm dish coated with 0.1% gelatin in N2B27 
media for 9 days. Media was changed every second day. Images were 
captured on days 3, 6 and 9. Scale bar measures 100 µm. The above 
images are representative of six biological replicates. 
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Figure 4.3: RAM expression is repressed during 
neural differentiation.  
mESCs were seeded into a 10 cm dish coated with 
0.1% gelatin in N2B27 media for 9 days. Media was 
changed every second day. Cell extracts collected at 24 
hr intervals were analysed by Western blot with 
antibodies against the indicated proteins. Actin serves 
as loading control. The above image is representative 
of six biological replicates. 
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To investigate whether the reduction in RAM expression during in vitro neural 
differentiation was due to transcriptional down-regulation, RT-qPCR was 
performed (Figure 4.4). The mRNA levels of RNMT, Klf4 and Nanog were 
consistent with the protein expression with RNMT stably expressed and Klf4 
and Nanog dramatically reduced after two days of neural differentiation. On the 
contrary, Sox2 transcripts differently from the protein levels that gradually 
decreased over time, halved on day 2 and remained so until the end of the 
protocol. Oct4 transcripts were gradually reduced over time. Interestingly, the 
mRNA levels of RAM did not significantly go down and remained stable over 
time whereas Nestin, neural progenitor marker (Lendahl et al., 1990), with its 
gradual increase over time confirmed the emerging phenotype. Taken together 
these data suggest that RAM expression is not transcriptionally regulated during 
in vitro neural differentiation but other regulatory mechanisms at post-
transcriptional level are possibly involved.  
 
Validation of the neural differentiation came also from Immunofluorescence 
study where mESCs, seeded onto Laminin coated coverslip in N2B27 media, 
were fixed and stained on day 3, 6 and 9 (Figure 4.5). Immunofluorescence 
data were consistent with the analysis of protein levels, where the RNMT signal 
was invariant throughout the protocol (Figure 4.5a). High level of Oct4 
expression were initially observed but then the signal intensity per nucleus 
decreased becoming weaker towards the last day. On day 9, those cells with 
low level of Oct4 showed a concomitant increase in the GFP signal (from 
Sox1:GFP) indicating that cells were differentiated (Figure 4.5). RAM signal, as 
previously observed by Western blot, decreased over time (Figure 4.5b). 
Noteworthy, on day 6, the few cells which retained Oct4 expression retained 
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high levels of RAM expression too. In addition, cells were also stained for Pax6, 
another neural marker (Walther & Gruss, 1991), and its gradual increase was 
perfectly consistent with the expression pattern of Sox1:GFP levels (Figure 
4.5c).  
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Figure 4.4: RAM expression during in vitro neural differentiation is not regulated 
at the level of the transcripts. 
mESCs were seeded into a 10 cm dish coated with 0.1% gelatin in N2B27 media for 9 
days. Media was changed every second day. RNA extracted on day 2, 4, 6 and 8 of 
differentiation was analysed by RT-qPCR. Day 0 refers to undifferentiated mESCs. The 
data were normalised to Actin mRNA levels. Bar charts depicts the average values and 
relative standard deviation of three independent experiments. The above images are 
representative of three biological replicates. 
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(a) 
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Figure 4.5: Immunofluorescence confirms the neural differentiation of mESCs and the 
associated reduction in RAM expression. 
Immunofluorescence microscopy was used to confirm the neuronal differentiation. mESCs were 
seeded onto coverslip coated with Laminin in N2B27 media. Cells were fixed with 4% PFA and 
stained with the indicated antibodies on days 3, 6 and 9. DAPI staining was used to detect 
nuclei. High-resolution images were collected with an imaging system (DeltaVision Restoration; 
Applied Precision) using a 40X/1.514 oil (Olympus) objective lens. Images were then processed 
using OMERO software. Scale bar measures 20µm. (a) RNMT staining; (b) RAM staining; (c) 
Pax6 staining. The above images are representative of two biological replicates. 
 
 
 
 
 
 
(c) 
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Considering the data so far, it was interesting to further investigate how the 
RNA methyltransferase activity was affected during in vitro neural 
differentiation. In order to address this, the in vitro methyltransferase activity 
assay was performed (Figure 4.6). From titrations performed in Figure 3.4, 0.5 
µg of mESC protein lysate was the minimal amount of protein required for 
maximal conversion from cap to methyl cap. Thus, the subsequent assay was 
performed with 0.5 µg lysate of mESCs and in vitro differentiated neural cell. 
Cells were differentiated in N2B27 media as previously described, and 
according to the Western blot analysis, cells on day 8 were found to contain 
minimal RAM levels (Figure 4.6a). Recent unpublished data have shown that 
RAM may help recruitment of the S-adenosylmethionine (SAM), the methyl 
donor, to RNMT (data not show, Dr. Dhaval Varshney). Thus, to test whether 
the low level of RAM on day 8 of neural differentiation may affect SAM 
recruitment and thus the methyltransferase reaction, the in vitro MT assay was 
performed for 10 min in presence and absence of SAM (Figure 4.6b). 
Surprisingly, in both cases, the methyltransferase activity of neural cell extracts 
was found to be slightly higher than mESC extracts. The presence or absence 
of SAM did not alter the percentage methylation indicating that high levels of 
SAM are present in cell extracts. To remove SAM from cell extracts different 
lysis buffers were tested but they were found to inefficiently extracting the cell 
proteins (data not shown). Taken together these data suggest that neural 
differentiated cells, despite containing low levels of RAM, still have high levels 
of methyltransferase activity. 
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Figure 4.6: RNMT activity is slightly higher in neural cells than mESCs. 
(a) mESCs were seeded into a 10 cm dish coated with 0.1% gelatin in N2B27 
media for 9 days. Media was changed every second day. Cell extracts collected at 
24 hr intervals were analysed by Western blot with antibodies against the indicated 
proteins. Actin serves as loading control. (b) Relative cap methyltransferase activity 
was detected in cell extracts using an in vitro cap methyltransferase assay. Activity 
was measured for 10 min with 0.5 µg of mESCs lysate and the neural cell. 
Quantification of thin layer chromatography was performed using ImageJ 
densitometry and the activity expressed as percentage methylation (i.e. (m7GpppG 
x 100) / (m7GpppG + GpppG)). The above data are representative of two biological 
replicates. 
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4.2.3 In vitro neural differentiation with hESCs 
Lastly, the in vitro neural differentiation was repeated using hESCs. Dr Lindsay 
Davidson kindly provided and seeded the cells for this experiment. The protocol 
was performed for 13 days and on each day cells were collected for analysing 
protein and mRNA levels (Figure 4.7a and b). Excitingly, the neural 
differentiation with hESCs confirmed the expression pattern of RNMT and RAM 
observed with mESCs, whereby RNMT protein expression is maintained over 
time and RAM is similarly lost after day 6. The progressive decrease in protein 
levels of OCT4 and SOX2 confirmed the loss of pluripotency. Opposite trend 
was observed for PAX6, human neuroectodermal marker as well (Zhang et al., 
2010), which was detectable only towards the end of the protocol (the day one 
signal may be caused by blot dirtiness), confirming that the neural differentiation 
had occurred.  
 
Consistent results were also obtained with RT-qPCR, where RNMT and RAM 
mRNA levels behaved similarly to what previously observed in mESCs as they 
remained unaltered over the differentiation protocol (Figure 4.7b). OCT4 mRNA 
expression decreased over time, whereas the mRNA levels of SOX2, despite 
significantly fluctuating, never decreased. PAX6 expression increased over time 
consistently to the protein levels. Moreover, Dr. Lindsay Davidson fixed and 
stained hESCs neural differentiated to confirm the differentiation process 
(Figure 4.7c). Immunofluorescence was performed by on day 11 and revealed 
high expression levels of two neural markers, Tubulin-βIII and PAX6. Due to 
limited sample availability it was not possible to perform in vitro 
methyltransferase assay with hESCs and the derived neurons.  
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The data indicate that the regulation of RNMT and RAM levels during neural 
differentiation appears to be conserved between mouse and human ESCs, 
where RNMT expression is maintained and RAM strongly down-regulated. 
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Figure 4.7: RAM expression is also reduced upon neuronal differentiation of hESCs. 
(a) Cell extracts were collected at 24 hr intervals of the neural differentiation and analysed by 
Western blot with antibodies against the indicated proteins. Actin serves as loading control. (B) 
RNA extracted on day 0, 2, 4, 6 and 8 of the differentiation process was analysed by RT-qPCR. 
The data were normalised to GAPDH mRNA levels. (C) Immunofluorescence of human ES cells 
differentiated on day 11 was performed by Dr. Lindsay Davidson (Cell and Developmental 
Biology, University of Dundee). Cells were fixed with 10% neutral buffer formalin and stained 
with the indicated antibodies. Nuclei were stained with DAPI. Scale bar measures 100 µm. The 
above images are representative of two biological sample. 
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4.3  Discussion 
In the previous chapter, RNMT and RAM were found to be highly expressed in 
pluripotent stem cells when compared to differentiated cells. In addition to this, it 
was shown that in different mouse organs, the stoichiometry of RNMT and RAM 
expression varies according to the cell lineage commitment. For example, the 
brain represents a really interesting case-study as RNMT is highly expressed 
whereas RAM is surprisingly not. With the purpose to better understand the 
dynamics of RNMT and RAM regulation, we decided to in vitro differentiate 
mESCs into neural lineage commitment and monitor the expression of the two 
proteins. The result was extremely interesting because it mirrors the data 
obtained with the brain; in fact, during in vitro neural differentiation high levels of 
RNMT expression were maintained whereas RAM was dramatically reduced. 
This observation is important because it highlights the reproducibility between in 
vivo data (mouse organs) with in vitro results (in vitro neural differentiation).  
 
In order to elucidate whether RAM down regulation occurs at transcriptional 
level, RT-qPCR was performed. Data revealed that the protein was not 
transcriptionally regulated, highlighting a certain discrepancy between transcript 
and protein levels. However, it is important to stress that RT-qPCR only 
measures the amount of viable mRNAs and regulation of transcription 
represents only one of the multiple mechanisms by which the level of the final 
protein is controlled. In fact, decrease in the gene product may be caused by 
problems related to the incorrect folding of the proteins or to lysosomal 
degradation.  
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Moreover, a central role is played by covalent modifications described as post 
translation modifications, e.g. addition of ubiquitin labels proteins for 
proteosomal degradation (Chau et al., 1989). PTMs may also interfere or favour 
the association of the protein with others, leading to activate or inactivate the 
protein complex. Possible mechanisms of RAM regulation will be discussed in 
chapter 6 of this thesis. 
 
Previous findings in our laboratory have shown that RAM stimulates RNMT 
activity both in vitro and in vivo (Gonatopoulos-Pournatzis et al., 2011). In vitro 
RAM has been found to highly promote recombinant RNMT activity and in 
cellular extracts RAM depletion reduced the methyl cap levels on endogenous 
transcripts. Considering these evidence we next measured the 
methyltransferase activity to see whether the down-regulation of RAM in neural 
cells affects the ability to methylate capped mRNAs. Unexpectedly, the 
methyltransferase activity was slightly higher in neural cell lysates compared to 
mESCs. One hypothesis is that due to the different nucleus/cytoplasm ratio 
between mESCs and neural differentiated cells, during the protein extraction 
other enzymatic activities e.g. decapping enzymes, could have interfered with 
the assay. To discard this possibility, mESCs expressing HA-RNMT were 
generated and in future will be neural differentiated, RNMT will be 
immunoprecipitated and the assay will be repeated. However, this result 
combined with the previous gel filtration and IP data (not all RNMT may be 
bound to RAM in mESCs) could be explained by two hypotheses: the first being 
that RNMT may interact with other RAM-like proteins that somehow replace 
RAM during lineage specification.  
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The second explanation could be that monomeric RNMT in stem cells does not 
need RAM to increase its already high activity. Furthermore, if the preliminary 
data obtained in our laboratory about RAM facilitating the recruitment of SAM to 
RNMT (data not published, Dr Dhaval Varshney) will be validated, in agreement 
with the second scenario, another possible explanation of higher MT activity in 
neural cells is that those cells have excess of SAM and therefore RAM is not 
essential. However, this latter hypothesis does not consider the evidence that 
RAM contains the RNA binding domain within the RNMT complex and therefore 
RAM has the role to bind RNA and make it available for the cap methylation. 
According to this, changes in RAM expression may be explained by speculating 
that RAM does not bind all mRNAs but specifically recognizes certain 
transcripts required for that particular cell state. Thus, relatively to the 
transcriptional changes that occur during stem cells differentiation, RAM may be 
less or more required e.g. respectively brain and heart. Taken together these 
observations suggest that RAM expression may be context–dependent and 
emphasise the potential role of cap methylation in stem cell fate determination. 
 
Extremely exciting are the in vitro neural differentiation data with human ESCs. 
In fact, as it has been reported for the mESCs, the in vitro neural differentiation 
is able to derive neural progenitors in a rosette-like structure that recapitulates 
the neural tube formation (Gerrard et al., 2005). These evidence strongly 
strengthen the reliability of the in vitro observations because the same 
dynamics will very likely occur in vivo. Data obtained with hESCs perfectly 
reproduced the same pattern of RNMT and RAM expression described in 
mESCs indicating that the mechanisms regulating RAM expression appear to 
be conserved in mice and humans. The in vitro-neural differentiation has been 
130 
 
repeated with H9 hESCs and the lost in RAM expression was confirmed (data 
not shown). Unfortunately, MT activity was not performed with in vitro neural 
differentiated hESCs and it will be interesting in the future to repeat the assay to 
see whether the same results are obtained. These evidences strongly 
encourage further investigations particularly into the role of RAM in stem cell 
fate decision, and raise the question whether RAM reduction during neural 
differentiation may be a cause or a consequence of the lineage specification 
process.  
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5 Investigating the biological role of 
RAM in embryonic stem cells 
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5.1 Introduction 
Eukaryotic protein synthesis comprises three stages and the rate-limiting step is 
usually translation initiation. In the cap-dependent translation, eIF4F complex 
via eIF4E, its cap binding subunit that specifically recognizes the methyl cap at 
the 5’ end of mRNA, mediates the interaction between mRNA and 43S pre-
initiation complex (PIC) (Sonenberg & Hinnebusch, 2009). Once the PIC is 
bound to the cap proximal region of mRNA, it starts to scan the 5’-untranslated 
region in the 5’-3’ direction until if finds the start initiation codon. As soon as the 
AUG codon is found, a dynamic change and removal of factors results in the 
formation of elongation-competent 80S ribosome (Jackson et al., 2010).  
 
Polysome profiling relies on the ability of mRNA to recruit more than one 80S 
ribosome resulting in the so called polysome. Therefore the polysome profiling 
analysis is a reliable method to characterize mRNA actively engaged in 
translation (Masek et al., 2011). However, because translation is a highly 
dynamic process, cells are treated with the translational elongation inhibitor 
cyclohexamide in order to prevent polysome run–off during sample preparation. 
Cyclohexamide is the most common inhibitor of eukaryotic translation and it 
functions by binding 60S and blocking the release of the deacylated tRNA from 
ribosome E site, thus stalling the ribosome in a polysome state (Schneider-
Poetsch et al., 2010). Polysome preparation can then be separated through a 
sucrose gradient thus allowing the subsequent fractionation of mRNAs 
according to the number of ribosomes bound. This technique divides mRNAs 
into: monosomal (free ribosomal subunits and mRNA associated with few 
ribosome) and polysomal (mRNA bound at multiple ribosome) fractions. 
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In the previous chapters, RNMT and RAM were shown to be highly expressed 
in ESCs, whereas in vitro neural differentiated cells were found to contain 
dramatically reduced levels of RAM. These observations suggest that high 
levels of RNMT and particularly of RAM, may be required to maintain 
pluripotency. Therefore, this chapter will investigate the biological role of RAM 
in mESCs. 
 
5.2  Results 
5.2.1 Depletion of RAM impairs Oct4 expression  
In order to address the aim of this chapter, a loss of function study was 
performed using the RNAi methodology. To rule out off-target effects and 
considering that both RNMT and RAM are highly expressed in mESCs and are 
both required for optimal methylation of the cap, the majority of the knockdown 
assays were carried out with three independent siRNAs. The efficiency of the 
siRNAs has already been tested in chapter 3, whereby the siRNAs were 
employed to verify the specificity of RNMT and RAM antibodies. Briefly, cells 
were seeded and immediately transfected with siRNAs and with non-targeting 
control. To test the knockdown efficiency, cells were lysed 2, 3 and 4 days 
following transfection. Initial experiments indicated that two days of treatment 
with siRNAs was sufficient to obtain a substantial depletion of the proteins (data 
not shown), thus all further experiments described in this chapter were 
performed with a 48 hr siRNAs treatment. The Western blot depicted in figure 
3.2, showed that all the siRNAs employed successfully impaired the expression 
of their target protein compared to cells incubated with non-targeting control.  
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Quantification of the western blot (Fig 5.1c), showed that depletion of RNMT or 
RAM had similar effect on the other protein levels, with particularly the siRNA 
number 3 affecting the expression of the interacting partner. In order to evaluate 
the impact of RNMT or RAM knockdown on cell pluripotency, Oct4 levels were 
investigated (Figure 5.1a). Interestingly, all three siRNAs against RAM 
consistently impaired Oct4 expression, whereas RNMT knockdown did not lead 
to consistent alterations as siRNA 3 caused reduction in Oct4 levels and siRNA 
2 caused an increase. This data represents the first evidence that directly 
correlates RAM expression with one of the pluripotency factors.  
 
5.2.2 High RAM expression is required for the maintenance of 
pluripotency 
The finding that RAM alters Oct4 expression combined with the previous data 
strongly supports the hypothesis that high levels of RAM specifically correlate 
with a pluripotent state and prompted us to focus on the role of RAM in mESCs. 
To further investigate how RAM depletion affects stem cell, its impact on cell 
proliferation was determined (Figure 5.1c). None of the three siRNAs caused 
significant delay in cell growth as cells transfected with siRNA showed similar 
level of cell proliferation when compared to control transfected cells. 
Next, the ability to form undifferentiated colonies following RAM depletion was 
assessed. To do this, cells were dissociated following 48hr siRNA treatment, re-
seeded at a low density and allowed to grow for 7 days in the usual mESCs 
media. Cells where then fixed and stained for AP activity (Figure 5.2a). 
According to the colony morphologies, the associated intensity and distribution 
of the AP staining, three different populations were identified: undifferentiated 
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colonies were characterised by homogenous edges and intense purple staining; 
mixed colonies were poorly stained and with deformed edges (sign of 
differentiation) and lastly differentiated colonies, which lacked clear staining (Fig 
5.2a). Images of the different colonies were taken from cells treated with non 
targeting control and were representative of the morphology observed in 
experimental conditions too. The percentage of undifferentiated, mixed and 
differentiated colonies was calculated for each transfection condition (Figure 
5.2b). It emerged that RAM depletion impaired the ability of cells to form 
undifferentiated colonies. More precisely, following siRNA 1 treatment against 
RAM, cells showed a slight reduction in the number of positive colonies, on the 
contrary when cells were treated with siRNA 2 and 3 against RAM, the number 
of mixed colonies increased significantly compared to the control. These data 
suggest that despite not being essential for cell proliferation, high level of RAM 
in stem cells may be required for the maintenance of pluripotency. Its depletion 
reduces Oct4 expression and may therefore push cells towards differentiation.  
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Figure 5.1: RAM knockdown has an effect on Oct4 expression but does not 
effect cell proliferation. 
mESCs were transfected with three independent siRNAs against RNMT, three 
independent siRNAs against RAM (1, 2, and 3) and a non-targeting control (siCt), 
for 48 hr. (a) Cell extracts were analysed by Western blot with antibodies against 
the indicated proteins. Actin serves as loading control. (b) Quantification of western 
blot was performed with Image J Software. (c) Cell counts were determined 48 hr 
post-transfection using a Countess cell counter. Bar charts depict the average cell 
number and relative standard deviation of three independent experiments (n=3). 
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Figure 5.2: RAM knockdown alters the ability of mESCs to form undifferentiated 
colonies. 
mESCs were transfected with three independent siRNAs (1, 2 and 3) against RAM or with 
non-targeting control (siCt) for 48 hr following which cells were dissociated with trypsin and 
plated in a 6 well plate. After one week colonies were stained for Alkaline phosphatase 
activity. Colonies were categorized as undifferentiated (stained with intense purple), mixed 
(poorly stained and with deformed edges) and differentiated (not stained). (a) Bright field 
image of colonies of cells treated with siRNA control and classified as undifferentiated, 
mixed and differentiated. Images were taken with Canon camera EOS 100D. Scale bar 500 
µm. (b) Graphs display the percentage of undifferentiated, mixed or differentiated colonies 
for the siCt and for each individual siRAM. The percentage was calculated on the average 
value of three wells. The above images are representative of two biological replicates. 
 
138 
 
5.2.3 RAM knockdown affects cap methylation of certain transcripts 
In order to gain further insight into how depletion of RAM impacts pluripotency, 
Western blot and RT-qPCR analyses of the major stemness markers Oct4, 
Sox2, Nanog and Klf4 was performed. Western blot analysis was carried out 
more than 5 times and the most representative results, chosen according to the 
quality of the blots, are presented (Figure 5.3a). As expected, RAM depletion 
caused alteration in the protein levels of some of the pluripotency factors. In 
particular, Oct4, Sox2 and Klf4 levels in every experiment were found to 
decrease more consistently with all the three siRNAs against RAM. Contrary to 
this, discordant results were obtained with Nanog, whereby protein levels were 
down regulated in 50% of the experiments and upregulated in the other half and 
the effect was not always consistent among the three siRNAs employed. The 
quantification of more than three western blot analyses corroborated as 
described above with RAM depletion having a major effect on three out four 
pluripotency factors analysed. 
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Figure 5.3: RAM knockdown affects Oct4 and Sox2 expression 
levels. 
(a) Western blot analysis with antibodies against the indicated 
proteins on extracts from mESCs 48 hr following transfections with 
three independent siRNAs (1, 2 and 3) against RAM or with non-
targeting siRNA (siCt). Actin serves as a loading control. The above 
images are representative of three biological replicates. (b) 
Quantification of western blot analyses was performed using Image 
J software. Bar charts depicts the average values and relative 
standard deviation of at least three biological replicates. Statistical 
significance (p<0.05) for all measurements was determined by two-
tailed student’s test, assuming unequal variance (n=3). * indicates 
p<0.05, ** indicates p<0.005 and *** indicates p<0.001. 
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Next, to assess whether this effects was mirrored at transcript level, RT-qPCR 
analysis was performed (Figure 5.4). The dramatic reduction of RAM mRNA 
levels clearly confirmed the knockdown efficiency and as expected, RNMT 
transcripts were not affected. If anything the depletion of RAM induced a slight 
increase in the transcript levels of RNMT. Surprisingly, silencing of RAM did not 
consistently affect the transcripts of the pluripotency factors as Oct4, Klf4 and 
Nanog mRNA levels were particularly downregulated with only siRNA number 2 
whereas no impairment was revealed for Sox2 transcripts. Discrepancy 
between protein and transcript levels following RAM depletion implicates a post-
transcriptional mechanism in the regulation of gene expression by RAM 
depletion. 
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Figure 5.4: RAM knockdown does not affect the transcript levels of pluripotency 
markers. 
RT-qPCR analysis performed on RNA from mESCs 48 hr post-transfection with three 
independent siRNAs (1, 2 and 3) against RAM or with non-targeting siRNA (siCt). The 
data were normalised to Actin mRNA levels. Bar charts depicts the average value and 
relative standard deviation of three independent experiments. Statistical significance 
(p<0.05) for all measurements was determined by two-tailed student’s test, assuming 
unequal variance (n=3). * indicates p<0.05, ** indicates p<0.005 and *** indicates 
p<0.001.  The above images are representative of three biological replicates. 
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As discussed previously, one of the multiple functions of the methyl cap is to 
recruit eIF4E and other translation initiation factors, thus promoting the 
engagement of the ribosome with mRNA, which leads to translation initiation 
(Topisirovic et al., 2011). To study whether RAM depletion could affect the 
ribosomal loading onto mRNA and thus explaining the reduction in the protein 
levels of the pluripotency factors, polysome profiling was performed. As 
mentioned earlier, this technique separates mRNA by ultracentrifugation across 
a sucrose gradient, fractionating mRNA into monosomal and polysomal 
fractions. Considering that the experiment needs to be performed quickly in 
order to avoid ribosomal run-off from the transcripts, and the high number of 
cells required, we decided to perform the analysis with control transfected cells 
or cells transfected with one siRNA against RAM. Given the Western blot data 
and particularly the AP staining where siRNA 2 against RAM caused a 
significant increase in the population of mixed colonies, siRNA 2 was chosen for 
the analysis (Figure5.5).  
 
Following 48 hr siRNA treatment, cells were provided with fresh media in order 
to promote translation prior to cyclohexamide treatment. The RNA content and 
separation between monosome and polysome was monitored by UV 
absorbance at 254 nm and plotted (Figure 5.5a). The lighter monosomal 
fractions are found on the left side representing the top of the gradient, whereas 
the heavier polysome are found on the right side representing the bottom of the 
gradient. From the UV profiles, it is apparent that the siRNA against RAM 
caused a reduction in the overall translation rate of the cells as seen by the 
narrower and flatter polysome peak compared to the control.  
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After fractionation, RNA was extracted from each fraction and analysed by RT-
qPCR (Figure 5.5b). Following RAM knockdown, mRNA distribution of Oct4, 
Sox2, Klf4 and Nanog, clearly showed a shift from the polysome (from fractions 
6 to 8) to the monosome (from fractions 1 to 5) fraction. This effect seems 
specific since Actin mRNA was not found to follow this trend. The RT-qPCR of 
three biological replicates are further summarised in Figure 5.5c, where the 
RNA content of the polysomal fractions was pooled together for the siRNA 
against RAM treatment and for the control treated cells. Clearly, following RAM 
depletion, mRNAs expressing the pluripotency markers showed a substantial 
reduction in the amount of polysome engaged compared to the control treated 
cells. In fact, following RAM knockdown the amount of polysome loaded into the 
pluripotency factors Nanog, Klf4, Sox2 and Oct4 mRNAs was almost halved 
compared to the control cells. On the contrary, translation from Actin transcripts 
was not affected, indicating that the effect of RAM impairment is specific and 
not generalised to translation from all RNA Pol II transcripts. The diminished 
levels of polysome loading on transcripts of the pluripotency factors correlates 
with the reduction of their relative protein levels.  
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Figure 5.5: RAM depletion leads to reduced translation of the major pluripotency 
markers. 
mESCs were transfected with siRNA 2 against RAM or non-targeting control and cells were 
collected 48 hr after transfection. Polysome associated RNAs were fractionated by sucrose-
gradient ultracentrifugation. (a) Relative absorbance (254 nm) trace measuring the RNA 
distribution following polysome fractionation for siRNA or non-targeting control treated cells. (b) 
RT-qPCR analysis performed on fractions with primers against indicated target transcripts 
measuring their relative distribution amongst the fractions. (c) Percentage of a given mRNA 
present in polysomal fractions (6-8) to the total mRNA in all fractions (Polysome (6-8)/ total 
mRNA (monosome+polysome)). Ct values were normalised to the input (RNA prior 
fractionation). The graph is representative of three biological replicates. Statistical significance 
(p<0.05) for all measurements was determined by two-tailed student’s test, assuming unequal 
variance (n=3). * indicates p<0.05, ** indicates p<0.005. 
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In addition to this, Dr. Victoria Cowling performed immunoprecipitation 
experiments using an antibody that specifically recognises methyl capped 
transcripts in order to investigate the effect of RAM knockdown on methyl cap 
formation on mRNAs expressing the pluripotency markers (Cole & Cowling, 
2009) (Figure 5.6). It was observed that following RAM depletion with the three 
siRNAs, the amount of methyl capped Actin mRNA immunoprecipitated did not 
change compared to cells treated with non-targeting control as only siRNA1 
slightly affected the m7G levels. On the contrary, following RAM depletion, the 
levels of methyl capped mRNAs for Oct4, Sox2 and Klf4 were clearly reduced 
with all the three siRNAs compared to the non-targeting control. Nanog mRNA 
was not efficiently immunoprecipitated in this experiment. 
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Figure 5.6: Depletion of RAM impairs the formation of the methylguanosine cap of 
pluripotency factors. 
Data were kindly provided by Dr. Victoria Cowling. Methyl cap immunoprecipitations were 
performed on mESCs transfected with three independent siRNAs or non-targeting control. 
Methyl cap levels of endogenous transcripts indicated were determined relative to control IP 
using RT-qPCR following 7-methyl guanosine immunoprecipitations. Bar charts depicts the 
average values and mean relative standard deviation of three independent experiments. The 
above data are representative of three biological replicates. 
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Combined together, these results indicate that loss of RAM has some specificity 
towards the pluripotency factors transcripts that being efficiently cap 
methylated, are more efficiently engaged into the translation machinery thus 
explaining the elevated protein expression. On the other hand, following RAM 
impairment, reduced cap methylation of these transcripts occurs and 
consequently they are less efficiently translated resulting in lower protein 
expression. These data, for the first time, shed light on the function of RAM 
where it specifically recognises some transcripts rather than others. However, 
the exact mechanism for this selectivity is not clear and further studies will be 
needed to elucidate it. 
 
5.2.4 RAM over-expression directly affects Oct4 and Sox2 
So far, the loss of function studies have described a correlation between RAM 
and the pluripotency markers. To further confirm this relationship, gain function 
experiments where RAM was exogenously expressed were performed, using 
the in vitro neural differentiation model. As described previously, RAM protein 
levels were found to be down-regulated during the in vitro neural differentiation, 
therefore stable cell lines expressing exogenous RAM were created to study 
how the over expression of RAM impacts the differentiation process. Three 
different cells lines were made: mESCs transfected with empty vector, mESCs 
transfected with RAM fused to Green Fluorescent Protein on the C terminal 
domain (RAM-GFP) and mESCs transfected with RAM fused to Flag on the N 
terminal domain (FG-RAM). The expression of the exogenous protein was 
evaluated by Western blot analysis (Figure 5.7).  
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The double band in the RAM blot and the correspondent band in the Flag blot 
confirmed the expression of the FG-RAM exogenous protein (Figure 5.7a). For 
the RAM-GFP cell line, in the membrane blotted with GFP, the RAM-GFP 
expression was confirmed by the band of appropriate band (~ 40 kDa), the 
middle band at 35 kDa could be the product of an internal ribosome entry 
present on the GFP tag protein whereas the band at 27 kDa represented the 
GFP protein alone. Although the expression of GFP in ES cells derives from the 
expression of Sox1-GFP, the GFP protein was detectable also in ES. The 
explanation is likely due to the leaky GFP promoter (Stavridis, unpublished 
data). Expression of RAM-GFP was corroborated also by immunofluorescence 
(Figure 5.7c) that showed the RAM-GFP signal co-localise with the DAPI 
staining indicating that RAM-GFP was present in the nucleus of the cells. 
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Figure 5.7: Characterization of the stable cell lines expressing exogenous RAM. 
Stable cells lines were created with mESCs transfected with pPyPCAGGS-Fg-RAM (FG), 
RAM-GFP (GFP) or with empty vector. (a and b) Western blot analysis on extracts from 
mESCs expressing exogenous RAM (FG or GFP) with the indicated antibodies. * 
indicates the FG-RAM band. Samples derive from the same gel. Actin serves as loading 
control. (c) Immunofluorescence of mESCs stably expressing RAM-GFP. Nuclei were 
stained with DAPI. Scale bar measures 10 µm. 
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A preliminary in vitro neural differentiation was performed with the three 
different cell lines in order to see whether the expression of exogenous RAM 
was sustained over the differentiation process or down-regulated similarly to the 
endogenous protein (Figure 5.8). Due to number of samples, the different cell 
lines were collected and analysed every three days. All the three cell lines 
successfully underwent neural differentiation as seen by the reduction in Oct4 
expression by day 6. As expected RNMT expression was consistently 
maintained over time. In the cell line transfected with the empty vector, RAM 
was still detectable at day 6 but as previously observed disappeared at day 9. In 
the cell line transfected with FG-RAM, the levels of exogenous FG-RAM (the 
upper band in RAM blot labelled with *) were lower than the endogenous as 
early as day 3 and lost by day 6. Contrary to the exogenous RAM, endogenous 
RAM was barely detectable on day 6 but then reappeared again on day 9.  
 
As opposed to FG-RAM, the RAM-GFP cells maintained high expression of the 
exogenous RAM (RAM-GFP detectable at the top of the blot) over time whereas 
the endogenous fluctuated as described for the FG-RAM cells. Given the more 
consistent and stable expression of exogenous RAM-GFP, this cell line could 
be used as system where RAM expression is maintained over the differentiation 
process and thus study its effect on pluripotency factors.  
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Figure 5.8: Expression of RAM-GFP is not reduced through neural 
differentiation.  
In vitro neural differentiation protocol was performed with mESCs 
transfected with pPyPCAGGS-FgRAM (FG), RAMGFP (GFP) or with 
empty vector. Samples were collected on day 3, 6 and 9. Cell extracts 
were analysed by Western blot with the indicated antibodies. * Indicates 
the FG-RAM band. Actin serves as loading control. 
 
152 
 
Similarly to the control cells, the morphology of mESCs overexpressing RAM-
GFP showed evidence of differentiation such as the production of protrusions 
that connected cells to each other (Figure 5.9a). Western blot analysis was 
employed to investigate whether and how overexpression of RAM could affect 
pluripotency factors expression during lineage commitment (Figure 5.9b). As 
expected, the RAM-GFP expression was maintained over the differentiation 
process. The upper band in the GFP blot indicated RAM-GFP whereas the 
lower one was representative of Sox1:GFP. The loss of Klf4 signal indicated 
that cells were losing the pluripotent phenotype towards the lineage 
commitment in agreement with the increase of Sox1:GFP signal. However, both 
Oct4 and Sox2 expression were maintained over time and did not decrease as 
observed in the control cell line. The experiment was repeated four times and 
quantification of Oct4 and Sox2 blots in control cells or cells over expressing 
RAM-GFP during the neural differentiation are shown (Figure 5.9c). 
Maintenance of RAM coincides with the maintenance of Oc4 and Sox2, which 
remained expressed until the last day of in vitro neural differentiation. This result 
is consistent with the siRNA study as it shows how RAM expression directly 
impacts Oct4 and Sox2 expression levels.  
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Figure 5.9: RAM overexpression maintains Oct4 and Sox2 expression during in vitro 
neural differentiation.  
mESCs exogenously expressing RAM-GFP were seeded into a 10 cm dish coated with 0.1% 
gelatin in N2B27. Media was changed every second day. (a) Bright field of mESCs 
overexpressing RAM-GFP. Images were captured on days 3,6 and 9. Scale bar measures 20  
µm. (b) Cell extracts collected at 24 hr intervals and analysed by Western blot with antibodies 
against the indicated proteins. Actin serves as loading control. (c) Quantification of western blots 
of Oct4 and Sox2 expression (relative to Actin expression) during the neural differentiation of 
mESCs and mESCs expressing exogenous RAM. Bar charts depicts the average values and 
relative standard deviation of four biological replicates. Quantification of western blot analyses 
was performed using Image J software. 
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The concomitant expression of neural marker, Sox:1-GFP and the maintenance 
of the pluripotency factors Oct4 and Sox2, prompted further investigation into 
the phenotype of mESCs over expressing RAM-GFP during the neural 
differentiation. Immunofluorescence was performed (Figure 5.10) and the 
expression of Oct4 and Tubulin-βIII, another neural marker, were investigated 
during the differentiation protocol in mESC control cells, used as positive 
control, and in mESCs over expressing RAM-GFP. As can be observed in the 
images, when mESCs are committed to the neural lineage, expression of 
Tubulin-βIII protein was observed within neurites. As previously described, Oct4 
signal instead followed the opposite pattern, whereby high level of the 
transcription factors could be appreciated on day 0 and 3 of differentiation then 
decrease by day 6 and becoming further lower and similar to noise by day 9. On 
the other hand, in mESCs RAM-GFP, the Tubulin-βIII remained unspecific and 
never reached the high level of expression observed in the mESCs. Differently 
from the mESCs, was also the Oct4 expression that remained elevated until day 
6 and on day 9 single cells were still expressing the protein. The microscopy 
data were consistent with the western blot analysis whereby Oct4 levels in 
mESCs over expressing RAM-GFP were maintained rather than decrease. 
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Figure 5.10: Immunofluorescence of mESCs and mESCs over expressing RAM-GFP shows 
that RAM expression delays the aquitance of neural phenotype compared to mESCs. 
Immunofluorescence microscopy was used to investigate whether cells that continue to express 
Oct4 are also co-expressing neural marker such as Tubulin-βIII. mESCs and mESCs over 
expressing RAM0GFP were seeded onto coverslip coated with Laminin in N2B27 media. Cells 
were fixed with 4% PFA and stained with the indicated antibodies on days 0, 3, 6 and 9. DAPI 
staining was used to detect nuclei. High-resolution images were collected with an imaging 
system (DeltaVision Restoration; Applied Precision) using a 60X/1.514 oil (Olympus) objective 
lens. Images were then processed using OMERO software. Scale bar measures 10µm. The 
above images are representative of two biological replicates (five fields were taken for each 
image). 
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Lastly, to see whether Oct4 and Sox2 expression was regulated at 
transcriptional level during the in vitro neural differentiation in the RAM-GFP 
cells, RT-qPCR analysis was carried out (Figure 5.11). RNMT and RAM 
transcript levels were maintained stable, whereas Oct4 mRNA levels, as 
described for the plain mESCs (Figure 4.4) were found to be gradually 
decreasing. On the contrary, Sox2 transcript levels remained steadily expressed 
over time, without neither halving as observed in the plain mESCs (Figure 4.4). 
The neuronal marker Nestin increased over time further confirming that mESCs 
despite maintaining RAM expression, gradually acquired a neural phenotype.  
Thus these data showed that when RAM is overexpressed, despite the Oct4 
protein expression was sustained during the protocol, the Oct4 mRNA 
continued to going down whereas Sox2 mRNA was consistent with the protein 
levels and remained steadily expressed. Considering the previous data on 
methyl capped mRNAs, it will be interesting to see whether the levels of methyl 
capped Oct4 and Sox2 transcripts in RAM-GFP neural differentiated are higher 
compared to control cells. This result confirms that RAM effect has a major 
impact on the translation of certain genes rather than on their transcription. All 
together these data describe a scenario whereby RAM directly affects the 
expression of Oct4 and Sox2 via regulating their methyl cap levels and thus 
their translational rate. Therefore these findings give an insight into the 
mechanism by which RAM expression contributes to maintain pluripotency in 
mESCs. 
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Figure 5.11: RAM overexpression affects protein levels of Oct4 and Sox2 but not 
transcripts. 
mESCs expressing RAM-GFP were seeded into a 10 cm dish coated with 0.1% gelatin in 
N2B27 media for 9 days. Media was changed every second day. RNA extracted on day 2, 4, 6 
and 8 of differentiation was analysed by RT-qPCR. The data were normalised to Actin mRNA 
levels. Bar charts depicts the average values and relative standard deviation of three biological 
replicates. Statistical significance (p<0.05) for all measurements was determined by two-tailed 
student’s test, assuming unequal variance (n=3). * indicates p<0.05, ** indicates p<0.005. 
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5.3  Discussion 
This chapter aimed to elucidate the function of RAM in mESCs and with this 
purpose loss and gain of function studies were performed. First, a preliminary 
Western blot analysis following RNMT or RAM knockdown showed that RAM 
depletion caused an impairment in Oct4 expression. Oct4 is a master 
pluripotency factor, required in critical amount as up or downregulation of Oct4 
protein levels induce alternative lineage commitment (Niwa et al., 2000) . Due to 
the RAM effect on Oct4 expression and the possible consequences on loss of 
pluripotency, the overall effect of RAM on cell pluripotency was assessed. RAM 
knockdown was found to impair the ability of cells to form undifferentiated 
colonies and these findings combined together strongly support the hypothesis 
that high RAM expression in ESCs could have a functional role in the 
maintenance of pluripotency. This observation was further validated by the 
Western blot analysis of four of the main pluripotency markers. Results between 
independent biological replicates showed that RAM depletion particularly 
impairs Oct4, Sox2 and Klf4 and with lesser extent also Nanog protein levels. 
Surprisingly, RAM effect was not transcriptionally mediated, since none of the 
transcripts expressing Oct4, Sox2, Nanog and Klf4 were dramatically affected 
by its depletion. However, it is important to remember that RNMT possess the 
domain to catalyse the methylation of the cap but RAM harbours the RNA 
binding domain (Gonatopoulos-Pournatzis et al., 2011). Thus, the explanation 
for this could be that RAM depletion could affect the recruitment of mRNAs 
expressing the pluripotency markers to RNMT. This seems to be the case as 
observed by the methyl cap immunoprecipitations performed by Dr Victoria 
Cowling, which showed that differently from Actin, methyl cap levels of Oct4, 
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Sox2 and Klf4 transcripts were impaired after RAM depletion. These data 
correlate with the results obtained with polysome profiling where RAM 
knockdown was found to half polysome recruitment by mRNA transcripts 
expressing the pluripotency factors, thus explaining the lower protein 
expression. To discard the hypothesis that the RAM depletion causes a total 
reduction in RNA levels and consequently the decrease in polysome 
engagement, total RNA in fractions was calculated in cells treated with non 
targeting siRNA and with siRNA against RAM. The analysis was performed by 
Olga Suska and showed that RAM depletion led to a ~20% reduction in total 
RNA compared to control treated cells. Moreover, previous experiments 
showed that the overall yield of total RNA extracted from cells treated with non 
targeting control or siRNA against RAM was very similar (data not shown). 
Therefore, we can assume that the changes in translational rate of the 
pluripotency factors are due to RAM effect on their mRNA and not a lower RNA 
content. 
 
The variability of the Nanog levels following RAM depletion observed by 
western blot may be explained by the following observation. It has been 
described that Nanog expression is highly heterogeneous within a stem cell 
population (Chambers et al., 2007), which may justify the discordant results 
obtained between the different experiments, and also in cells treated with non-
targeting control, which showed low levels of Nanog expression. Furthermore, 
compensatory mechanisms could justify the evidence that Nanog expression 
has been not consistently affected by treatment with siRNA against RAM. 
Alternatively, RAM may have a preference towards Oct4, Sox2 and Klf4 
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transcripts but more studies are needed to sustain this latter hypothesis. On the 
other side, Oct4 functions as heterodimer with Sox2 in ESCs (Ambrosetti et al., 
2000; Avilion et al., 2003; Masui et al., 2007), and additionally they regulate 
each other in an autoregulatory mechanism (Boyer et al., 2005; Chew et al., 
2005). Thus, it does not surprise that RAM equally impacts on both transcription 
factors. Therefore, these data support a scenario where RAM specifically 
targets the methyl cap machinery to mRNAs for pluripotency markers to 
maintain their requisite levels of expression.  
 
Considering the different effect of single siRNA against RAM, e.g. siRNA 
number 2 seemed the more effective, in the future it will be interesting to 
evaluate the efficiency of transfection of siRNAs. This can be addressed by 
quantifying the number of cells that are effectively transfected with the 
oligonucleotide sequence of the siRNA. Previous experiments in the lab were 
performed with rhodamine labelled siRNA against RNMT and RAM in human 
cells and showed that the siRNA uptake was 95% (unpublished data/data not 
shown). These validation need to be performed in mESCs.  
 
Moreover, data shown in Figure 5.1 revealed that RNMT and RAM depletion 
cause and impairment on the other interacting partner although the reduction is 
less dramatic than that observed in human cell lines previously analysed 
(Gonatopoulos-Pournatzis et al., 2011). It will be interesting in the future to 
evaluate whether mouse RNMT and RAM have the same half-lives of the 
human orthologues (12 hr, unpublished data). In order to determine protein half-
life, we can either treat cells with cycloheximide to block protein synthesis and 
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then detect the rate of loss of RNMT or RAM protein by western blot, or we can 
incubate methionine-starved cells with 35S methionine to label RNMT and RAM 
and then measure decay by SDS-PAGE and phosphor imaging. Unfortunately 
cycloheximide and methionine starvation treatments are toxic for mESCs and 
could not be used for the time length required to measure RNMT or RAM 
decay.  
 
To confirm the effect of RAM on Oct4 and Sox2, mESCs expressing RAM-GFP 
were neural differentiated and showed that rather than decreasing over time as 
expected, Oct4 and Sox2 were stably maintained. Also in this context, the 
influence of RAM particularly on Oct4 was not transcriptional since its mRNA 
levels were gradually decreased. So it can be hypothesised that despite mRNA 
of Oct4 being downregulated, the pool of mRNA remaining was ensured to be 
translated.  
 
The immunofluorescence between mESCs and mESCs over expressing RAM-
GFP data clearly showed as contrary to mESCs, the Tubulin-βIII neural marker 
expression is delayed and minimal in the cells exogenously expressing RAM. It 
was worth to investigate whether those cells could be double positive and could 
co-express Oct4 and Tubulin-βIII but this was not the case as Tubulin-βIII signal 
was definitely lower and unspecific compared to mESCs. Therefore, overall, it 
may be speculated that over expression of RAM sustains the expression of 
Oct4 and Sox2, therefore resulting in a delay of the differentiation process. 
However, once the lineage commitment has been triggered by the external 
stimuli (media composition) RAM may not be enough to reverse the 
differentiation process as suggested by the neural phenotype observed by the 
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bright field, which resembled that one of the mESCs neural differentiated cell 
morphology, but also by the increase in Nestin mRNA levels and in Sox:1-GFP 
protein level. In the future it will be interesting to perform the neural 
differentiation for longer period of time and closely observed the delay 
described. 
Moreover, it was not clear whether RAM upregulates one of the factors first, 
which then leads to higher expression of the other. Overall these data strongly 
support the previous results obtained with the siRNA study. 
 
The neural differentiation protocol has been extensively repeated and it has 
been observed that the day RAM goes down may vary from one experiment to 
the other. Variations may be likely due to the different passage cells were used 
for the protocol. However, the dynamic of RAM regulation was always 
confirmed indicating that towards the last days of the neural differentiation the 
protein is downregulated. Additionally, sometimes upon expression of RAM-
GFP, the expression of the endogenous RAM protein was markedly reduced in 
comparison to the exogenous one (Figure 5.8). This phenomenon has been 
previously observed and may indicate a negative feedback loop mechanism 
that regulates the physiological levels of RAM protein. More experimentation is 
required to validate and understand this process.  
 
Thus data presented here support the hypothesis that RAM could preferentially 
recognise specific transcripts involved in the maintenance of pluripotency and 
recruit them to RNMT to allow the efficient methylation of their inverted mRNA 
guanosine cap. This assumption justifies the high expression levels of RAM in 
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stem cells, and as soon as cells differentiate and the global transcription 
decreases in favour of lineage specific markers genes, high levels of RAM are 
no longer required to sift through the transcriptional noise and thus is 
downregulated. 
This chapter has described that RAM is the critical and fine tuning component 
within the methyltransferase complex. These data encourage further 
investigation of the global effects of alterations in RAM expression in mESCs. 
To address this a proteomics analysis following RAM depletion is currently 
being performed by Olga Suska in our laboratory. 
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6 Possible mechanism for regulation 
of RAM 
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6.1 Introduction 
After RNA has been translated, the polypeptide chain undergoes folding and is 
often post-translationally modification to generate a final functionally active 
product. Post-translation modification by the covalent addition of chemical 
groups represents an important strategy through which cells diversify and 
extend protein function beyond what is dictated by gene transcripts (Uy & Wold, 
1977). To further amplify this functional complexity, a plethora of PTMs 
including phosphorylation, ubiquitination, sumoylation, neddylation, acetylation, 
methylation, glycosylation and many more, have been reported. PTMs can be 
extremely dynamic and reversible. They can regulate the protein function 
affecting its activity, protein-protein interaction, localisation and stability (Seo & 
Lee, 2004). Recent large scale analyses have identified how key proteins in the 
pluripotency network are modified, especially phosphorylated, adding a new 
layer of regulation to their expression and activity (Wang et al., 2014c; Cai et al., 
2012).  
 
The previous chapters have described RAM as a critical component of the 
methyltransferase complex as it is involved in the regulation of pluripotency 
markers and is down-regulated during in vitro neural differentiation. So far, no 
evidence has been collected regarding the potential mechanism for regulation 
of RAM expression. Therefore, in order to have a complete picture of the 
biological importance of RAM in mESCs, the mechanism that regulates its 
expression was investigated. This chapter will be focused in exploring the 
possibility that RAM may be regulated via PTMs. 
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6.2  Results 
6.2.1 RAM is degraded via proteasome degradation 
In figure 4.4, it was shown that during in vitro neural differentiation, RAM 
transcripts, differently from its protein levels, are not down-regulated. A 
plausible hypothesis to justify the discrepancy between transcript and protein 
levels is that the in vitro neural differentiation process impacts the stability of 
RAM protein. In order to address this, the MG132 proteosomal inhibitor was 
used. Briefly, cells were seeded into N2B27 media for in vitro neural 
differentiation and were treated with 1 µM MG132 or DMSO for 3 hr prior to 
collection (Figure 6.1). On day 7, untreated cells or DMSO-treated showed a 
substantial reduction in RAM expression compared to day 5, which is consistent 
with what has been previously observed. On the contrary, the treatment with 
MG132 stabilised RAM as seen by the presence of a clear band. As expected, 
no effect was observed on the RNMT or Oct4 signals, the latter of which was 
reduced compared to day 5 confirming that cells underwent neural 
differentiation. This evidence established that RAM expression is reduced due 
to proteosomal degradation.  
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Figure 6.1: RAM loss during in vitro neural 
differentiation occurs via proteasomal degradation. 
mESCs were cultured in a 10 cm dish coated with 0.1% 
gelatin in N2B27 media for 7 days. Cells were treated with 
1µM MG132 or DMSO for 3 hr prior collection. Western 
blot analysis with antibodies against the indicated proteins. 
Samples of the RAM blot derive from the same gel. Actin 
serves as loading control. The above data are 
representative of two biological replicates. 
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6.2.2 RAM S36 is involved in degradation of RAM 
Previous data have indicated that RAM is degraded during in vitro neural 
differentiation. It is well established that phosphorylation can often regulate the 
ubiquitin-mediated proteosomal degradation of target proteins (Hunter, 2007). 
The Serine-36 residue of RAM protein has been previously found to be 
phosphorylated (unpublished data, Thomas Gonatopoulos-Pournatzis), and as 
depicted in Figure 6.2, the amino acid sequence of RAM is well conserved from 
mice to humans, and so is the Serine-36 residue. In order to address if the 
phosphorylation of RAM at S36 is involved in the process of RAM degradation, 
the levels of this modification following in vitro neural differentiation were 
investigated using a phospho-specific antibody. Cells were seeded into N2B27 
differentiation medium and samples collected every day (Figure 6.3). Western 
blot analysis clearly revealed that concomitant to the expected decrease in 
RAM levels, RAM phospho-S36 signal increased and remained highly 
expressed until day 9. The RNMT levels did not change and Oct4 expression 
was diminished as expected. Combining these observations so far, it can be 
hypothesised that during in vitro neural differentiation RAM is phosphorylated 
and then degraded. 
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Figure 6.2: Amino acid sequence alignment of the Homo sapiens RAM protein 
and homologs in Mus musculus, Monodelphis domestica, Ornithorhynchus 
anatinus, Tangara guttata, and Xenopus tropicalis.I ClustalW2 Multiple Alignment 
software was used for the alignment, selecting the default parameters. Amino acids 
identical in H. sapiens RAM protein and at least another species are highlighted in grey, 
and those identical in all species investigated are indicated (*). 
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As seen previously, RAM is expressed at low levels in MEFs compared to 
mESCs and mouse iPSCs (Figure 3.9). In order to investigate whether the 
phosphorylation of RAM coincides with its reduced expression also in MEFs, 
Western blot analysis was performed in mESCs, MEFs and mouse iPSCs 
(Figure 6.3b). In agreement with the previous data, the RAM phospho-S36 
levels were higher in MEFs compared to mESCs and in mouse iPSCs, whereby 
the RAM phospho-S36 was undetectable. This evidence further supports the 
hypothesis that low levels of RAM are associated with its degradation via the 
phosphorylation at residue Serine-36.  
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Figure 6.3: RAM is phosphorylated on Serine-36 during in vitro 
neural differentiation and in MEFs. 
(a) Cells were seeded into a 10 cm dish pre-coated with 0.1% gelatin in 
N2B27 media for 9 days. Media was changed every second day, 
samples were collected at 24 hr intervals and analysed by Western blot 
with the antibodies against the indicated proteins. Actin serves as 
loading control. (b) Cell extracts from mESCs and MEFs and mouse 
iPSCs were analysed by Western blot to detect RAM phospho-S36. 
Actin serves as loading control. The above data are representative of 
three biological replicates. 
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6.2.3 RAM is regulated by Oct4. 
In addition to this, the hypothesis that pluripotency factors could be involved in 
the regulation of RAM was also explored. Oct4 and Nanog expression was 
knocked down in mESCs by siRNA transfection (Figure 6.4). Briefly, cells were 
treated with pool of three siRNAs against Oct4, Nanog or a non-targeting 
control siRNA for 72 hr, following which samples were analysed by Western 
blot. Excitingly, treatment with Oct4 siRNA caused impairment in RAM 
expression levels whereas treatment with Nanog siRNA did not. It must be 
noted that impairment in Oct4 levels also led to a decrease in Nanog 
expression, thus the reduction in RAM levels could be a consequence of the 
depletion in levels of either of these two crucial pluripotency factors. However, 
Oct4 seems the more likely candidate. Sox2 and Klf4 also need to be tested in 
order to fully evaluate which member of the core pluripotency network 
influences the expression of RAM protein. 
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Figure 6.4: RAM expression is regulated by Oct4. 
Western blot analysis performed on extracts from 
mESCs transfected with siRNA pools against Oct4, 
Nanog or non-targeting siRNA (siCt) for 72 hr with the 
antibodies against indicate proteins. Actin serves as 
loading control.  
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6.3  Discussion 
 
This chapter aimed to elucidate the mechanisms regulating the expression of 
RAM in mESCs. Thomas Gonatopoulos-Pournatzis, former PhD student in our 
laboratory, found that in human cell lines, RNMT and RAM stabilise each other 
from proteosomal degradation. Contrary to this, the data presented here have 
shown that in mESCs undergoing in vitro neural differentiation, RAM is 
degraded by proteosomal activity while RNMT is not. These observations 
highlight how in stem cells, differently from the other cell lines previously 
analysed, RNMT and RAM are independently and differently regulated. 
 
RAM was identified by mass spectrometry and the phosphorylation of Serine-36 
was the only post translation modification detected. Other phosphoproteomics 
studies have further validated the phosphorylation at this residue (Goswami et 
al., 2012; Wilson-Grady et al., 2013). A specific RAM phosho-S36 antibody was 
raised by the DSTT (Division of Signal Transduction Therapy) service at the 
University of Dundee, the specificity of which was confirmed by Thomas 
Gonatopoulos-Pournatzis. Immunoprecipitation and orthophosphate labelling 
studies were carried out with cells expressing GFP, RAM-GFP and RAM-GFP 
S36A, where the latter has the Serine-36 residue mutated to Alanine and thus 
cannot longer be phosphorylated. Results showed that the RAM phospho-S36 
antibody recognised only the wild type RAM and not the phospho null-mutant. 
The orthophosphate labelling revealed that RAM wild type was phosphorylated, 
whereas RAM S36A was not (data not shown). All together these data 
confirmed the presence of this post-translational modification and validated the 
tool to further investigate its role.  
175 
 
Data reported in this chapter showed that cells expressing low level of total 
RAM, such as MEFs and in vitro differentiated neural cells, show high levels of 
S36 phosphorylation on the remaining RAM molecules. Considering that the 
RAM antibody was raised against the full length RAM, these data strongly 
suggest that while the expression of total RAM decreases, the level of RAM 
phosphorylated at residue Serine-36 increases. In fact, the total RAM levels can 
be rescued by treatment with the proteosomal inhibitor MG132. These findings 
indicate that RAM is degraded via proteosomal degradation and the process is 
very likely triggered by its phosphorylation at Serine-36. It has already been 
described that phosphorylation can prime proteins for ubiquitination (Hunter, 
2007). In order to investigate whether RAM is ubiquitinated, two cell lines were 
made expressing FG-RAM and phospho-null FG-RAM S36A. Experiments 
performed by Olga Suska revealed that wild-type RAM is modified by the 
addition of ubiquitin chains, whereas RAM S36A was not (data not shown). 
Therefore, our data combined together strongly support the idea that the 
phosphorylation at residue S36 is required to mediate RAM degradation via the 
ubiquitin-proteasome system (UPS).  
 
Experiments performed by Dr. Dhaval Varshney in the lab have indicated that 
the phospho-null mutant RAM S36A or the phospho-mimic mutants RAM 
S36D/E do not impair its ability to enhance the methyltransferase activity of 
RNMT in vitro. These data need to be confirmed in vivo, however the recently 
resolved crystal structure of the RNMT-RAM complex and extensive 
mutagenesis of RAM have suggested that alterations in single residues are 
unlikely to dramatically impair its function (unpublished data, Dhaval Varshney).  
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The final data presented shed the light on the possibility of Oct4 being involved 
in the regulation of RAM expression. It is well established that Oct4 expression 
within a certain range is critical for stem-cell renewal, with any increase or 
decrease triggering differentiation to endoderm/mesoderm or trophectoderm, 
respectively (Niwa et al., 2000). In line with this observation, within one day of 
treatment with Oct4 siRNA, cells started to look different as they assumed a 
different morphology, indicating initiation of differentiation (data not shown). This 
strongly supports the finding that RAM is down-regulated when differentiation is 
triggered either during in vitro neural differentiation or due to loss of Oct4. 
However, the precise involvement of Oct4 in regulation of RAM expression still 
needs to be clarified.  
177 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 Final discussion and future work 
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7.1  Final discussion  
7.1.1 RNMT and RAM in mESCs 
The addition of the methylguanosine cap at the 5’ end of pre-mRNA is a critical 
event for the eukaryotic mRNA life cycle and consequently for cell viability (Chu 
& Shatkin, 2008; Mao et al., 1995; Tsukamoto et al., 1997). The co-
transcriptional addition of the methyl cap is achieved by sequential activity of 
two enzymes, the latter of which, RNMT and its coactivating subunit RAM, 
methylates the cap in position N7. Increasing evidence has pointed out that the 
methylation of the cap, despite being so crucial for mRNA metabolism, is not a 
constitutive process but similarly to other steps within the gene expression, is 
subjected to regulation (Cole & Cowling, 2009; Cowling & Cole, 2007; Jiao et 
al., 2013). A peculiar gene expression program allows stem cells to self-renew 
and thereby maintains their pluripotency (Smith, 2001). The core pluripotency 
network lies at the top of the transcriptional regulatory hierarchy that activates 
genes required to maintain pluripotency meanwhile repressing lineage-specific 
genes (Young, 2011). Considering how critical the methyl cap synthesis is for 
gene expression, we decided to investigate whether the synthesis of the methyl 
cap plays a role in the maintenance of pluripotency. 
 
The data presented in this thesis show that RNMT and RAM are highly 
expressed in mouse embryonic stem cells compared to differentiated cells. In 
addition to this, the expression of these two proteins is differentially regulated 
during development and differentiation as observed by their differential 
stoichiometry in various mouse organs. 
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As previously shown for TFIID and the RBP SON, when a protein is highly 
expressed in ESCs, it may likely be involved in the maintenance of pluripotency 
(Lu et al., 2013; Pijnappel et al., 2013). The evidence presented here also finds 
this to be the case for RNMT and RAM. In fact, the generation of iPS from 
MEFs restored the two proteins to high levels found in ESCs, indicating that the 
high RNMT and RAM expression is a feature of pluripotent stem cells. 
 
Gel filtration and immunoprecipitation analyses revealed that in mESCs not all 
RNMT may be bound to RAM and the methyltransferase activity assay showed 
that elevated levels of RNMT and RAM result in a higher enzymatic activity in 
mESCs compared to MEFs. Considering that the brain exhibited high RNMT to 
RAM ratio, the regulation mechanism of the two proteins within the neural 
differentiation process was investigated. Following in vitro neural differentiation, 
RNMT clearly remained steadily expressed whereas RAM protein, but not 
transcript, levels were found to be gradually reduced. When RAM was 
discovered, it was described as an obligate component for the activity of the 
mammalian cap methyltransferase, whereby it binds, stabilises and increases 
RNMT activity both in vitro and in vivo (Gonatopoulos-Pournatzis et al., 2011). 
However, the exact mechanism by which RAM functions and its regulation 
remains unresolved. Therefore, data collected so far strongly encourage the 
investigation of how the RNMT and RAM complex functions in stem cells and 
why its components are differentially regulated. 
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7.1.2 RAM contribution to pluripotency 
In order to address the role of RNMT and RAM complex in stem cells, gain or 
loss of function studies were performed. These revealed that RAM expression is 
integral to the control of the highly interconnected transcriptional network 
required for ESC pluripotency. Specifically high expression of RAM is required 
to maintain pluripotency as alterations in RAM levels directly affect important 
pluripotency factors. The important role of RAM is due to its ability to bind RNA. 
In fact, the central domain of RAM is characteristic of proteins with RNA binding 
activity (Bayer et al., 2005) and consistently to this, in our laboratory, it was 
shown that RAM was able to bind RNA in vitro whereas RNMT, despite 
possessing the catalytic domain to methylate the cap, did not (Gonatopoulos-
Pournatzis et al., 2011). Based on methylguanosine cap immunoprecipitation 
and polysome profiling following RAM depletion, whereby the first technique 
measures the amount of methyl capped mRNA of a given transcript and the 
second gives an indication of its relative translation, a substantial reduction in 
the methylated capped RNA and consequently protein levels of Oct4, Sox2 and 
Klf4 was observed. A minor degree of impairment was described Nanog. 
Parallel studies were performed with mESCs exogenously expressing RAM 
throughout neural differentiation. During the in vitro neural differentiation, 
concomitant to RAM being stably expressed, also Oct4 and Sox2 protein levels 
were unexpectedly maintained. These data together highlight RAM effect mainly 
on Oct4 and Sox2 protein expression. 
 
This finding adds another piece to the complex puzzle of transcriptional and 
translational regulation in stem cells. It has been published that ESCs have a 
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low-levels of global transcription, expressing regions of the genome that are 
normally silenced in differentiated cells (Efroni et al., 2008). As previously 
described, the core pluripotency factors can be found along with PRC2 at 
bivalent domains (Bernstein et al., 2006; Lee et al., 2006). Although originally 
thought to be silent, recent findings suggest that some of these polycomb-
repressed genes are in fact transcribed in ESCs (Brookes & Pombo, 2009). 
Nonetheless, the eventual fate of these transcripts is unclear because despite 
being capped (not clear whether methyl capped), they are not translated. It is 
possible that for some genetic loci, it may be energetically more convenient to 
recruit the whole transcriptional machinery to the transcription site and then 
regulate the fate of the transcripts (Pombo, personal communication). The data 
obtained in this study allow the speculation that transcripts required for 
pluripotency are recruited by RAM and presented to RNMT for the methylation 
of their cap, thus resulting in the final gene product being expressed. It can be 
hypothesised that transcripts from bivalent genes which should be repressed, 
are not recruited by RAM to RNMT, thus their cap structure is not methylated, 
and consequently targeted by decapping enzymes. This model will agree with 
the observed presence of decapping machineries that specifically degrade 
unmethylated capped transcripts (Jiao et al., 2013; Song et al., 2013). 
Moreover, the finding that undifferentiated embryonic cell transcription factor 1 
(Utf1) recruits DCp1, a component of the mRNA decapping machinery, to 
bivalent leaky promoters mediating the cytoplasmic degradation of their relative 
mRNAs (Jia et al., 2012), further supports this model. 
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The reduced transcriptional noise in differentiated cells (Efroni et al., 2008; 
Meshorer & Misteli, 2006) reduces the requirement for increased specificity of 
cap methylation, thus diminishing the requirement for elevated RAM expression. 
In order to confirm this hypothesis, m7G immunoprecipitation and polysome 
profiling need to be extended to other transcription factors of the pluripotency 
network as well as lineage specific genes. For what concerns translation in 
stem cells, two studies based on polysome and ribosome profiling revealed that 
stem cells are characterized by low translation levels with surfeit of free 
ribosomes. On the contrary, differentiation in embryoid bodies induces an 
anabolic switch that leads to increase their Golgi apparatus and rough 
endoplasmic reticulum coordinated with increase in the ratio Cytoplasm/Nucleus 
ratio and synthesis of ribosomal proteins (Ingolia et al., 2011; Sampath et al., 
2008). Consequently, EBs present higher engagement of polysome loaded onto 
mRNAs and thus protein synthesis. In line with our model, these evidences 
together sustain that in stem cells high levels of transcriptional noise are 
coupled to a parsimonious translation whereby the fate of specific transcripts is 
decided by targeted cap methylation.  
 
7.1.3 RAM-Oct4-Sox2 network 
Besides this, the findings that Oct4 and Sox2 are specifically sensitive to RAM 
expression levels are further supported by other studies where RNA binding 
proteins display preferential activity towards certain transcripts. For example, 
the Thoc5 subunit of the THO complex specifically mediates the export and 
expression of Nanog and Klf4, but not Oct4 (Wang et al., 2013). 
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Considering that Oct4 is a central pluripotency marker and its expression levels 
need to be within a certain threshold concentration (Niwa et al., 2000), it is 
plausible to think that different and several regulatory mechanisms collaborate 
to maintain its required expression levels. This study describes cap methylation 
as another important step through which the expression of pluripotency markers 
could be tightly and specifically regulated to maintain stem cells in a pluripotent 
state.  
 
The previous data explains how alterations in RAM levels leads mainly to 
perturbation in Oct4 and Sox2 protein levels. Considering that during the in vitro 
neural differentiation RAM levels are dramatically reduced, and so the Oct4 and 
Sox2 levels, and when RAM is exogenously expressed, Oct4 and Sox2 
expression is maintained throughout the differentiation process, it can be 
speculated that RAM reduction contributes to the differentiation process. On the 
other side, Oct4 depletion was shown to impair RAM expression, (current 
studies in the lab are showing that Sox2 has the same effect), therefore 
combining these evidence together seems that a RAM-Oct4-Sox2 are co-
dependent. However, all together these data make difficult to distinguish 
whether RAM downregulation is cause or consequence of the differentiation 
process. In order to discern between the two possibilities future experiments will 
deplete RAM to than perform the in vitro neural differentiation protocol to see 
whether and how the dynamic of the differentiation process is affected (Figure 
7.1).  
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Figure 7.1: Is RAM lost cause or consequence of 
differentiation? 
Specifically high expression of RAM is required to maintain 
pluripotency as alterations in RAM levels directly affect important 
pluripotency factors, particularly Oct4 and Sox2. Gain and loss of 
function studies revealed RAM and Oct4 and Sox2 ae co-
dependent. More work is needed to elucidate the interplay 
between RAM and the pluripotency factors. 
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A recent study has shown that the abundance of SAM is required for 
maintenance of pluripotency in mESCs and its levels are regulated by threonine 
metabolism. Therefore, when authors depleted threonine from the culture or 
impair the threonine dehydrogenase in mESCs, it leads to decreased SAM 
levels that causes a reduction in H3K4me3, which ultimately induced 
differentiation (Shyh-Chang et al., 2013). This observation has also been 
confirmed in hESCs and hiPSCs, whereby SAM was demonstrated to also be 
required for self-renewal (Shiraki et al., 2014). The scenario that emerges is that 
SAM is required in abundance in stem cells but it is highly used and therefore 
limiting. In fact, both works pointed out that reduction of SAM levels leads to 
decrease in histone methylation, however, in light of our findings, we can 
speculate that since SAM is limiting and highly competed for, high RAM levels 
will enable RNMT to recruit SAM more efficiently and consequently enable 
optimal cap methylation. 
 
Data presented here corroborate the increasing number of evidence that 
depicts the methylation of the cap as a more regulated modification than was 
originally thought (Cowling & Cole, 2010; Jiao et al., 2010). An important aspect 
of the research presented here is that part of the results obtained with mESCs 
have also been validated in hESCs. In fact, human embryonic stem cells and 
human iPS also exhibit high levels of RNMT and RAM, the latter of which is 
similarly lost during in vitro neural differentiation of hESCs. Therefore, our 
findings in mESCs represent a promising model for a better understanding of 
the regulation of pluripotency in hESCs, and can also be relevant for the 
generation of hiPSCs. The data previously discussed and presented here 
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emphasise the critical role of RNA and consequently RNA binding proteins in 
the maintenance of pluripotency. 
 
7.1.4 Regulation of RAM 
Data presented in chapter 6 has paved the way to further investigate the 
mechanism of regulation of RAM expression. As previously discussed, when 
stem cells differentiate, they down regulate RAM expression via proteasomal 
degradation targeted through phosphorylation at Serine-36 residue. Among the 
different degradation pathways, the 26 proteosome, which degrades 
ubiquitinated proteins to small peptides, is one of the most characterized. 
Ubiquitination consist in the covalent attachment of ubiquitin (Ub) to a substrate 
through an enzymatic cascade involving ubiquitin-activating (E1), ubiquitin-
conjugating (E2), and ubiquitin-ligating (E3) enzymes. Briefly the E3 ligase 
binds to both substrate and E2 to facilitate the ubiquitin transfer from E2 to the 
substrate (Deshaies & Joazeiro, 2009). Evidence collected over the last 
decades demonstrated a crosstalk between phosphorylation and ubiquitination 
(Hunter, 2007). In fact, phosphorylation can regulate ubiquitination in three main 
mechanisms: firstly directing regulating the activity of the E3 ligase responsible 
for Ub transfer. Secondly it can promote recognition by an E3 ligase generating 
a phosphodegron and thirdly, phosphorylation can regulate the subcellular 
localization of substrate/ligase interaction (Hunter, 2007). The hypothesis that 
RAM is ubiquitinated is currently being tested in the lab.  
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Moreover, preliminary experiments have suggested that RAM can be 
phosphorylated by ERK in vitro (unpublished data, Lize Wasmus). ERK is the 
final effector of the MAPK pathway and although recent findings support the 
opposite (Hamilton & Brickman, 2014), multiple evidence have revealed that 
ERK is required to sustain neurodifferentiation (Kunath et al., 2007; Stavridis et 
al., 2007). Thus, it is plausible to hypothesise that RAM is phosphorylated by 
ERK, and that this aids the ERK-mediated neurodifferentiation program. 
Therefore, future experiments will verify this possibility.  
 
7.2  Future work 
 
This PhD project offers a new prospective into the regulation of pluripotency in 
stem cells. However, from this study many new questions arise, which need to 
be addressed in order to have a clear picture regarding the contribution of 
mRNA cap methylation in the maintenance of stem cell pluripotency. 
1. CLIP analysis combined with RNA sequencing 
Our current hypothesis is that RAM functions as a sieve in stem cells to 
specifically recruit mRNAs expressing pluripotency factors to RNMT, 
which then methylates their cap. Therefore, it is important to understand 
how RAM is able to distinguish and recognise specific transcripts. 
Currently, Dr. Dhaval Varshney is optimizing a high throughput 
sequencing following cross-linking and immunoprecipitation (HITS-CLIP) 
protocol to identify specific sequences bound to the RNMT-RAM 
complex.  
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In the future, we will use this technique to analyse how the RNA binding 
profile for RNMT and RAM complex changes between mESCs and in 
vitro neural differentiated cells. This will enable a direct analysis of any 
specific targeting of cap methylation and its contribution to the 
pluripotency program. We would also like to evaluate the impact of the 
dramatic reduction in RAM expression levels on RNMT RNA-binding.  
 
2. Proteomic analysis following RAM depletion 
In order to have a broader view on the RAM-dependent proteome in 
stem cells, Olga Suska is currently performing proteomic studies 
following depletion of RAM with siRNA. 
 
3. Establishing the mechanism that regulates RAM expression in stem 
cells 
Data presented here shed the light on RAM being degraded via 
proteasomal degradation in a mechanism that requires the 
phosphorylation of RAM at Serine-36 residue. Further experiments will 
be focused on unrevealing how exactly the mechanism occurs. 
Moreover, preliminary studies have shown that Oct4 (maybe along with 
Nanog) impairs RAM expression. Consistently to the post-transcriptional 
regulation of RAM, published ChIP-seq datasets do not show Oct4 nor 
Nanog occupancy on the RAM promoter (Mathur et al., 2008; Chen et 
al., 2008), therefore possibly Oct4 will activate a kinase that in turn will 
phosphorylate RAM and thus label it for degradation. 
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Nevertheless, E2F1 has clearly been shown to occupy RAM promoter, 
whereas Myc, Esrrb, Klf4, n-Myc and Zfx have been detected at the 
RNMT promoter (Chen et al., 2008). E2F1 and c-Myc are part of the c-
Myc-centric module, which as previously mentioned, is typical of genes 
that are actively transcribed in stem cells (Chen et al., 2008). However, 
ChIP data showed that SIN3b, a cofactor of the RE1 silencing 
transcription factor (REST) occupies the RAM, but not the RNMT 
promoter (Yu et al., 2011). Therefore RNMT, which contains the catalytic 
subunit to methylate the cap, is constantly active whereas RAM can be 
activated or repressed. Thus, the possibility that also a transcriptional 
mechanism could contribute to the expression levels of RAM further 
emphasises the role of RAM as a critical component of the 
methyltransferase complex in stem cells. Future studies are required to 
validate this hypothesis. 
 
4. Exploring the role of RNMT and RAM in other organs 
Song and colleagues observed that Dcp2 (a decapping enzyme) was 
differentially expressed in mouse organs and showed that knockout of 
Dcp2 had no adverse consequences in mice. Taking these results into 
account, they suggested that Dcp2 could not be the sole decapping 
protein. Indeed they have identified another decapping enzyme called 
Nud16, which possibly works on different subset of mRNAs (Song et al., 
2010). Similarly, the differential stoichiometry of RNMT and RAM in 
different mouse organs supports the possibility that other interacting 
partners may be involved in the RNMT and RAM complex. This is further 
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support by our gel filtration and immuprecipitation data that clearly 
suggest that not all RNMT is bound to RAM and that the RNMT and RAM 
complex migrates higher than the expected molecular weight, indicating 
that other partners may take part in the complex. Another hypothesis is 
that once RAM is down regulated during in vitro neural differentiation, 
other RAM-like proteins may function in the opposite way and thus 
present lineage specific mRNAs to RNMT. Therefore, similarly to Song 
approach, RNMT and RAM KO mice will be generated to investigate 
whether other proteins take part in the methyltransferase complex. 
Moreover, based on the results obtained with different organs, it is likely 
that some organs will be more affected than others by RNMT and RAM 
KO. For example, the heart represents an extremely interesting case 
study since the RNMT and RAM pattern expression is exactly opposite to 
what has been described so far in neurons, whereby RNMT expression 
is reduced and RAM is present at elevated levels. Therefore, in the 
future, it will be also interesting to study the expression pattern of these 
proteins during mESCs differentiation into cardiomyocytes 
 
Since as previously mentioned, is not easy to discern whether loss of 
RAM is cause or consequence of differentiation, the KO mice will help to 
clarify the importance of the methyltransferase complex during 
development. In fact, only two main works have been performed during 
early development. The first was carried out in sea urchin 
Strongylocentrotus purpuratus and showed that N7 ribose methylation 
occurs following fertilization but prior to the two cell stage (Caldwell & 
Emerson, 1985).  
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Later studies on in vitro RNA injected in X. leavis, showed that the 
activity of cytoplasmic guanine-7-methyltransferase increases during 
oocyte maturation and stimulates translation of unmethylated cap. This 
process is promoted by progesterone and the increase in 
methyltransferase activity is concurrent with nuclear breakdown (Gillian-
Daniel et al., 1998).  
 
The model proposed in this work, further support the relation between 
methyl cap formation and protein translation that seems to be specifically 
regulated by RAM in embryonic stem cells. eIF4E and c-Myc are 
fundamental for translation. The former is the cap-binding initiation 
factors, required for efficient and correct translation (Topisirovic et al., 
2011). Whereas c-Myc is involved in numerous processes, amongst 
which it upregulates the methyl cap formation of its target genes 
(Cowling & Cole, 2010), which lead to cell proliferation. No data are 
available on eIF4E KO mice, possibly because they are not viable 
whereas Myc KO mice are lethal between day 9.5 or 10 (Davis et al., 
1993). Therefore, considering the intimately link between methyl cap 
moiety and translation, it will be extremely interesting to see how the KO 
RNMT and RAM mice behave. Possibly, more dramatic consequences 
could be observed in case of double KO of RNMT and RAM 
simultaneously. 
 
Overall, this pioneering work has revealed the regulation of mRNA cap 
methylation as an additional mechanism that contributes to maintain 
stem cell pluripotency (Figure 7.2).  
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Figure 7.2: Cap methylation of mRNAs adds a new step of regulation of the ESCs state. 
Additionally to other mechanisms previously described, cap methylation joins the long list of 
event that stem cells use to maintain the undifferentiated state. RAM functioning as sieve, 
present the mRNA of pluripotency factors to RNMT that will proceed with the methylation of 
their cap and thus promoting their expression. Depletion of RAM results in reduction of protein 
levels of the main transcription factors. 
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